Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Inflammatory Bowel Diseases

  Free Subscription


Articles published in J Crohns Colitis

Retrieve available abstracts of 773 articles:
HTML format



Single Articles


    June 2024
  1. NARULA N, Hamam H, Liu J, Wong ECL, et al
    Adaptive steroid tapering impedes corticosteroid-free remissions compared to forced tapering in clinical trials of ulcerative colitis.
    J Crohns Colitis. 2024 Jun 13:jjae092. doi: 10.1093.
    PubMed     Abstract available


  2. DANESE S, Dignass A, Matsuoka K, Ferrante M, et al
    Early and Sustained Symptom Control with Mirikizumab in Patients with Ulcerative Colitis in the Phase 3 LUCENT Program.
    J Crohns Colitis. 2024 Jun 13:jjae088. doi: 10.1093.
    PubMed     Abstract available


  3. SUAREZ RG, Guruprasad N, Tata G, Zhang Z, et al
    Serum Metabolites Relate to Mucosal and Transmural Inflammation in Pediatric Crohn Disease.
    J Crohns Colitis. 2024 Jun 6:jjae085. doi: 10.1093.
    PubMed     Abstract available


  4. TAMBURINI FB, Tripathi A, Gold MP, Yang JC, et al
    Gut microbial species and endotypes associate with remission in ulcerative colitis patients treated with anti-TNF or anti-integrin therapy.
    J Crohns Colitis. 2024 Jun 5:jjae084. doi: 10.1093.
    PubMed     Abstract available


  5. GHOSH S, Feagan BG, Parra RS, Lopes S, et al
    Impact of upadacitinib induction and maintenance therapy on health-related quality of life, fatigue, and work productivity in patients with moderately-to-severely active Crohn's disease.
    J Crohns Colitis. 2024 Jun 5:jjae083. doi: 10.1093.
    PubMed     Abstract available


  6. ZHU F, Chen X, Qiu X, Guo W, et al
    Seeing Beyond the Surface: Superior performance of Ultrasound elastography over Milan ultrasound criteria in distinguishing fibrosis of ulcerative colitis.
    J Crohns Colitis. 2024 Jun 3:jjae081. doi: 10.1093.
    PubMed     Abstract available


  7. OGATA N, Maeda Y, Misawa M, Takenaka K, et al
    Artificial intelligence-assisted video colonoscopy for disease monitoring of ulcerative colitis: A prospective study.
    J Crohns Colitis. 2024 Jun 3:jjae080. doi: 10.1093.
    PubMed     Abstract available


  8. REVES J, Torres J
    Real-world Positioning and Effectiveness of First- and Second-Line Biological Therapy in Inflammatory Bowel Diseases.
    J Crohns Colitis. 2024;18:787-789.
    PubMed    


  9. HASHIMOTO H, Takagi T, Asaeda K, Yasuda T, et al
    D-alanine Inhibits Murine Intestinal Inflammation by Suppressing IL-12 and IL-23 Production in Macrophages.
    J Crohns Colitis. 2024;18:908-919.
    PubMed     Abstract available


    May 2024
  10. WETWITTAYAKHLANG P, Lakatos PL
    Unravelling the Smoke Trail: Maternal Smoking, Childhood Exposure, and their Impact on Inflammatory Bowel Diseases.
    J Crohns Colitis. 2024;18:659-660.
    PubMed    


  11. ZAMAN S, Mohamedahmed AYY, Yassin NA
    Letter to the Editor - Minimally invasive surgery for Inflammatory Bowel Disease: a systematic review and meta-analysis of robotic versus laparoscopic surgical techniques.
    J Crohns Colitis. 2024 May 23:jjae065. doi: 10.1093.
    PubMed    


  12. RIMOLA J, Castro-Poceiro J, Sapena V, Aduna M, et al
    MRI features indicative of permanent colon damage in ulcerative colitis: an exploratory study.
    J Crohns Colitis. 2024 May 20:jjae075. doi: 10.1093.
    PubMed     Abstract available


  13. CHIRRA P, Sleiman J, Gandhi NS, Gordon IO, et al
    Radiomics to Detect Inflammation and Fibrosis on Magnetic Resonance Enterography in Stricturing Crohn's Disease.
    J Crohns Colitis. 2024 May 18:jjae073. doi: 10.1093.
    PubMed     Abstract available


  14. GIORDANO A, Rovira M, Veny M, Barastegui R, et al
    Cyclophosphamide-free mobilisation increases safety while preserving the efficacy of autologous haematopoietic stem cell transplantation in refractory Crohn's disease patients.
    J Crohns Colitis. 2024 May 17:jjae076. doi: 10.1093.
    PubMed     Abstract available


  15. THOMANN AK, Schmitgen MM, Stephan JC, Ebert MP, et al
    Associations between brain morphology, inflammatory markers and symptoms of fatigue, depression or anxiety in active and remitted Crohn's disease.
    J Crohns Colitis. 2024 May 17:jjae078. doi: 10.1093.
    PubMed     Abstract available


  16. KELLERMANN L, Hansen SL, Maciag G, Granau AM, et al
    Influence of vitamin D receptor signaling and vitamin D on colonic epithelial cell fate decisions in ulcerative colitis.
    J Crohns Colitis. 2024 May 15:jjae074. doi: 10.1093.
    PubMed     Abstract available


  17. MONFORT-FERRE D, Boronat-Toscano A, Sanchez-Herrero JF, Caro A, et al
    Genome-wide DNA methylome and transcriptome profiling reveals key genes involved in the dysregulation of adipose-stem cells in Crohn's disease.
    J Crohns Colitis. 2024 May 15:jjae072. doi: 10.1093.
    PubMed     Abstract available


  18. FUMERY M, Serrero M, Bouguen G, Amiot A, et al
    Real-world comparison of the effectiveness between ustekinumab and vedolizumab in patients with ulcerative colitis exposed to at least one anti-TNF agent.
    J Crohns Colitis. 2024 May 14:jjae063. doi: 10.1093.
    PubMed     Abstract available


  19. POULSEN A, Rasmussen J, Wewer MD, Holm Hansen E, et al
    Re-resection Rates and Disease Recurrence in Crohn's Disease - A Population-Based Study Using Individual-Level Patient Data.
    J Crohns Colitis. 2024 May 10:jjae070. doi: 10.1093.
    PubMed     Abstract available


  20. UKASHI O, Lahat A, Ungar B, Levy H, et al
    Pan-enteric Crohn's capsule (Eliakim) score reliability and responsiveness to change in active Crohn's disease.
    J Crohns Colitis. 2024 May 9:jjae068. doi: 10.1093.
    PubMed     Abstract available


  21. LEIBOVITZH H, Sarbagili Shabat C, Hirsch A, Zittan E, et al
    Fecal transplantation for ulcerative colitis from diet conditioned donors followed by dietary intervention results in favorable gut microbial profile compared to fecal transplantation alone.
    J Crohns Colitis. 2024 May 9:jjae062. doi: 10.1093.
    PubMed     Abstract available


  22. MUNIZ PEDROGO DA, Sears CL, Melia JMP
    Colorectal cancer in inflammatory bowel disease: a review of the role of gut microbiota and bacterial biofilms in disease pathogenesis.
    J Crohns Colitis. 2024 May 4:jjae061. doi: 10.1093.
    PubMed     Abstract available


  23. TAVARES DE SOUSA H, Ferreira M, Gullo I, Rocha AM, et al
    Fibrosis-related transcriptome unveils a distinctive remodeling matrix pattern in penetrating ileal Crohn's disease.
    J Crohns Colitis. 2024 May 3:jjae064. doi: 10.1093.
    PubMed     Abstract available


  24. REGUEIRO M, Siegmund B, Yarur AJ, Steinwurz F, et al
    Etrasimod for the Treatment of Ulcerative Colitis: Analysis of Infection Events From the ELEVATE UC Clinical Program.
    J Crohns Colitis. 2024 May 3:jjae060. doi: 10.1093.
    PubMed     Abstract available


    April 2024
  25. CHETWOOD JD, Tran Y, Subramanian S, Smith PJ, et al
    Intravenous Versus Subcutaneous Infliximab in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    J Crohns Colitis. 2024 Apr 24:jjae059. doi: 10.1093.
    PubMed     Abstract available


  26. VIEUJEAN S, Lindsay JO, D'Amico F, Ahuja V, et al
    Analysis of Clinical Trial Screen Failures in Inflammatory Bowel Diseases [IBD]: Real World Results from the International Organization for the study of IBD.
    J Crohns Colitis. 2024;18:548-559.
    PubMed     Abstract available


  27. HINDMARCH DC, Malashanka S, Shows DM, Clarke AS, et al
    Janus Kinase Inhibitors Differentially Inhibit Specific Cytokine Signals in the Mesenteric Lymph Node Cells of Inflammatory Bowel Disease Patients.
    J Crohns Colitis. 2024;18:628-637.
    PubMed     Abstract available


  28. OLLECH JE, Yanai H
    Navigating Postoperative Management in Crohn's Disease: Insights from the PORCSE Study.
    J Crohns Colitis. 2024 Apr 20:jjae054. doi: 10.1093.
    PubMed    


  29. SCHROEDER MK, Abushamma S, George AT, Ravella B, et al
    TOpCLASS Expert Consensus Classification of Perianal Fistulizing Crohn's Disease: A Real-World Application in a Serial Fistula MRI Cohort.
    J Crohns Colitis. 2024 Apr 20:jjae056. doi: 10.1093.
    PubMed     Abstract available


  30. BURTON-MURRAY H, Kiser K, Gurung J, Williams K, et al
    Avoidant/restrictive food intake disorder symptoms are not as frequent as other eating disorder symptoms when ulcerative colitis is in remission.
    J Crohns Colitis. 2024 Apr 18:jjae052. doi: 10.1093.
    PubMed     Abstract available


  31. BROWN M, Dodd A, Shi F, Greenwood E, et al
    Concordant B and T Cell Heterogeneity Inferred from the Multiomic Landscape of Peripheral Blood Mononuclear Cells in a Crohn's Disease Cohort.
    J Crohns Colitis. 2024 Apr 13:jjae055. doi: 10.1093.
    PubMed     Abstract available


  32. PETIT P, Leroyer A, Chamot S, Fumery M, et al
    Farming activities and risk of inflammatory bowel disease: a French nationwide population-based cohort study.
    J Crohns Colitis. 2024 Apr 12:jjae050. doi: 10.1093.
    PubMed     Abstract available


  33. MOHAMEDRASHED M, Garg M, Bohra A
    Advocating for Consensus: The crucial role of standardised Magnetic resonance imaging (MRE) protocols and image quality metrics in assessment of Crohn's disease.
    J Crohns Colitis. 2024 Apr 12:jjae051. doi: 10.1093.
    PubMed    


  34. TIONG HT, Fan D, Frampton C, Ananthakrishnan AN, et al
    Physical Activity Is Associated With A Decreased Risk Of Developing Inflammatory Bowel Disease: A Systematic Review And Meta-Analysis.
    J Crohns Colitis. 2024 Apr 10:jjae053. doi: 10.1093.
    PubMed     Abstract available


  35. ZADORA W, Innocenti T, Verstockt B, Meijers B, et al
    Chronic kidney disease in inflammatory bowel disease, a systematic review and meta-analysis.
    J Crohns Colitis. 2024 Apr 8:jjae049. doi: 10.1093.
    PubMed     Abstract available


  36. MERTZ NORGARD B, Garvik OS, Zegers FD, Nielsen J, et al
    New surgery and hospital-diagnosed infections in elderly patients with inflammatory bowel disease undergoing surgery - a nationwide cohort study.
    J Crohns Colitis. 2024 Apr 5:jjae047. doi: 10.1093.
    PubMed     Abstract available


  37. VAN LINGEN E, Nooij S, Terveer E, Crossette E, et al
    Fecal Microbiota Transplantation engraftment after budesonide or placebo in patients with active ulcerative colitis using pre-selected donors: a randomized pilot study.
    J Crohns Colitis. 2024 Apr 4:jjae043. doi: 10.1093.
    PubMed     Abstract available


    March 2024
  38. KUMAR S, De Kock I, Blad W, Hare R, et al
    Magnetic resonance enterography and intestinal ultrasound for the assessment and monitoring of Crohn's disease.
    J Crohns Colitis. 2024 Mar 30:jjae042. doi: 10.1093.
    PubMed     Abstract available


  39. VAN DEN HOUTE M, Guadagnoli L, Ohman L, Bergstedt A, et al
    Predictors of symptom trajectory in newly diagnosed ulcerative colitis: a 3-year follow-up cohort study.
    J Crohns Colitis. 2024 Mar 29:jjae046. doi: 10.1093.
    PubMed     Abstract available


  40. CUNHA MF, Roseira J
    Letter to the Editor regarding the article Minimally invasive surgery for Inflammatory Bowel Disease: a systematic review and meta-analysis of robotic versus laparoscopic surgical techniques.
    J Crohns Colitis. 2024 Mar 28:jjae045. doi: 10.1093.
    PubMed    


  41. SCIBERRAS M, Farrugia Y, Gordon H, Furfaro F, et al
    Accuracy of Information given by ChatGPT for patients with Inflammatory Bowel Disease in relation to ECCO Guidelines.
    J Crohns Colitis. 2024 Mar 23:jjae040. doi: 10.1093.
    PubMed     Abstract available


  42. SHRESTHA S, Brand JS, Osooli M, Eriksson C, et al
    Spondyloarthritis in first-degree relatives and spouses of patients with inflammatory bowel disease: A nationwide population-based cohort study from Sweden.
    J Crohns Colitis. 2024 Mar 22:jjae041. doi: 10.1093.
    PubMed     Abstract available



  43. Corrigendum to: Influence of Early Life Factors, including breast milk Composition, on the Microbiome of Infants Born to Mothers with and without Inflammatory Bowel Disease.
    J Crohns Colitis. 2024 Mar 20:jjae021. doi: 10.1093.
    PubMed    


  44. VAN GENNEP S, Fung ICN, de Jong DC, Ramkisoen RK, et al
    Histological Outcomes And Jak-Stat Signalling In Ulcerative Colitis Patients Treated With Tofacitinib.
    J Crohns Colitis. 2024 Mar 20:jjae031. doi: 10.1093.
    PubMed     Abstract available


  45. CON D, Hilley P, Chin S, Corte C, et al
    Safety and effectiveness of Janus kinase inhibitors in the management of inflammatory bowel disease following liver transplantation.
    J Crohns Colitis. 2024 Mar 19:jjae039. doi: 10.1093.
    PubMed     Abstract available


  46. FUNG M, Farbod Y, Kankouni H, Singh S, et al
    Does combined medical and surgical treatment improve perianal fistula outcomes in patients with Crohn's disease? A systematic review and meta-analysis.
    J Crohns Colitis. 2024 Mar 16:jjae035. doi: 10.1093.
    PubMed     Abstract available


  47. GENG Z, Li J, Zuo L, Zhang X, et al
    Intestinal adipocytes transdifferentiate into myofibroblast-like cells and contribute to fibrosis in Crohn's disease.
    J Crohns Colitis. 2024 Mar 11:jjae036. doi: 10.1093.
    PubMed     Abstract available


  48. ZAMAN S, Mohamedahmed AYY, Abdelrahman W, Abdalla HE, et al
    Minimally invasive surgery for Inflammatory Bowel Disease: a systematic review and meta-analysis of robotic versus laparoscopic surgical techniques.
    J Crohns Colitis. 2024 Mar 11:jjae037. doi: 10.1093.
    PubMed     Abstract available


  49. LEHMANN M, Weixler B, Elezkurtaj S, Loddenkemper C, et al
    Spatial single cell profiling using imaging mass cytometry - inflammatory versus penetrating Crohn's disease.
    J Crohns Colitis. 2024 Mar 11:jjae033. doi: 10.1093.
    PubMed     Abstract available


  50. ELLRICHMANN M, Schulte B, Conrad CC, Schoch S, et al
    Contrast enhanced endoscopic ultrasound detects early therapy response following anti-TNF-therapy in patients with ulcerative colitis.
    J Crohns Colitis. 2024 Mar 8:jjae034. doi: 10.1093.
    PubMed     Abstract available


  51. TEUGELS A, van den Eijnden I, Keersmaekers B, Verstockt B, et al
    Disease acceptance, but not perceived control, is uniquely associated with inflammatory bowel disease-related disability.
    J Crohns Colitis. 2024 Mar 6:jjae025. doi: 10.1093.
    PubMed     Abstract available


  52. BIEL C, Faber KN, Bank RA, Olinga P, et al
    Matrix metalloproteinases in intestinal fibrosis.
    J Crohns Colitis. 2024;18:462-478.
    PubMed     Abstract available


  53. WARSOP ZI, Manzo CA, Yu N, Yusuf B, et al
    Patient-reported Outcome Measures in Ileoanal Pouch Surgery: a Systematic Review.
    J Crohns Colitis. 2024;18:479-487.
    PubMed     Abstract available


  54. JOJART B, Resal T, Kata D, Molnar T, et al
    Plasminogen Activator Inhibitor 1 Is a Novel Faecal Biomarker for Monitoring Disease Activity and Therapeutic Response in Inflammatory Bowel Diseases.
    J Crohns Colitis. 2024;18:392-405.
    PubMed     Abstract available


  55. WEBER S, Sitte S, Voegele AL, Sologub L, et al
    NLRP3 Inhibition Leads to Impaired Mucosal Fibroblast Function in Patients with Inflammatory Bowel Diseases.
    J Crohns Colitis. 2024;18:446-461.
    PubMed     Abstract available


    February 2024
  56. ROSH JR, Turner D, Hyams JS, Dubinsky M, et al
    Outcomes in Adult Inflammatory Bowel Disease Clinical Trials: Assessment of Similarity Among Participants with Adolescent-Onset and Adult-Onset Disease.
    J Crohns Colitis. 2024 Feb 26:jjae030. doi: 10.1093.
    PubMed     Abstract available


  57. TORRES J, Colombel JF, Mary JY
    Lemman Index in Children: Still an Open Question.
    J Crohns Colitis. 2024;18:331-332.
    PubMed    


  58. GEBEYEHU GG, Taylor F, Dobson L, Cummings JRF, et al
    Validation of the IBD-Control Questionnaire across different sociodemographic and clinical subgroups: secondary analysis of a nationwide electronic survey.
    J Crohns Colitis. 2024;18:275-285.
    PubMed     Abstract available


  59. GRANT RK, Jones GR, Plevris N, Lynch RW, et al
    Validation of the ACE [Albumin, CRP, and Endoscopy] Index in Acute Colitis: Analysis of the CONSTRUCT dataset.
    J Crohns Colitis. 2024;18:286-290.
    PubMed     Abstract available


  60. DHALIWAL J, Tertigas D, Carman N, Lawrence S, et al
    Outcomes Following Acute Severe Colitis at Initial Presentation: A Multi-centre, Prospective, Paediatric Cohort Study.
    J Crohns Colitis. 2024;18:233-245.
    PubMed     Abstract available


  61. LO B, Biederman L, Rogler G, Dora B, et al
    Specific antibiotics increases the risk of flare-ups in patients with inflammatory bowel disease - results from a Danish nationwide population-based nested case-control study.
    J Crohns Colitis. 2024 Feb 17:jjae027. doi: 10.1093.
    PubMed     Abstract available


  62. ARJOMAND FARD N, Wine E
    Clostridium perfringens: A Potential Pathobiont in Inflammatory Bowel Disease.
    J Crohns Colitis. 2024 Feb 16:jjae019. doi: 10.1093.
    PubMed    


  63. KOELINK PJ, Gomez-Mellado VE, Duijst S, van Roest M, et al
    The phospholipid flippase ATP8B1 is involved in the pathogenesis of Ulcerative Colitis via establishment of intestinal barrier function.
    J Crohns Colitis. 2024 Feb 16:jjae024. doi: 10.1093.
    PubMed     Abstract available


  64. REINISCH W, Colombel JF, D'Haens GR, Rimola J, et al
    Efficacy and Safety of Filgotinib for the Treatment of Perianal Fistulizing Crohn's Disease [DIVERGENCE 2]: a Phase 2, Randomized, Placebo-Controlled Trial.
    J Crohns Colitis. 2024 Feb 16:jjae003. doi: 10.1093.
    PubMed     Abstract available


  65. PRENTICE R, Flanagan E, Wright E, Prideaux L, et al
    Thiopurine metabolite shunting in late pregnancy increases the risk of intrahepatic cholestasis of pregnancy in women with inflammatory bowel disease, and can be managed with split-dosing.
    J Crohns Colitis. 2024 Feb 15:jjae023. doi: 10.1093.
    PubMed     Abstract available


  66. VLADIMIROVA N, Terslev L, Attauabi M, Madsen G, et al
    Peripheral joint and enthesis involvement in patients with newly diagnosed inflammatory bowel disease: symptoms, clinical and ultrasound findings - a population-based cohort study.
    J Crohns Colitis. 2024 Feb 15:jjae022. doi: 10.1093.
    PubMed     Abstract available


  67. SIGVARDSSON I, Ludvigsson J, Andersson B, Stordal K, et al
    Tobacco smoke exposure in early childhood and later risk of inflammatory bowel disease: A Scandinavian birth cohort study.
    J Crohns Colitis. 2024 Feb 8:jjae020. doi: 10.1093.
    PubMed     Abstract available


  68. GHOSH S, Feagan BG, Ott E, Gasink C, et al
    Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis Through 5 Years in Crohn's Disease and 4 Years in Ulcerative Colitis.
    J Crohns Colitis. 2024 Feb 4:jjae013. doi: 10.1093.
    PubMed     Abstract available


    January 2024
  69. KUO J, Uzunovic J, Jacobson A, Dourado M, et al
    Toxigenic Clostridium perfringens isolated from at-risk pediatric inflammatory bowel disease patients.
    J Crohns Colitis. 2024 Jan 24:jjae016. doi: 10.1093.
    PubMed     Abstract available


  70. DUAN M, Lu M, Diao Y, Cao L, et al
    Azathioprine plus exclusive enteral nutrition versus azathioprine monotherapy for the prevention of postoperative recurrence in patients with Crohn's disease: an open-label, single-centre, randomised controlled trial.
    J Crohns Colitis. 2024 Jan 22:jjae015. doi: 10.1093.
    PubMed     Abstract available


  71. YARUR AJ, Chiorean MV, Panes J, Jairath V, et al
    Achievement of clinical, endoscopic, and histologic outcomes in patients with ulcerative colitis treated with etrasimod, and association with fecal calprotectin and C-reactive protein: results from the Phase 2 OASIS trial.
    J Crohns Colitis. 2024 Jan 20:jjae007. doi: 10.1093.
    PubMed     Abstract available


  72. MAGRO F, Fernandes S, Patita M, Arroja B, et al
    The influence of subclinical active inflammation on IFX pharmacokinetic modeling and disease progression assessment: findings from a prospective real-world study in inflammatory bowel disease patients.
    J Crohns Colitis. 2024 Jan 19:jjae014. doi: 10.1093.
    PubMed     Abstract available



  73. Erratum to: Ustekinumab as Induction and Maintenance Therapy in Patients with Inflammatory Bowel Disease and Type II Autoimmune Pancreatitis: Report of Two Cases.
    J Crohns Colitis. 2024 Jan 19:jjae005. doi: 10.1093.
    PubMed    


  74. BITTERLIN T, Valibouze C, Lenne X, Bruandet A, et al
    Hospital surgical volume-outcome relationship of postoperative morbidity for ileocolic resection in Crohn's disease: A French nationwide study of 4,205 patients.
    J Crohns Colitis. 2024 Jan 18:jjae010. doi: 10.1093.
    PubMed     Abstract available


  75. CHULKINA M, Rohmer C, McAninch S, Panganiban RP, et al
    Increased activity of MAPKAPK2 within mesenchymal cells as a target for inflammation associated fibrosis in Crohn's Disease.
    J Crohns Colitis. 2024 Jan 15:jjae009. doi: 10.1093.
    PubMed     Abstract available


  76. DESAI A, Hashash JG, Kochhar GS, Hayney MS, et al
    Recombinant Zoster Vaccine (RZV) is Effective in Patients with Inflammatory Bowel Disease: A US Propensity Matched Cohort Study.
    J Crohns Colitis. 2024 Jan 15:jjae008. doi: 10.1093.
    PubMed     Abstract available


  77. RODRIGUEZ-ALCOLADO L, Grueso-Navarro E, Arias A, Lucendo AJ, et al
    Impact of HLA-DQA1 *05 Genotype in Immunogenicity and Failure to Treatment with Tumor Necrosis Factor-alpha Antagonists in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    J Crohns Colitis. 2024 Jan 14:jjae006. doi: 10.1093.
    PubMed     Abstract available


  78. WONG C, van Oostrom J, Pittet V, Bossuyt P, et al
    Baseline Data and Measurement Instruments Reported In Observational Studies In Inflammatory Bowel Disease: Results From A Systematic Review.
    J Crohns Colitis. 2024 Jan 12:jjae004. doi: 10.1093.
    PubMed     Abstract available


  79. TIMAR AE, Parniczky A, Budai KA, Hernadfoi MV, et al
    Beyond the Gut: A Systematic Review and Meta-analysis of Advanced Therapies for Inflammatory Bowel Disease-associated Extraintestinal Manifestations.
    J Crohns Colitis. 2024 Jan 8:jjae002. doi: 10.1093.
    PubMed     Abstract available


  80. PRUIJT MJ, de Voogd FAE, Montazeri NSM, van Etten-Jamaludin FS, et al
    DIAGNOSTIC ACCURACY OF INTESTINAL ULTRASOUND IN THE DETECTION OF INTRA-ABDOMINAL COMPLICATIONS IN CROHN'S DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS.
    J Crohns Colitis. 2024 Jan 4:jjad215. doi: 10.1093.
    PubMed     Abstract available


    December 2023
  81. TAL N, Tzivinikos C, Gasparetto M, Serban DE, et al
    Clinical Features and Natural History of Paediatric Patients with Ulcerative Proctitis: A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN.
    J Crohns Colitis. 2023;17:1939-1948.
    PubMed     Abstract available


  82. HASSAN-ZAHRAEE M, Ye Z, Xi L, Dushin E, et al
    Baseline serum and stool microbiome biomarkers predict clinical efficacy and tissue molecular response after ritlecitinib induction therapy in ulcerative colitis.
    J Crohns Colitis. 2023 Dec 23:jjad213. doi: 10.1093.
    PubMed     Abstract available


  83. DOLINGER MT, Aronskyy I, Kellar A, Spencer E, et al
    Early Intestinal Ultrasound Response to Biologic Therapy Predicts Endoscopic Remission in Children with Ileal Crohn's Disease: Results from the Prospective Super Sonic Study.
    J Crohns Colitis. 2023 Dec 23:jjad216. doi: 10.1093.
    PubMed     Abstract available



  84. Correction to: Female and Male Fertility after Colectomy and Reconstructive Surgery in Inflammatory Bowel Disease: A National Cohort Study from Sweden.
    J Crohns Colitis. 2023 Dec 23:jjad210. doi: 10.1093.
    PubMed    


  85. VUYYURU SK, Solitano V, Singh S, Hanzel J, et al
    Scoring indices for perianal fistulizing Crohn's disease: A systematic review.
    J Crohns Colitis. 2023 Dec 21:jjad214. doi: 10.1093.
    PubMed     Abstract available


  86. HAMMOUDI N, Sachar D, D'Haens G, Reinisch W, et al
    Outcomes and endpoints of postoperative recurrence in Crohn's Disease: systematic review and consensus conference.
    J Crohns Colitis. 2023 Dec 19:jjad205. doi: 10.1093.
    PubMed     Abstract available


  87. NIEVA C, Pryor J, Williams GM, Hoedt EC, et al
    The Impact of Dietary Interventions on the Microbiota in Inflammatory Bowel Disease: A Systematic Review.
    J Crohns Colitis. 2023 Dec 15:jjad204. doi: 10.1093.
    PubMed     Abstract available


  88. VERMEIRE S, Danese S, Sandborn WJ, Schreiber S, et al
    Efficacy and Safety of the Anti-Mucosal Addressin Cell Adhesion Molecule-1 Antibody Ontamalimab in Patients with Moderate-to-Severe Ulcerative Colitis or Crohn's Disease.
    J Crohns Colitis. 2023 Dec 14:jjad199. doi: 10.1093.
    PubMed     Abstract available


  89. LEWIS A, Humphreys DT, Pan-Castillo B, Berti G, et al
    Epigenetic and metabolic reprogramming of fibroblasts in Crohn's disease strictures reveals histone deacetylases as therapeutic targets.
    J Crohns Colitis. 2023 Dec 9:jjad209. doi: 10.1093.
    PubMed     Abstract available


  90. COLOMBEL JF, Schreiber S, D'Haens G, Rizzo J, et al
    Risankizumab Induction Therapy Achieves Early Symptom Improvements That Are Associated With Future Clinical and Endoscopic Outcomes in Crohn's Disease: Post Hoc Analysis of the ADVANCE, MOTIVATE, and FORTIFY Phase 3 Studies.
    J Crohns Colitis. 2023 Dec 9:jjad206. doi: 10.1093.
    PubMed     Abstract available


  91. GROS B, Goodall M, Plevris N, Constantine-Cooke N, et al
    Real-World Cohort Study on the Effectiveness and Safety of Filgotinib Use in Ulcerative Colitis.
    J Crohns Colitis. 2023 Dec 8:jjad187. doi: 10.1093.
    PubMed     Abstract available


  92. KAPIZIONI C, Desoki R, Lam D, Balendran K, et al
    Biologic therapy for inflammatory bowel disease: Real-world comparative effectiveness and impact of drug sequencing in 13,222 patients within the UK IBD BioResource.
    J Crohns Colitis. 2023 Dec 2:jjad203. doi: 10.1093.
    PubMed     Abstract available


  93. VAN DER DOES DE WILLEBOIS EML, Sari C, Mookhoek A, Joustra V, et al
    The clinical relevance of an inflamed appendix in Crohn's disease.
    J Crohns Colitis. 2023 Dec 1:jjad202. doi: 10.1093.
    PubMed     Abstract available


  94. HU L, Wu S, Shu Y, Su K, et al
    Impact of Maternal Smoking, Offspring Smoking, and Genetic Susceptibility on Crohn's Disease and Ulcerative Colitis.
    J Crohns Colitis. 2023 Dec 1:jjad200. doi: 10.1093.
    PubMed     Abstract available


    November 2023
  95. WATANABE K, Peyrin-Biroulet L, Danese S, Fujitani Y, et al
    Impact of Concomitant Thiopurine on the Efficacy and Safety of Filgotinib in Patients with Ulcerative Colitis: Post hoc Analysis of the Phase 2b/3 SELECTION Study.
    J Crohns Colitis. 2023 Nov 29:jjad201. doi: 10.1093.
    PubMed     Abstract available


  96. KLOMBERG RCW, van der Wal HC, Aardoom MA, Kemos P, et al
    Improved clinical outcomes with early anti-tumour necrosis factor alpha therapy in children with newly diagnosed Crohn's disease: real world data from the international prospective PIBD-SETQuality inception cohort study.
    J Crohns Colitis. 2023 Nov 27:jjad197. doi: 10.1093.
    PubMed     Abstract available


  97. SCHELLENBERG C, Lagrange J, Ahmed MU, Arnone D, et al
    The role of platelets and von Willebrand factor in the procoagulant phenotype of inflammatory bowel disease.
    J Crohns Colitis. 2023 Nov 27:jjad198. doi: 10.1093.
    PubMed     Abstract available


  98. WANG Y, He Q, Yao D, Huang Y, et al
    Histologic image-based ensemble model to identify myenteric plexitis and predict endoscopic postoperative recurrence in Crohn's disease: a multicentre, retrospective study.
    J Crohns Colitis. 2023 Nov 24:jjad196. doi: 10.1093.
    PubMed     Abstract available


  99. BISHU S
    Nurturing the Gut, Moms with IBD and Their Babies.
    J Crohns Colitis. 2023;17:1705-1706.
    PubMed    


  100. DORK R, Pelczar P, Shiri AM, Volmari A, et al
    Myeloid Cell-Specific Deletion of PDGFR-alpha Promotes Dysbiotic Intestinal Microbiota and thus Increased Colitis Susceptibility.
    J Crohns Colitis. 2023;17:1858-1869.
    PubMed     Abstract available


  101. PUGLIESE N, Dal Buono A, Armuzzi A
    Unveiling the Complexity of Porto-Sinusoidal Vascular Disorder in Inflammatory Bowel Disease: A Call for Further Investigation.
    J Crohns Colitis. 2023;17:1892.
    PubMed    


  102. REVES J, Mascarenhas A, Jose Temido M, Morao B, et al
    Early intervention with biologic therapy in Crohn s disease: how early is early?
    J Crohns Colitis. 2023;17:1752-1760.
    PubMed     Abstract available


  103. SCHULZE LL, Becker E, Dedden M, Liu LJ, et al
    Differential Effects of Ontamalimab Versus Vedolizumab on Immune Cell Trafficking in Intestinal Inflammation and Inflammatory Bowel Disease.
    J Crohns Colitis. 2023;17:1817-1832.
    PubMed     Abstract available


  104. MEHTA S
    Intestinal Failure: A Small but Imperfectly Phenotyped Complication of Crohn's Disease.
    J Crohns Colitis. 2023 Nov 21:jjad154. doi: 10.1093.
    PubMed    


  105. ROCHA CH, Walshe M, Birch S, Sabic K, et al
    Clinical predictors of early and late endoscopic recurrence following ileocolonic resection in Crohn's disease.
    J Crohns Colitis. 2023 Nov 17:jjad186. doi: 10.1093.
    PubMed     Abstract available


  106. RONSIN C, Le Berre C, Ville S
    Kidney injuries as Extra Intestinal Manifestation of Inflammatory Bowel Disease.
    J Crohns Colitis. 2023 Nov 15:jjad191. doi: 10.1093.
    PubMed    


  107. VERSTOCKT B, Vermeire S, Peyrin-Biroulet L, Mosig R, et al
    The Safety, Tolerability, Pharmacokinetics and Clinical Efficacy of the NLRX1 agonist NX-13 in Active Ulcerative Colitis: Results of a Phase 1b Study.
    J Crohns Colitis. 2023 Nov 11:jjad192. doi: 10.1093.
    PubMed     Abstract available


  108. SZEKELY H, Th LMT, Rancz A, Walter A, et al
    Anti-tumor necrosis factor alpha versus corticosteroids: a threefold difference in the occurence of venous thromboembolism in Inflammatory Bowel Disease - a systematic review and meta-analysis.
    J Crohns Colitis. 2023 Nov 11:jjad193. doi: 10.1093.
    PubMed     Abstract available


  109. TANDON P, Huang VW, Feig DS, Saskin R, et al
    Differences in Healthcare Utilization in Women with and without Inflammatory Bowel Diseases During Preconception, Pregnancy and Postpartum: A Population-Based Cohort Study.
    J Crohns Colitis. 2023;17:1587-1595.
    PubMed     Abstract available


  110. DRUVEFORS E, Myrelid P, Andersson RE, Landerholm K, et al
    Female and Male Fertility after Colectomy and Reconstructive Surgery in Inflammatory Bowel Diesase: A National Cohort Study from Sweden.
    J Crohns Colitis. 2023;17:1631-1638.
    PubMed     Abstract available


  111. RAINE T, Ishiguro Y, Rubin DT, Finney-Hayward T, et al
    Impact of Baseline Corticosteroid Use on the Efficacy and Safety of Upadacitinib in Patients with Ulcerative Colitis: a Post Hoc Analysis of the Phase 3 Clinical Trial Programme.
    J Crohns Colitis. 2023 Nov 6:jjad190. doi: 10.1093.
    PubMed     Abstract available


  112. LIU Z, Alexander JL, Eng KY, Ibraheim H, et al
    Antibody responses to Influenza vaccination are diminished in patients with inflammatory bowel disease on infliximab or tofacitinib.
    J Crohns Colitis. 2023 Nov 6:jjad182. doi: 10.1093.
    PubMed     Abstract available


  113. VERMEIRE S, Hanzel J, Lowenberg M, Ferrante M, et al
    Early versus Late Use of Vedolizumab in Ulcerative Colitis: Clinical, Endoscopic, and Histological Outcomes.
    J Crohns Colitis. 2023 Nov 2:jjad179. doi: 10.1093.
    PubMed     Abstract available


  114. ROBLIN X, Nancey S, Papamichael K, Duru G, et al
    Higher serum infliximab concentrations following subcutaneous dosing are associated with deep remission in patients with inflammatory bowel disease.
    J Crohns Colitis. 2023 Nov 2:jjad188. doi: 10.1093.
    PubMed     Abstract available


  115. VUYYURU SK, Solitano V, Narula N, Lee MJ, et al
    Pharmacological therapies for the management of fistulising Crohn's disease: A systematic review and meta-analysis.
    J Crohns Colitis. 2023 Nov 2:jjad185. doi: 10.1093.
    PubMed     Abstract available


  116. GISBERT JP, Chaparro M
    De-escalation of biological treatment in inflammatory bowel disease: A comprehensive review.
    J Crohns Colitis. 2023 Nov 1:jjad181. doi: 10.1093.
    PubMed     Abstract available


  117. CASAS DEZA D, Polo Cuadro C, de Francisco R, Vela Gonzalez M, et al
    Initial management of intraabdominal abscesses and preventive strategies for abscess recurrence in penetrating Crohn's disease: a national multicenter study based on ENEIDA registry.
    J Crohns Colitis. 2023 Nov 1:jjad184. doi: 10.1093.
    PubMed     Abstract available


    October 2023
  118. BOYD T, Araka EB, Kochar B, Ananthakrishnan AN, et al
    Differences in Management and Outcomes of Older and Younger Adults with Acute Severe Ulcerative Colitis.
    J Crohns Colitis. 2023 Oct 28:jjad183. doi: 10.1093.
    PubMed     Abstract available


  119. COHEN NA, Weber CR, Cheng JX, Choi D, et al
    Ozanimod-Exposed Patients with Ulcerative Colitis Undergoing Total Colectomy Exhibit Unique Lymph Node Histologic Changes.
    J Crohns Colitis. 2023 Oct 25:jjad174. doi: 10.1093.
    PubMed     Abstract available


  120. ASSCHER VER, Rodriguez Girondo MDM, Fens J, Waars SN, et al
    Frailty screening associates with hospitalization and decline in quality of life and functional status in older patients with inflammatory bowel disease.
    J Crohns Colitis. 2023 Oct 23:jjad175. doi: 10.1093.
    PubMed     Abstract available


  121. MULLER M, Broseus J, Guilloteau A, Wasse S, et al
    Lymphoma In Patients With Inflammatory Bowel Disease: A Multicenter Collaborative Study Between Getaid And Lysa.
    J Crohns Colitis. 2023 Oct 18:jjad177. doi: 10.1093.
    PubMed     Abstract available


  122. ALIBERT L, Betton L, Falcoz A, Manceau G, et al
    Does KONO-S anastomosis reduce recurrence in Crohn's disease compared to conventional ileocolonic anastomosis? A nationwide propensity score-matched study from GETAID Chirurgie Group (KoCoRICCO study).
    J Crohns Colitis. 2023 Oct 18:jjad176. doi: 10.1093.
    PubMed     Abstract available


  123. ROBLIN X, Paul S
    Adalimumab: A 'Maillon Faible' in the Treatment of Ulcerative Colitis?
    J Crohns Colitis. 2023 Oct 17:jjad167. doi: 10.1093.
    PubMed    


  124. RYMARCZYK D, Schultz W, Borowa A, Friedman JR, et al
    Deep learning models capture histological disease activity in Crohn's Disease and Ulcerative Colitis with high fidelity.
    J Crohns Colitis. 2023 Oct 10:jjad171. doi: 10.1093.
    PubMed     Abstract available


  125. VERSTOCKT B, Pivorunas V, Mahi NA, Smaoui N, et al
    Baseline TREM-1 Whole Blood Gene Expression Does Not Predict Response to Adalimumab Treatment in Patients with Ulcerative Colitis or Crohn's Disease in the SERENE Studies.
    J Crohns Colitis. 2023 Oct 6:jjad170. doi: 10.1093.
    PubMed     Abstract available


  126. FERRANTE M, Irving PM, Abreu MT, Axler J, et al
    Maintenance Risankizumab Sustains Induction Response in Patients with Crohn's Disease in a Randomized Phase 3 Trial.
    J Crohns Colitis. 2023 Oct 5:jjad168. doi: 10.1093.
    PubMed     Abstract available


    September 2023
  127. ATREYA R, Kuhbacher T, Waldner MJ, Hirschmann S, et al
    Submucosal injection of the RNA oligonucleotide GUT-1 in active ulcerative colitis patients: A randomized, double-blind, placebo-controlled phase 2a induction trial.
    J Crohns Colitis. 2023 Sep 30:jjad162. doi: 10.1093.
    PubMed     Abstract available


  128. BAI BYH, Reppell M, Smaoui N, Waring JF, et al
    Baseline expression of immune gene modules in blood is associated with primary response to anti-TNF therapy in Crohn's disease patients.
    J Crohns Colitis. 2023 Sep 30:jjad166. doi: 10.1093.
    PubMed     Abstract available


  129. BONAZ B, Sinniger V
    Targeting the Vagus Nerve to Treat Inflammatory Bowel Disease?
    J Crohns Colitis. 2023 Sep 21:jjad149. doi: 10.1093.
    PubMed    


  130. D'HAENS G, Eberhardson M, Cabrijan Z, Danese S, et al
    Neuroimmune modulation through vagus nerve stimulation reduces inflammatory activity in Crohn's disease patients: a prospective open label study.
    J Crohns Colitis. 2023 Sep 21:jjad151. doi: 10.1093.
    PubMed     Abstract available


  131. FOCHT G, Turner D
    Lemman Index in pediatric Crohn's disease - evidence is accumulating.
    J Crohns Colitis. 2023 Sep 14:jjad161. doi: 10.1093.
    PubMed    


  132. JEW M, Meserve J, Eisenstein S, Jairath V, et al
    Temporary Faecal Diversion for Refractory Perianal and/or Distal Colonic Crohn's Disease in the Biologic Era: An Updated Systematic Review with Meta-Analysis.
    J Crohns Colitis. 2023 Sep 14:jjad159. doi: 10.1093.
    PubMed     Abstract available


  133. VIOLA A, Li Voti R, Bivacqua C, de Francesco C, et al
    Mitigating the risk of Tofacitinib-induced adverse events in the elderly population with Ulcerative Colitis.
    J Crohns Colitis. 2023 Sep 13:jjad158. doi: 10.1093.
    PubMed     Abstract available


  134. BEHESHTI MAAL A, Shahrbaf MA, Sadri B, Hossein-Khannazer N, et al
    Prevalence of hepatobiliary manifestations in inflammatory bowel disease: a GRADE assessed systematic review and meta-analysis on more than 1.7 million patients.
    J Crohns Colitis. 2023 Sep 11:jjad157. doi: 10.1093.
    PubMed     Abstract available


  135. HARNIK S, Abitbol CM, Haj Natour O, Yavzori M, et al
    Prospective Observational Evaluation of the Time-Dependency of Adalimumab Immunogenicity and Drug Concentration in Ulcerative Colitis Patients: the POETIC II Study.
    J Crohns Colitis. 2023 Sep 11:jjad156. doi: 10.1093.
    PubMed     Abstract available


  136. NIELSEN KR, Midjord J, Lophaven SN, Langholz E, et al
    The incidence and prevalence of inflammatory bowel disease continues to increase in the Faroe Islands - a cohort study from 1960-2020.
    J Crohns Colitis. 2023 Sep 5:jjad155. doi: 10.1093.
    PubMed     Abstract available


  137. SINGH A, Midha V, Kaur K, Mahajan R, et al
    Tofacitinib versus oral prednisolone for induction of remission in moderately active ulcerative colitis (ORCHID): A prospective, open-label, randomized, pilot study.
    J Crohns Colitis. 2023 Sep 1:jjad153. doi: 10.1093.
    PubMed     Abstract available


    August 2023
  138. DANESE S, Panaccione R, Abreu MT, Rubin DT, et al
    Efficacy and safety of approximately 3 years of continuous ozanimod in moderately to severely active ulcerative colitis: interim analysis of the True North open-label extension.
    J Crohns Colitis. 2023 Aug 31:jjad146. doi: 10.1093.
    PubMed     Abstract available


  139. TRINH S, Andrew B, Vasudevan A
    6-mercaptopurine in ulcerative colitis: the potential of upfront dosing with allopurinol.
    J Crohns Colitis. 2023 Aug 29:jjad150. doi: 10.1093.
    PubMed    


  140. PIAZZA O SED N, Noviello D, Filippi E, Conforti F, et al
    Superior predictive value of transmural over endoscopic severity for colectomy risk in ulcerative colitis: a multicenter prospective cohort study.
    J Crohns Colitis. 2023 Aug 26:jjad152. doi: 10.1093.
    PubMed     Abstract available


  141. MILO F, Imondi C, D'Amore C, Angelino G, et al
    Short Term Psychodynamic Psychotherapy in addition to standard medical therapy increases clinical remission in Adolescents and Young Adults with Inflammatory Bowel Disease: a randomised controlled trial.
    J Crohns Colitis. 2023 Aug 24:jjad145. doi: 10.1093.
    PubMed     Abstract available


  142. REINISCH W, Pradhan V, Ahmad S, Zhang Z, et al
    Alternative endoscopy reading paradigms determine score reliability and effect size in ulcerative colitis.
    J Crohns Colitis. 2023 Aug 24:jjad134. doi: 10.1093.
    PubMed     Abstract available


  143. FEAKINS R, Borralho Nunes P, Driessen A, Gordon IO, et al
    Definitions of histological abnormalities in inflammatory bowel disease: an ECCO position paper.
    J Crohns Colitis. 2023 Aug 22:jjad142. doi: 10.1093.
    PubMed     Abstract available


  144. WEWER MD, Jansson S, Malham M, Burisch J, et al
    Disease Activity Patterns of Paediatric Inflammatory Bowel Disease - A Danish Nationwide Cohort Study (1996-2018).
    J Crohns Colitis. 2023 Aug 21:jjad144. doi: 10.1093.
    PubMed     Abstract available


  145. QIAN W, Xu Y, Wen W, Huang L, et al
    Exosomal miR-103a-3p from Crohn's Creeping Fat-Derived Adipose-Derived Stem Cells Contributes to Intestinal Fibrosis by Targeting TGFBR3 and Activating Fibroblasts.
    J Crohns Colitis. 2023;17:1291-1308.
    PubMed     Abstract available


  146. HU X, Jiao F, Deng J, Zhou Z, et al
    Intestinal Epithelial Cell-specific Deletion of Cytokine-inducible SH2-containing Protein Alleviates Experimental Colitis in Ageing Mice.
    J Crohns Colitis. 2023;17:1278-1290.
    PubMed     Abstract available


  147. GORDON H, Rodger B, Lindsay JO, Stagg AJ, et al
    Recruitment and Residence of Intestinal T Cells - Lessons for Therapy in Inflammatory Bowel Disease.
    J Crohns Colitis. 2023;17:1326-1341.
    PubMed     Abstract available


  148. WRIGHT EK, Chaparro M, Gionchetti P, Hamilton AL, et al
    Adalimumab Clearance, rather than Trough Level, May Have Greatest Relevance to Crohn's Disease Therapeutic Outcomes Assessed Clinically and Endoscopically.
    J Crohns Colitis. 2023 Aug 18:jjad140. doi: 10.1093.
    PubMed     Abstract available


  149. KIM K, Park S, Lee Y, Baek J, et al
    Transcriptomic Profiling and Cellular Composition of Creeping Fat in Crohn's disease.
    J Crohns Colitis. 2023 Aug 18:jjad141. doi: 10.1093.
    PubMed     Abstract available



  150. Corrigendum to: Efficacy of Filgotinib in Patients with Ulcerative Colitis by Line of Therapy in the Phase 2b/3 SELECTION Trial.
    J Crohns Colitis. 2023 Aug 17:jjad136. doi: 10.1093.
    PubMed    


  151. PELTON M, Ssentongo P, Sun A, Groff D, et al
    Race & Ethnic Representation in Crohn's Disease Trials of Biologic and Small Molecule Medications: A Systematic Review and Meta-Analysis.
    J Crohns Colitis. 2023 Aug 16:jjad138. doi: 10.1093.
    PubMed     Abstract available


  152. SCHREIBER S, Danese S, Dignass A, Domenech E, et al
    Defining Comprehensive Disease Control for use as a Treatment Target for Ulcerative Colitis in Clinical Practice: International Delphi Consensus Recommendations.
    J Crohns Colitis. 2023 Aug 16:jjad130. doi: 10.1093.
    PubMed     Abstract available


  153. RANJAN MK, Kumar P, Kumar Vuyyuru S, Kante B, et al
    Thiopurines have sustained long-term effectiveness in patients with inflammatory bowel disease which is independent of disease duration at initiation: A propensity score matched analysis.
    J Crohns Colitis. 2023 Aug 16:jjad135. doi: 10.1093.
    PubMed     Abstract available


  154. WIESE JJ, Manna S, Kuhl AA, Fasci A, et al
    Myenteric plexus immune cell infiltrations and neurotransmitter expression in Crohn's disease and ulcerative colitis.
    J Crohns Colitis. 2023 Aug 11:jjad122. doi: 10.1093.
    PubMed     Abstract available


  155. LIN S, Hannon E, Reppell M, Waring JF, et al
    Whole blood DNA methylation changes are associated with anti-TNF drug concentration in patients with Crohn's disease.
    J Crohns Colitis. 2023 Aug 8:jjad133. doi: 10.1093.
    PubMed     Abstract available


  156. VERMEIRE S, Feagan BG, Peyrin-Biroulet L, Oortwijn A, et al
    Withdrawal and Re-treatment with Filgotinib in Ulcerative Colitis: Post Hoc Analyses of the Phase 2b/3 SELECTION and SELECTIONLTE Studies.
    J Crohns Colitis. 2023 Aug 4:jjad123. doi: 10.1093.
    PubMed     Abstract available


  157. KRISHNAMOORTHY A, Chandrapalan S, Ahmed M, Arasaradnam RP, et al
    The Diagnostic Utility of Volatile Organic Compounds in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    J Crohns Colitis. 2023 Aug 4:jjad132. doi: 10.1093.
    PubMed     Abstract available


  158. HURYCH J, Mascellani Bergo A, Lerchova T, Hlinakova L, et al
    Faecal bacteriome and metabolome profiles associated with decreased mucosal inflammatory activity upon anti-TNF therapy in paediatric Crohn's disease.
    J Crohns Colitis. 2023 Aug 1:jjad126. doi: 10.1093.
    PubMed     Abstract available


  159. BRODERSEN JB, Jensen MD, Leenhardt R, Kjeldsen J, et al
    Artificial intelligence-assisted analysis of pan-enteric capsule endoscopy in patients with suspected Crohn's disease. A study on diagnostic performance.
    J Crohns Colitis. 2023 Aug 1:jjad131. doi: 10.1093.
    PubMed     Abstract available


  160. JOUSTRA V, Li Yim AYF, van Gennep S, Hageman I, et al
    Peripheral blood DNA methylation signatures and response to tofacitinib in moderate-to-severe ulcerative colitis.
    J Crohns Colitis. 2023 Aug 1:jjad129. doi: 10.1093.
    PubMed     Abstract available


  161. GUADAGNOLI L, Horrigan J, Walentynowicz M, Salwen-Deremer JK, et al
    Sleep quality drives next day pain and fatigue in adults with inflammatory bowel disease: A short report.
    J Crohns Colitis. 2023 Aug 1:jjad128. doi: 10.1093.
    PubMed     Abstract available


    July 2023
  162. KIM K, Oh SJ, Lee J, Kwon A, et al
    Regulatory Variants on the Leukocyte Immunoglobulin-Like Receptor Gene Cluster are Associated with Crohn's Disease and Interact with Regulatory Variants for TAP2.
    J Crohns Colitis. 2023 Jul 31:jjad127. doi: 10.1093.
    PubMed     Abstract available


  163. CARON B, Jairath V, Laurent V, Stoker J, et al
    Defining magnetic resonance imaging treatment response and remission in Crohn's disease: a systematic review.
    J Crohns Colitis. 2023 Jul 31:jjad125. doi: 10.1093.
    PubMed     Abstract available


  164. GARCIA MJ, Rivero M, Fernandez-Clotet A, de Francisco R, et al
    Comparative Study Of The Effectiveness Of Vedolizumab Versus Ustekinumab After Anti-Tnf Failure In Crohn's Disease (Versus-Cd): Data From Eneida Registry.
    J Crohns Colitis. 2023 Jul 31:jjad124. doi: 10.1093.
    PubMed     Abstract available


  165. UNGARO RC, Kadali H, Zhang W, Adsul S, et al
    Impact of Concomitant 5-Aminosalicylic Acid Therapy on Vedolizumab Efficacy and Safety in Inflammatory Bowel Disease: Post Hoc Analyses of Clinical Trial Data.
    J Crohns Colitis. 2023 Jul 26:jjad113. doi: 10.1093.
    PubMed     Abstract available


  166. ATIA O, Friss C, Focht G, Magen Rimon R, et al
    Durability of the first biologic in patients with Crohn's disease: A nationwide study from the epi-IIRN.
    J Crohns Colitis. 2023 Jul 19:jjad121. doi: 10.1093.
    PubMed     Abstract available


  167. PARONI M, Leccese G, Ranzani V, Moschetti G, et al
    An intestinal Th17 subset is associated with inflammation in Crohn's Disease and activated by adherent-invasive Escherichia coli (AIEC).
    J Crohns Colitis. 2023 Jul 18:jjad119. doi: 10.1093.
    PubMed     Abstract available


  168. UEDA T, Koyama F, Sugita A, Ikeuchi H, et al
    Endoscopic lesions of postoperative anastomotic area in patients with Crohn's disease in the biologic era: A Japanese multi-center nationwide cohort study.
    J Crohns Colitis. 2023 Jul 14:jjad116. doi: 10.1093.
    PubMed     Abstract available


  169. HUININK STB, Thomassen D, Steyerberg EW, Pauwels RWM, et al
    Discontinuation of Anti-Tumour Necrosis Factor Therapy in Patients with Perianal Fistulizing Crohn's Disease: Individual Participant Data Meta-Analysis of 309 patients from 12 studies.
    J Crohns Colitis. 2023 Jul 12:jjad118. doi: 10.1093.
    PubMed     Abstract available


  170. SANDS BE, Schreiber S, Blumenstein I, Chiorean MV, et al
    Clinician's Guide to Using Ozanimod for the Treatment of Ulcerative Colitis.
    J Crohns Colitis. 2023 Jul 12:jjad112. doi: 10.1093.
    PubMed     Abstract available


  171. GONCZI L, Lakatos L, Golovics PA, Ilias A, et al
    Declining trends of reoperations and disease behavior progression in Crohn's disease over different therapeutic eras - a prospective population-based study from western Hungary between 1977-2020, data from the Veszprem cohort.
    J Crohns Colitis. 2023 Jul 9:jjad117. doi: 10.1093.
    PubMed     Abstract available


  172. GILMORE R, Tan L, Fernandes R, An YK, et al
    Upadacitinib Salvage Therapy for Infliximab experienced patients with Acute Severe Ulcerative Colitis.
    J Crohns Colitis. 2023 Jul 9:jjad115. doi: 10.1093.
    PubMed     Abstract available


  173. BRYANT RV, Travis SPL
    APOLLO Has Landed: PROMS and Histology in UC.
    J Crohns Colitis. 2023;17:1027-1028.
    PubMed    


  174. UZZAN M, Bouhnik Y, Abreu M, Ahmad HA, et al
    Declining Enrolment and Other Challenges in IBD Clinical Trials: Causes and Potential Solutions.
    J Crohns Colitis. 2023;17:1066-1078.
    PubMed     Abstract available


  175. LEDDER O, Turner D
    Multi-item Measures for Paediatric Inflammatory Bowel Diseases: The ABCs of All Those Acronyms.
    J Crohns Colitis. 2023;17:1154-1168.
    PubMed     Abstract available


  176. GRIMSDOTTIR S, Attauabi M, Kristine Dahl E, Burisch J, et al
    Systematic Review with Meta-analysis: The Impact of Cancer Treatments on the Disease Activity of Inflammatory Bowel Diseases.
    J Crohns Colitis. 2023;17:1139-1153.
    PubMed     Abstract available


  177. ALEXANDERSSON BT, Andreasson A, Hedin C, Broms G, et al
    Inflammatory bowel disease is not linked to a higher rate of adverse events in colonoscopy - a nationwide population-based study in Sweden.
    J Crohns Colitis. 2023 Jul 4:jjad114. doi: 10.1093.
    PubMed     Abstract available


  178. SCHREIBER S, Rubin DT, Ng SC, Peyrin-Biroulet L, et al
    Major Adverse Cardiovascular Events by Baseline Cardiovascular Risk in Patients with Ulcerative Colitis Treated with Tofacitinib: Data from the OCTAVE Clinical Programme.
    J Crohns Colitis. 2023 Jul 4:jjad104. doi: 10.1093.
    PubMed     Abstract available


    June 2023
  179. PARIGI TL, Cannatelli R, Nardone OM, Zammarchi I, et al
    Neutrophil-only histological assessment of ulcerative colitis correlates with endoscopic activity and predicts long-term outcomes in a multicenter study.
    J Crohns Colitis. 2023 Jun 30:jjad110. doi: 10.1093.
    PubMed     Abstract available


  180. SEETHARAMAN J, Srivastava A, Yadav RR, Singh SK, et al
    Visceral fat indices: Do they help differentiate Crohn's disease and Intestinal tuberculosis in children?
    J Crohns Colitis. 2023 Jun 30:jjad109. doi: 10.1093.
    PubMed     Abstract available


  181. GORDON H, Burisch J, Ellul P, Karmiris K, et al
    ECCO Guidelines on Extraintestinal Manifestations in Inflammatory Bowel Disease.
    J Crohns Colitis. 2023 Jun 23:jjad108. doi: 10.1093.
    PubMed    


  182. FENG R, Tian Z, Mao R, Ma R, et al
    Gut microbiome generated phenylacetylglutamine from dietary protein is associated with Crohn's Disease and exacerbates colitis in mouse model possibly via platelet activation.
    J Crohns Colitis. 2023 Jun 23:jjad098. doi: 10.1093.
    PubMed     Abstract available


  183. MATHEWS SN, Lukin DJ
    Shifting the Inflammatory Balance in Ulcerative Colitis Through Diet: A Mediterranean Diet Pattern is Associated with Improvements in Dysbiosis and Disease Activity.
    J Crohns Colitis. 2023 Jun 23:jjad095. doi: 10.1093.
    PubMed    


  184. YU N, Sriranganathan D, Walker GJ, Sazonovs A, et al
    Prevalence of NUDT15 genetic variants and incidence of thiopurine-induced leukopenia in Inflammatory Bowel Disease: A systematic review and meta-analysis.
    J Crohns Colitis. 2023 Jun 22:jjad107. doi: 10.1093.
    PubMed     Abstract available


  185. BURISCH J, Safroneeva E, Laoun R, Ma C, et al
    Lack of benefit for early escalation to advanced therapies in ulcerative colitis: critical appraisal of current evidence.
    J Crohns Colitis. 2023 Jun 22:jjad106. doi: 10.1093.
    PubMed     Abstract available


  186. KOPCZYNSKA M, Crooks B, Deutsch L, Conley T, et al
    Disease recurrence and long-term outcomes following the development of intestinal failure in Crohn's disease: over 20 years of experience from a national reference centre.
    J Crohns Colitis. 2023 Jun 21:jjad105. doi: 10.1093.
    PubMed     Abstract available


  187. FOCHT G, Kuint RC, Greer MC, Pratt LT, et al
    Prospective Validation of the Lemann Index in Children: A Report From the Multicentre Image Kids Study.
    J Crohns Colitis. 2023;17:943-949.
    PubMed     Abstract available


  188. KANTASIRIPITAK W, Wicha SG, Thomas D, Hoffman I, et al
    A Model-Based Tool for Guiding Infliximab Induction Dosing to Maximize Long-term Deep Remission in Children with Inflammatory Bowel Diseases.
    J Crohns Colitis. 2023;17:896-908.
    PubMed     Abstract available


  189. GISBERT JP, Chaparro M
    Vaccines in Children Exposed to Biological Agents In Utero and/or During Breastfeeding: Are They Effective and Safe?
    J Crohns Colitis. 2023;17:995-1009.
    PubMed     Abstract available


  190. WEBER MC, Bauer J, Buck A, Clees Z, et al
    Perioperative Low-Dose Prednisolone Treatment Has Beneficial Effects on Postoperative Recovery and Anastomotic Healing in a Murine Colitis Model.
    J Crohns Colitis. 2023;17:950-959.
    PubMed     Abstract available


  191. SOLITANO V, Vuyyuru SK, MacDonald JK, Zayadi A, et al
    Efficacy and safety of advanced oral small molecules for inflammatory bowel disease: Systematic review and meta-analysis.
    J Crohns Colitis. 2023 Jun 15:jjad100. doi: 10.1093.
    PubMed     Abstract available


  192. JANSEN FM, van Linschoten RCA, Kievit W, Smits LJT, et al
    Cost-effectiveness analysis of increased adalimumab dose intervals in Crohn's disease patients in stable remission: the randomised controlled LADI trial.
    J Crohns Colitis. 2023 Jun 13:jjad101. doi: 10.1093.
    PubMed     Abstract available


  193. MATINI L, Chapman TP, Kantschuster R, Wilson J, et al
    Development of the Escalation of Therapy or Intervention (ETI) calculator for patients with ulcerative colitis using ePROMS.
    J Crohns Colitis. 2023 Jun 12:jjad099. doi: 10.1093.
    PubMed     Abstract available


  194. EDER P, Verstock B, Culver E, Dragoni G, et al
    Autoimmune pancreatitis in patients with inflammatory bowel disease - a real-world multicentre collaborative ECCO CONFER study.
    J Crohns Colitis. 2023 Jun 7:jjad097. doi: 10.1093.
    PubMed     Abstract available


  195. SUN Z, Braga-Neto MB, Xiong Y, Bhagwate AV, et al
    Hypomethylation and overexpression of Th17-associated genes is a hallmark of intestinal CD4+ lymphocytes in Crohn's disease.
    J Crohns Colitis. 2023 Jun 6:jjad093. doi: 10.1093.
    PubMed     Abstract available


  196. SABINO J, Tarassishin L, Eisele C, Hawkins K, et al
    Influence of Early Life Factors, including Breastmilk Composition, on the Microbiome of Infants Born to Mothers with and without Inflammatory Bowel Disease.
    J Crohns Colitis. 2023 Jun 6:jjad096. doi: 10.1093.
    PubMed     Abstract available


  197. HOLTEN KA, Bernklev T, Opheim R, Johansen I, et al
    Fatigue in patients with newly diagnosed inflammatory bowel disease: Results from a prospective inception cohort, the IBSEN III study.
    J Crohns Colitis. 2023 Jun 5:jjad094. doi: 10.1093.
    PubMed     Abstract available


    May 2023
  198. BRUGGELING CE, Te Groen M, Garza DR, van Heeckeren Tot Overlaer F, et al
    Bacterial oncotraits rather than spatial organization are associated with dysplasia in ulcerative colitis.
    J Crohns Colitis. 2023 May 27:jjad092. doi: 10.1093.
    PubMed     Abstract available


  199. MOTWANI KK, Hashash JG, Farraye FA, Kappelman MD, et al
    Impact of Holding Immunosuppressive Therapy in Patients with Inflammatory Bowel Disease Around mRNA COVID-19 Vaccine Administration on Humoral Immune Response and Development of COVID-19 Infection.
    J Crohns Colitis. 2023 May 26:jjad085. doi: 10.1093.
    PubMed     Abstract available



  200. Correction to: Corticosteroid-Sparing Effects of Filgotinib in Moderately to Severely Active Ulcerative Colitis: Data from the Phase 2b/3 SELECTION Study.
    J Crohns Colitis. 2023 May 24:jjad082. doi: 10.1093.
    PubMed    


  201. PEYRIN-BIROULET L, Arenson E, Rubin DT, Siegel CA, et al
    A comparative evaluation of the measurement properties of three histological indices of mucosal healing in ulcerative colitis: Geboes Score, Robarts Histopathology Index, and Nancy Index.
    J Crohns Colitis. 2023 May 24:jjad087. doi: 10.1093.
    PubMed     Abstract available


  202. HONAP S, Buisson A, Danese S, Laurent B, et al
    Patient and Public Involvement in Research: Lessons for Inflammatory Bowel Disease.
    J Crohns Colitis. 2023 May 23:jjad090. doi: 10.1093.
    PubMed     Abstract available


  203. PIERRE N, Vieujean S, Peyrin-Biroulet L, Meuwis MA, et al
    Defining biological remission in Crohn's disease: interest, challenges and future directions.
    J Crohns Colitis. 2023 May 19:jjad086. doi: 10.1093.
    PubMed     Abstract available


  204. STAFFORD IS, Ashton JJ, Mossotto E, Cheng G, et al
    Supervised machine learning classifies inflammatory bowel disease patients by subtype using whole exome sequencing data.
    J Crohns Colitis. 2023 May 19:jjad084. doi: 10.1093.
    PubMed     Abstract available


  205. KABIR M, Thomas-Gibson S, Tozer PJ, Warusavitarne J, et al
    DECIDE: Delphi Expert Consensus Statement on Inflammatory Bowel Disease Dysplasia Shared Management Decision-Making.
    J Crohns Colitis. 2023 May 12:jjad083. doi: 10.1093.
    PubMed     Abstract available


  206. ITZKOWITZ S, Farraye FA, Limburg P, Gagrat Z, et al
    Assessment of Stool DNA Markers to Detect Colorectal Neoplasia in Patients with Inflammatory Bowel Disease: A Multi-site Case-control Study.
    J Crohns Colitis. 2023 May 11:jjad069. doi: 10.1093.
    PubMed     Abstract available


  207. OHLMANN H, Lanters LR, Theysohn N, Langhorst J, et al
    Distinct alterations in central pain processing of visceral and somatic pain in quiescent ulcerative colitis compared to irritable bowel syndrome and health.
    J Crohns Colitis. 2023 May 10:jjad080. doi: 10.1093.
    PubMed     Abstract available


  208. IRVING PM
    Thiopurines for Ulcerative Colitis: Old Favourite or Old Hat?
    J Crohns Colitis. 2023 May 4:jjad062. doi: 10.1093.
    PubMed    


  209. BAI L, Dermadi D, Kalesinskas L, Dvorak M, et al
    Mass-Cytometry-Based Quantification of Global Histone Post-Translational Modifications at Single-Cell Resolution Across Peripheral Immune Cells in IBD.
    J Crohns Colitis. 2023;17:804-815.
    PubMed     Abstract available


  210. GODNY L, Svolos V, Williams AJ, Czuber-Dochan W, et al
    Multidisciplinary Perinatal Care in IBD.
    J Crohns Colitis. 2023;17:663-680.
    PubMed     Abstract available


  211. VERMEIRE S, Solitano V, Peyrin-Biroulet L, Tilg H, et al
    Obefazimod: A First-in-class Drug for the Treatment of Ulcerative Colitis.
    J Crohns Colitis. 2023 May 2:jjad067. doi: 10.1093.
    PubMed     Abstract available


    April 2023
  212. MCCURDY JD, Weng R, Parlow S, Dawkins YM, et al
    Video capsule endoscopy can identify occult luminal Crohn's disease in patients with isolated perianal fistulas.
    J Crohns Colitis. 2023 Apr 26:jjad078. doi: 10.1093.
    PubMed     Abstract available


  213. ATIA O, Friss C, Ledderman N, Greenfeld S, et al
    Thiopurines have longer treatment durability than methotrexate in adults and children with Crohn's Disease: a nationwide analysis from the epi-IIRN cohort.
    J Crohns Colitis. 2023 Apr 26:jjad076. doi: 10.1093.
    PubMed     Abstract available


  214. KURIAKOSE KUZHIYANJAL AJ, Nigam GB, Antoniou GA, Farraye FA, et al
    Management of Inflammatory Bowel Disease Using E-Health Technologies: A Systematic Review and Meta-Analysis.
    J Crohns Colitis. 2023 Apr 26:jjad075. doi: 10.1093.
    PubMed     Abstract available


  215. TSCHURTSCHENTHALER M, Verstockt B
    Targeting a Hallmark of Crohn's Disease: Browning of the Hypertrophic Mesenteric Adipose Tissue as a Novel Strategy to Reduce Inflammation?
    J Crohns Colitis. 2023 Apr 26:jjad059. doi: 10.1093.
    PubMed    


  216. ALSOUD D, Ho J, Verstockt B
    The Serum-Based Endoscopic Healing Index Can Monitor Therapeutic Response in Crohn's Disease.
    J Crohns Colitis. 2023 Apr 26:jjad077. doi: 10.1093.
    PubMed    


  217. HASKEY N, Estaki M, Ye J, Shim RK, et al
    A Mediterranean Diet Pattern improves intestinal inflammation concomitant with reshaping of the bacteriome in ulcerative colitis: A randomized controlled trial.
    J Crohns Colitis. 2023 Apr 24:jjad073. doi: 10.1093.
    PubMed     Abstract available


  218. LAURI G, D'Amico F, Allocca M, Palumbo D, et al
    Ustekinumab as induction and maintenance therapy in patients with inflammatory bowel disease and type II autoimmune pancreatitis: report of two cases.
    J Crohns Colitis. 2023 Apr 22:jjad072. doi: 10.1093.
    PubMed    


  219. ALLOCCA M, Dell'Avalle C, Furfaro F, Zilli A, et al
    Early intestinal ultrasound predicts long-term endoscopic response to biologics in ulcerative colitis.
    J Crohns Colitis. 2023 Apr 21:jjad071. doi: 10.1093.
    PubMed     Abstract available


  220. GORELIK Y, Ghersin I, Shlon D, Friss C, et al
    Association of Antibiotic Use with Durability of Biologic Agents in Inflammatory Bowel Disease: a report from the epi-IIRN.
    J Crohns Colitis. 2023 Apr 21:jjad070. doi: 10.1093.
    PubMed     Abstract available


  221. LIGHTNER AL, Reese J, Ream J, Nachand D, et al
    A Phase IB/IIA Study of Allogeneic, Bone Marrow-derived, Mesenchymal Stem Cells for the Treatment of Refractory Ileal-anal Anastomosis and Peripouch Fistulas in the Setting of Crohn's Disease of the Pouch.
    J Crohns Colitis. 2023;17:480-488.
    PubMed     Abstract available


  222. CAO D, Qian K, Zhao Y, Hong J, et al
    Association of Neutrophil Extracellular Traps with Fistula Healing in Patients with Complex Perianal Fistulizing Crohn's Disease.
    J Crohns Colitis. 2023;17:580-592.
    PubMed     Abstract available


  223. VIEUJEAN S, De Vos M, Paridaens K, Daftary GS, et al
    Fertility and Assisted Reproductive Technologies Outcomes of Women with Non-surgically Managed Inflammatory Bowel Diseases: A Systematic Review.
    J Crohns Colitis. 2023;17:614-632.
    PubMed     Abstract available


  224. NIGHOT M, Liao PL, Morris N, McCarthy D, et al
    Long-Term Use of Proton Pump Inhibitors Disrupts Intestinal Tight Junction Barrier and Exaggerates Experimental Colitis.
    J Crohns Colitis. 2023;17:565-579.
    PubMed     Abstract available


  225. CHEN J, Wellens J, Kalla R, Fu T, et al
    Intake of Ultra-processed Foods Is Associated with an Increased Risk of Crohn's Disease: A Cross-sectional and Prospective Analysis of 187 154 Participants in the UK Biobank.
    J Crohns Colitis. 2023;17:535-552.
    PubMed     Abstract available


  226. CHUGH R, Braga-Neto MB, Fredrick TW, Ramos GP, et al
    Multicentre Real-world Experience of Upadacitinib in the Treatment of Crohn's Disease.
    J Crohns Colitis. 2023;17:504-512.
    PubMed     Abstract available


  227. SHARMA T, Ma C, Sedano R, Hanzel J, et al
    Placebo Response Rates in Randomized Controlled Trials for Perianal Crohn's Disease: A Systematic Review and Meta-Analysis.
    J Crohns Colitis. 2023;17:644-658.
    PubMed     Abstract available


  228. ELMAGHRAWY K, Fleming P, Fitzgerald K, Cooper S, et al
    The Oral Microbiome in Treatment-Naive Paediatric IBD Patients Exhibits Dysbiosis Related to Disease Severity that Resolves Following Therapy.
    J Crohns Colitis. 2023;17:553-564.
    PubMed     Abstract available


  229. ZHAO J, Lin Z, Ying P, Zhao Z, et al
    circSMAD4 Promotes Experimental Colitis and Impairs Intestinal Barrier Functions by Targeting Janus Kinase 2 Through Sponging miR-135a-5p.
    J Crohns Colitis. 2023;17:593-613.
    PubMed     Abstract available


  230. DRAGONI G, Allocca M, Myrelid P, Noor NM, et al
    Results of the Eighth Scientific Workshop of ECCO: Diagnosing postoperative recurrence of Crohn's disease after an ileocolonic resection with ileocolonic anastomosis.
    J Crohns Colitis. 2023 Apr 18:jjad055. doi: 10.1093.
    PubMed     Abstract available


  231. RIVIERE P, Bislenghi G, Hammoudi N, Verstockt B, et al
    Results of the Eighth Scientific Workshop of ECCO: Pathophysiology and risk factors of postoperative Crohn's disease recurrence after an ileocolic resection.
    J Crohns Colitis. 2023 Apr 18:jjad054. doi: 10.1093.
    PubMed     Abstract available


  232. FERRANTE M, Pouillon L, Manosa M, Savarino E, et al
    Results of the Eighth Scientific Workshop of ECCO: Prevention and treatment of postoperative recurrence in patients with Crohn's disease undergoing an ileocolonic resection with ileocolonic anastomosis.
    J Crohns Colitis. 2023 Apr 18:jjad053. doi: 10.1093.
    PubMed     Abstract available


  233. YAZAKI T, Kawashima K, Ishihara S
    Azathioprine-induced porto-sinusoidal vascular disease complicated with esophageal varices in Crohn's disease patient - Case report.
    J Crohns Colitis. 2023 Apr 17:jjad066. doi: 10.1093.
    PubMed    



  234. Erratum to: Anogenital Crohn's Disease and Granulomatosis: A Systematic Review of Epidemiology, Clinical Manifestations, and Treatment.
    J Crohns Colitis. 2023 Apr 15:jjad044. doi: 10.1093.
    PubMed    


  235. MAGRO F, Pai RK, Kobayashi T, Jairath V, et al
    Resolving Histologic Inflammation in Ulcerative Colitis With Mirikizumab in the LUCENT Induction and Maintenance Trial Programs.
    J Crohns Colitis. 2023 Apr 14:jjad050. doi: 10.1093.
    PubMed     Abstract available


  236. JANSEN D, Falony G, Vieira-Silva S, Simsek C, et al
    Community Types Of The Human Gut Virome Are Associated With Endoscopic Outcome In Ulcerative Colitis.
    J Crohns Colitis. 2023 Apr 13:jjad061. doi: 10.1093.
    PubMed     Abstract available


  237. DRAGONI G, Gottin M, Innocenti T, Lynch EN, et al
    "Correlation of ultrasound scores with endoscopic activity in Crohn's disease: a prospective exploratory study".
    J Crohns Colitis. 2023 Apr 6:jjad068. doi: 10.1093.
    PubMed     Abstract available


  238. DOHERTY J, O Morain N, Stack R, Tosetto M, et al
    Reduced serological response to COVID-19 booster vaccine is associated with reduced B cell memory in patients with Inflammatory Bowel Disease; VARIATION (VAriability in Response in IBD AgainsT SARS-COV-2 ImmunisatiON).
    J Crohns Colitis. 2023 Apr 5:jjad065. doi: 10.1093.
    PubMed     Abstract available


  239. FURUKAWA S, Mizushima T, Nakaya R, Shibata M, et al
    Darvadstrocel for Complex Perianal Fistulas in Japanese Adults with Crohn's Disease: A Phase 3 Study.
    J Crohns Colitis. 2023;17:369-378.
    PubMed     Abstract available


  240. JOHANSEN MP, Wewer MD, Nordholm-Carstensen A, Burisch J, et al
    Perianal Crohn's Disease and the Development of Colorectal and Anal Cancer: A Systematic Review and Meta-analysis.
    J Crohns Colitis. 2023;17:361-368.
    PubMed     Abstract available


  241. JOUSTRA V, van Sabben J, van der Does de Willebois E, Duijvestein M, et al
    Benefit of Risk-stratified Prophylactic Treatment on Clinical Outcome in Postoperative Crohn's Disease.
    J Crohns Colitis. 2023;17:318-328.
    PubMed     Abstract available


  242. WONG ECL, Moayyedi P, Narula N
    Beyond the White Pill: Advocating for Racial Diversity in IBD Trials.
    J Crohns Colitis. 2023;17:459-461.
    PubMed     Abstract available


  243. ASHTON JJ, Seaby EG, Beattie RM, Ennis S, et al
    NOD2 in Crohn's Disease-Unfinished Business.
    J Crohns Colitis. 2023;17:450-458.
    PubMed     Abstract available


    March 2023
  244. AXELRAD J, Olen O, Soderling J, Roelstraete B, et al
    Inflammatory Bowel Disease and Risk of Colorectal Polyps: A nationwide population-based cohort study from Sweden.
    J Crohns Colitis. 2023 Mar 30:jjad056. doi: 10.1093.
    PubMed     Abstract available


  245. CHEN LA, Oliva-Hemker M, Radin A, Weidner M, et al
    Longitudinal bile acid composition changes following fecal microbiota transplantation for Clostridioides difficile infection in children with and without underlying inflammatory bowel disease.
    J Crohns Colitis. 2023 Mar 29:jjad057. doi: 10.1093.
    PubMed     Abstract available


  246. JANKER L, Schuster D, Bortel P, Hagn G, et al
    Multi-omics empowered deep phenotyping of ulcerative colitis identifies biomarker signatures reporting functional remission states.
    J Crohns Colitis. 2023 Mar 24:jjad052. doi: 10.1093.
    PubMed     Abstract available


  247. FADEL MG, Geropoulos G, Warren OJ, Mills SC, et al
    Risks factors associated with the development of Crohn's disease after ileal pouch-anal anastomosis for ulcerative colitis: a systematic review and meta-analysis.
    J Crohns Colitis. 2023 Mar 24:jjad051. doi: 10.1093.
    PubMed     Abstract available


  248. DE CODES LMG, de Jesus ACC, de Codes JJG, Ferreira RF, et al
    Anorectal function and clinical characteristics associated with fecal incontinence in patients with Crohn's disease.
    J Crohns Colitis. 2023 Mar 23:jjad048. doi: 10.1093.
    PubMed     Abstract available


  249. ALLEZ M, Sands BE, Feagan BG, D'Haens G, et al
    A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-arm, Multicenter Study Evaluating the Safety and Efficacy of Tesnatilimab in Patients With Moderately to Severely Active Crohn's Disease.
    J Crohns Colitis. 2023 Mar 20:jjad047. doi: 10.1093.
    PubMed     Abstract available


  250. RUNDE J, Veseli I, Fogarty EC, Watson AR, et al
    Transient Suppression of Bacterial Populations Associated with Gut Health is Critical in Success of Exclusive Enteral Nutrition for Children with Crohn's Disease.
    J Crohns Colitis. 2023 Mar 19:jjad031. doi: 10.1093.
    PubMed     Abstract available


  251. JONGSMA MME, Costes LMM, Tindemans I, Cozijnsen MA, et al
    Serum immune profiling in pediatric Crohn's disease demonstrates stronger immune modulation with first-line infliximab than conventional therapy and pre-treatment profiles predict clinical response to both treatments.
    J Crohns Colitis. 2023 Mar 19:jjad049. doi: 10.1093.
    PubMed     Abstract available


  252. ZUO L, Geng Z, Song X, Li J, et al
    Browning of mesenteric white adipose tissue in Crohn's disease: a new pathological change and therapeutic target.
    J Crohns Colitis. 2023 Mar 18:jjad046. doi: 10.1093.
    PubMed     Abstract available


  253. ROSS ADB, Zilbauer M
    Validation of IBD-associated Whole-blood DNA Methylation Changes-Where Do We Go From Here?
    J Crohns Colitis. 2023;17:151-152.
    PubMed    


  254. HARVEY PR, Trudgill NJ
    Venous Thromboembolism Following Discharge from Hospital in Patients Admitted for Inflammatory Bowel Diseases-Authors' Reply.
    J Crohns Colitis. 2023;17:306.
    PubMed    


  255. RIVIERE P, Pekow J, Hammoudi N, Wils P, et al
    Comparison of the Risk of Crohn's Disease Postoperative Recurrence Between Modified Rutgeerts Score i2a and i2b Categories: An Individual Patient Data Meta-analysis.
    J Crohns Colitis. 2023;17:269-276.
    PubMed     Abstract available


  256. ARKENBOSCH JHC, Beelen EMJ, Dijkstra G, Romberg-Camps M, et al
    Prophylactic Medication for the Prevention of Endoscopic Recurrence in Crohn's Disease: a Prospective Study Based on Clinical Risk Stratification.
    J Crohns Colitis. 2023;17:221-230.
    PubMed     Abstract available


  257. GONCZI L, Lakatos L, Kurti Z, Golovics PA, et al
    Incidence, Prevalence, Disease Course, and Treatment Strategy of Crohn's Disease Patients from the Veszprem Cohort, Western Hungary: A Population-based Inception Cohort Study Between 2007 and 2018.
    J Crohns Colitis. 2023;17:240-248.
    PubMed     Abstract available


  258. SEBASTIAN S, Segal JP, Hedin C, Pellino G, et al
    ECCO Topical Review: Roadmap to Optimal Peri-Operative Care in IBD.
    J Crohns Colitis. 2023;17:153-169.
    PubMed     Abstract available


  259. DAI C, Huang YH
    Venous Thromboembolism Following Discharge from Hospital Among Patients Admitted for Inflammatory Bowel Diseases.
    J Crohns Colitis. 2023;17:305.
    PubMed    


  260. LIANG ZX, Liu HS, Xiong L, Zeng ZW, et al
    GAS6 From CD200+ Adipose-Derived Stem Cells Mitigates Colonic Inflammation in a Macrophage-Dependent Manner.
    J Crohns Colitis. 2023;17:289-301.
    PubMed     Abstract available


  261. ALBUQUERQUE A, Cappello C, Stirrup O, Selinger CP, et al
    Anal high-risk human papillomavirus infection, squamous intraepithelial lesions and anal cancer in patients with inflammatory bowel disease: a systematic review and meta-analysis.
    J Crohns Colitis. 2023 Mar 17:jjad045. doi: 10.1093.
    PubMed     Abstract available


  262. DOTAN I, Feagan BG, Taliadouros V, Oortwijn A, et al
    Efficacy of Filgotinib in Patients with Ulcerative Colitis by Line of Therapy in the Phase 2b/3 SELECTION Trial.
    J Crohns Colitis. 2023 Mar 16:jjad039. doi: 10.1093.
    PubMed     Abstract available


  263. JIMBO K, Hosoi K, Suzuki M, Kyodo R, et al
    Accuracy of Transperineal Ultrasonography for Assessing Rectal Lesions in Pediatric Ulcerative Colitis: A Prospective Study.
    J Crohns Colitis. 2023 Mar 15:jjad035. doi: 10.1093.
    PubMed     Abstract available


  264. MACALUSO FS, Ventimiglia M, Orlando A
    Effectiveness and Safety of Vedolizumab in Inflammatory Bowel Disease: A Comprehensive Meta-analysis of Observational Studies.
    J Crohns Colitis. 2023 Mar 13:jjad043. doi: 10.1093.
    PubMed     Abstract available


  265. JANSSEN LM, Creemers RH, van Bodegraven AA, Pierik MJ, et al
    A systematic review on long-term efficacy outcome measures in Crohn's disease patients.
    J Crohns Colitis. 2023 Mar 13:jjad037. doi: 10.1093.
    PubMed     Abstract available



  266. Erratum to: Post-inflammatory Polyp Burden as a Prognostic Marker of Disease-outcome in Patients with Inflammatory Bowel Disease.
    J Crohns Colitis. 2023 Mar 9:jjad028. doi: 10.1093.
    PubMed    


  267. YAMAMOTO T, Nakase H, Watanabe K, Shinzaki S, et al
    Diagnosis and Clinical Features of Perianal Lesions in Newly Diagnosed Crohn's Disease: Subgroup Analysis from Inception Cohort Registry Study of Patients with Crohn's Disease (iCREST-CD).
    J Crohns Colitis. 2023 Mar 4:jjad038. doi: 10.1093.
    PubMed     Abstract available


  268. STEENHOLDT C, Ovesen PD, Brynskov J, Seidelin JB, et al
    Tofacitinib for acute severe ulcerative colitis: a systematic review.
    J Crohns Colitis. 2023 Mar 1:jjad036. doi: 10.1093.
    PubMed     Abstract available


    February 2023
  269. LOWENBERG M, Volkers A, van Gennep S, Mookhoek A, et al
    Mercaptopurine for the treatment of ulcerative colitis - a randomised placebo-controlled trial.
    J Crohns Colitis. 2023 Feb 27:jjad022. doi: 10.1093.
    PubMed     Abstract available


  270. LAHARIE D, Mary JY
    Should we target complete endoscopic healing in patients with acute severe ulcerative colitis?
    J Crohns Colitis. 2023 Feb 25:jjad032. doi: 10.1093.
    PubMed     Abstract available


  271. QUEIROZ NSF, Cheifetz AS, Papamichael K
    Going Beyond a Treat-To-Target to a Treat-To-Clear and a Treat-To-Trough Therapeutic Strategy in Patients with Inflammatory Bowel Disease?
    J Crohns Colitis. 2023 Feb 24:jjad014. doi: 10.1093.
    PubMed    


  272. WONG ECL, Dulai PS, Hasan B, Marshall JK, et al
    Combined Histologic and Endoscopic Endpoints at Post-induction Lack Additional Prognostic Value Compared to Endoscopic Improvement Alone in Ulcerative Colitis: A Post-hoc Analysis of the VARSITY study.
    J Crohns Colitis. 2023 Feb 23:jjad033. doi: 10.1093.
    PubMed     Abstract available


  273. WINOGRODZKI T, Metwaly A, Grodziecki A, Liang W, et al
    TNF DeltaARE pigs: a translational Crohn;s Disease model.
    J Crohns Colitis. 2023 Feb 23:jjad034. doi: 10.1093.
    PubMed     Abstract available


  274. RIBALDONE DG, Vieujean S, Julsgaard M, Armandi A, et al
    Non-hepatic solid organ transplant in patients with inflammatory bowel disease: an ECCO CONFER Multicentre Case Series.
    J Crohns Colitis. 2023 Feb 23:jjad030. doi: 10.1093.
    PubMed     Abstract available


  275. AHMAD HA, East JE, Panaccione R, Travis S, et al
    Artificial Intelligence in Inflammatory Bowel Disease Endoscopy: Implications for Clinical Trials.
    J Crohns Colitis. 2023 Feb 22:jjad029. doi: 10.1093.
    PubMed     Abstract available


  276. MENG G, Monaghan TM, Duggal NA, Tighe P, et al
    Microbial-Immune Crosstalk in Elderly-Onset Inflammatory Bowel Disease: Unchartered Territory.
    J Crohns Colitis. 2023 Feb 20:jjad025. doi: 10.1093.
    PubMed     Abstract available


  277. WANG Z, Gong J
    Causal effect of visceral adipose tissue accumulation on the inflammatory bowel disease: a Mendelian randomization study.
    J Crohns Colitis. 2023 Feb 20:jjad026. doi: 10.1093.
    PubMed    


  278. RISPO A, Calabrese G, Testa A, Imperatore N, et al
    Hocus Pocus: The Role Of Handheld Ultrasonography In Predicting Disease Extension And Endoscopic Activity In Ulcerative Colitis.
    J Crohns Colitis. 2023 Feb 16:jjad024. doi: 10.1093.
    PubMed     Abstract available


  279. REZAZADEH ARDABILI A, van Esser D, Wintjens D, Cilissen M, et al
    Development and validation of a remote monitoring tool for assessment of mild, moderate, and severe infections in Inflammatory Bowel Disease.
    J Crohns Colitis. 2023 Feb 16:jjad023. doi: 10.1093.
    PubMed     Abstract available


  280. DONNELLY M, Ryan OK, Ryan EJ, Bass GA, et al
    Comparison of restorative proctocolectomy with and without defunctioning loop ileostomy in patients with ulcerative colitis - A systematic review and meta-analysis.
    J Crohns Colitis. 2023 Feb 13:jjad021. doi: 10.1093.
    PubMed     Abstract available



  281. Corrigendum to: Long-term Oncological Outcome of Segmental Versus Extended Colectomy for Colorectal Cancer in Crohn's Disease: Results from an International Multicentre Study.
    J Crohns Colitis. 2023 Feb 9:jjac158. doi: 10.1093.
    PubMed    


  282. SCHREIBER S, Feagan BG, Peyrin-Biroulet L, Vermeire S, et al
    Filgotinib Improved Health-Related Quality of Life and Led to Comprehensive Disease Control in Individuals with Ulcerative Colitis: Data from SELECTION.
    J Crohns Colitis. 2023 Feb 9:jjad018. doi: 10.1093.
    PubMed     Abstract available


  283. REENAERS C, Gillard RP, Coimbra C, Gillard RM, et al
    Clinical and MRI evolution after local injection of bone marrow-derived mesenchymal stem cells in perianal fistulae in Crohn's disease: results from a prospective monocentric study.
    J Crohns Colitis. 2023 Feb 3:jjac192. doi: 10.1093.
    PubMed     Abstract available


    January 2023
  284. VERSTOCKT B, Pouillon L, Ballaux F, Jorissen C, et al
    Patient reported outcomes and disability are associated with histological disease activity in patients with ulcerative colitis: results from the APOLLO study.
    J Crohns Colitis. 2023 Jan 27:jjad015. doi: 10.1093.
    PubMed     Abstract available


  285. VERBURGT CM, Dunn KA, Ghiboub M, Lewis JD, et al
    Successful Dietary Therapy in Paediatric Crohn's Disease is Associated with Shifts in Bacterial Dysbiosis and Inflammatory Metabotype Towards Healthy Controls.
    J Crohns Colitis. 2023;17:61-72.
    PubMed     Abstract available


  286. SHARIP MT, Subramanian S
    IBD Risk-It Is All in the Family!
    J Crohns Colitis. 2023;17:28-29.
    PubMed    


  287. TORRES J, Chaparro M, Julsgaard M, Katsanos K, et al
    European Crohn's and Colitis Guidelines on Sexuality, Fertility, Pregnancy, and Lactation.
    J Crohns Colitis. 2023;17:1-27.
    PubMed    


  288. CASAS-DEZA D, Lamuela-Calvo LJ, Gomollon F, Arbones-Mainar JM, et al
    Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn's Disease: Real World Evidence From the ENEIDA Registry.
    J Crohns Colitis. 2023;17:83-91.
    PubMed     Abstract available


  289. AMIOT A, Rahier JF, Baert F, Nahon S, et al
    The Impact of COVID-19 on Patients with IBD in a Prospective European Cohort Study.
    J Crohns Colitis. 2023;17:37-48.
    PubMed     Abstract available


  290. SIMSEK M, Schepers F, Kaplan S, van Asseldonk D, et al
    Thioguanine is effective as maintenance therapy for inflammatory bowel disease: a prospective multicentre registry study.
    J Crohns Colitis. 2023 Jan 25:jjad013. doi: 10.1093.
    PubMed     Abstract available


  291. SHUBHAKAR A, Jansen BC, Adams AT, Reiding KR, et al
    Serum N-Glycomic Biomarkers Predict Treatment Escalation in Inflammatory Bowel Disease.
    J Crohns Colitis. 2023 Jan 24:jjad012. doi: 10.1093.
    PubMed     Abstract available


  292. CHANG MJ, Hao JW, Qiao J, Chen MR, et al
    A compendium of mucosal molecular characteristics provides novel perspectives on the treatment of ulcerative colitis.
    J Crohns Colitis. 2023 Jan 22:jjad011. doi: 10.1093.
    PubMed     Abstract available


  293. CAO S, Colonna M, Deepak P
    Pathogenesis of Perianal Fistulizing Crohn's Disease: Current knowledge, gaps in understanding and future research directions.
    J Crohns Colitis. 2023 Jan 19:jjad008. doi: 10.1093.
    PubMed     Abstract available


  294. SOSNOVSKI KE, Braun T, Amir A, Moshel D, et al
    GATA6-AS1 regulates intestinal epithelial mitochondrial functions, and its reduced expression is linked to intestinal inflammation and less favorable disease course in ulcerative colitis (UC).
    J Crohns Colitis. 2023 Jan 19:jjad006. doi: 10.1093.
    PubMed     Abstract available


  295. SUN Z, Liu MS
    Genetic evidence for causal relationship between body mass index and inflammatory bowel disease: a Mendelian randomisation study.
    J Crohns Colitis. 2023 Jan 19:jjad007. doi: 10.1093.
    PubMed    


  296. GISBERT JP, Garcia MJ, Chaparro M
    Rescue therapies for steroid-refractory acute severe ulcerative colitis: A review.
    J Crohns Colitis. 2023 Jan 18:jjad004. doi: 10.1093.
    PubMed     Abstract available


  297. NOOR NM, Sousa P, Bettenworth D, Gomollon F, et al
    ECCO Topical Review on Biological Treatment Cycles in Crohn's Disease.
    J Crohns Colitis. 2023 Jan 10:jjad001. doi: 10.1093.
    PubMed     Abstract available



  298. Corrigendum to: Efficacy and Outcomes of Faecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection in Children with Inflammatory Bowel Disease.
    J Crohns Colitis. 2023 Jan 4:jjac195. doi: 10.1093.
    PubMed    


    December 2022

  299. Erratum to: Tofacitinib for the Treatment of Ulcerative Colitis: An Integrated Summary of up to 7.8 Years of Safety Data from the Global Clinical Programme.
    J Crohns Colitis. 2022 Dec 29:jjac180. doi: 10.1093.
    PubMed    


  300. CHEN J, Zhou Y, Sun Y, Yuan S, et al
    Bi-directional Mendelian randomization analysis provides evidence for the causal involvement of dysregulation of CXCL9, CCL11 and CASP8 in the pathogenesis of ulcerative colitis.
    J Crohns Colitis. 2022 Dec 28:jjac191. doi: 10.1093.
    PubMed     Abstract available


  301. JE Y, Han K, Chun J, Kim Y, et al
    Association of Waist Circumference with the Risk of Inflammatory Bowel Disease: a Nationwide Cohort Study of 10 Million Individuals in Korea.
    J Crohns Colitis. 2022 Dec 23:jjac193. doi: 10.1093.
    PubMed     Abstract available


  302. WETWITTAYAKHLANG P, Gonczi L, Lakatos L, Kurti Z, et al
    Long-term Colectomy rates of Ulcerative Colitis over 40-year of Different Therapeutic eras - Results from Western Hungarian Population-based Inception Cohort between 1977-2020.
    J Crohns Colitis. 2022 Dec 20:jjac188. doi: 10.1093.
    PubMed     Abstract available


  303. GORDON H, Biancone L, Fiorino G, Katsanos KH, et al
    ECCO Guidelines on Inflammatory Bowel Disease and Malignancies.
    J Crohns Colitis. 2022 Dec 18:jjac187. doi: 10.1093.
    PubMed    


  304. TAKAHASHI K, Shigeyasu K, Kondo Y, Gotoh K, et al
    RNA editing is a valuable biomarker for predicting carcinogenesis in ulcerative colitis.
    J Crohns Colitis. 2022 Dec 18:jjac186. doi: 10.1093.
    PubMed     Abstract available


  305. TAKENAKA K, Kawamoto A, Kitazume Y, Fujii T, et al
    Transmural remission characterized by high biologic concentrations demonstrates better prognosis in Crohn's disease.
    J Crohns Colitis. 2022 Dec 17:jjac185. doi: 10.1093.
    PubMed     Abstract available


  306. KHALILI H, Hakansson N, Casey K, Lopes E, et al
    Diet Quality and Risk of Older-Onset Crohn's Disease and Ulcerative Colitis.
    J Crohns Colitis. 2022 Dec 15:jjac184. doi: 10.1093.
    PubMed     Abstract available


  307. CROUWEL F, Simsek M, de Boer MA, Mulder CJJ, et al
    Exposure to thioguanine during 117 pregnancies in women with inflammatory bowel disease.
    J Crohns Colitis. 2022 Dec 15:jjac183. doi: 10.1093.
    PubMed     Abstract available


  308. UCHIYAMA K, Takagi T, Mizushima K, Hirai Y, et al
    Mucosal addressin cell adhesion molecule 1 expression reflects mucosal inflammation and subsequent relapse in patients with ulcerative colitis.
    J Crohns Colitis. 2022 Dec 13:jjac182. doi: 10.1093.
    PubMed     Abstract available


  309. HAMON A, Cazals-Hatem D, Stefanescu C, Uzzan M, et al
    Crohn-like disease affecting small bowel due to monogenic SLCO2A1 mutations: First cases of Chronic Enteropathy Associated with SLCO2A1 gene (CEAS) in France.
    J Crohns Colitis. 2022 Dec 8:jjac181. doi: 10.1093.
    PubMed     Abstract available


  310. YANAI H, Kagramanova A, Knyazev O, Sabino J, et al
    Endoscopic Postoperative Recurrence in Crohn's Disease After Curative Ileocecal Resection with Early Prophylaxis by Anti-TNF, Vedolizumab or Ustekinumab: A Real-World Multicentre European Study.
    J Crohns Colitis. 2022;16:1882-1892.
    PubMed     Abstract available


  311. LIU Z, Julsgaard M, Zhu X, Martin J, et al
    Timing of Live Attenuated Vaccination in Infants Exposed to Infliximab or Adalimumab in Utero: A Prospective Cohort Study in 107 Children.
    J Crohns Colitis. 2022;16:1835-1844.
    PubMed     Abstract available


  312. BHAT S, Rieder F
    Hypoxia-Inducible Factor 1-Alpha Stabilizers in the Treatment of Inflammatory Bowel Diseases: Oxygen as a Novel IBD Therapy?
    J Crohns Colitis. 2022;16:1924-1932.
    PubMed     Abstract available


  313. MITROVA K, Pipek B, Bortlik M, Bouchner L, et al
    Safety of Ustekinumab and Vedolizumab During Pregnancy-Pregnancy, Neonatal, and Infant Outcome: A Prospective Multicentre Study.
    J Crohns Colitis. 2022;16:1808-1815.
    PubMed     Abstract available


  314. HAMILTON AL, De Cruz P, Wright EK, Dervieux T, et al
    Non-invasive Serological Monitoring for Crohn's Disease Postoperative Recurrence.
    J Crohns Colitis. 2022;16:1797-1807.
    PubMed     Abstract available


  315. LEE C, Song JH, Cha YE, Chang DK, et al
    Intestinal Epithelial Responses to IL-17 in Adult Stem Cell-derived Human Intestinal Organoids.
    J Crohns Colitis. 2022;16:1911-1923.
    PubMed     Abstract available


  316. PELLINO G, Rottoli M, Mineccia M, Frontali A, et al
    Segmental Versus Total Colectomy for Crohn's Disease in the Biologic Era: Results From The SCOTCH International, Multicentric Study.
    J Crohns Colitis. 2022;16:1853-1861.
    PubMed     Abstract available


  317. ARP L, Jansson S, Wewer V, Burisch J, et al
    Psychiatric Disorders in Adult and Paediatric Patients With Inflammatory Bowel Diseases - A Systematic Review and Meta-Analysis.
    J Crohns Colitis. 2022;16:1933-1945.
    PubMed     Abstract available


  318. BARBERIO B, Savarino E, Verstockt B, Fumery M, et al
    Hereditary Colorectal Cancer Syndromes and Inflammatory Bowel Diseases: an ECCO CONFER Multicentre Case Series.
    J Crohns Colitis. 2022;16:1845-1852.
    PubMed     Abstract available


  319. BATTAT R
    Serum Monitoring of Recurrence in Post-Operative Crohn's Disease: Have We Arrived?
    J Crohns Colitis. 2022;16:1795-1796.
    PubMed    


  320. MAHAJNA H, Verstockt B, Bergemalm D, Castiglione F, et al
    Idiopathic Thrombocytopenic Purpura associated with Inflammatory Bowel Disease: a multi-centre ECCO CONFER case series.
    J Crohns Colitis. 2022 Dec 2:jjac179. doi: 10.1093.
    PubMed     Abstract available


    November 2022
  321. EL-ZIMAITY H, Shaffer SR, Riddell RH, Pai RK, et al
    Beyond Neutrophils for predicting relapse and remission in ulcerative colitis.
    J Crohns Colitis. 2022 Nov 25:jjac178. doi: 10.1093.
    PubMed     Abstract available


  322. KONTOLA K, Oksanen P, Huhtala H, Jussila A, et al
    Increasing incidence of inflammatory bowel disease with greatest change among the elderly: a nationwide study in Finland, 2000-2020.
    J Crohns Colitis. 2022 Nov 24:jjac177. doi: 10.1093.
    PubMed     Abstract available


  323. FIOCCHI C, Iliopoulos D
    Numbers Do Not Lie: The Dire Need for New Directions in IBD.
    J Crohns Colitis. 2022;16:1649-1650.
    PubMed    


  324. KRUIS W, Siegmund B, Lesniakowski K, Simanenkov V, et al
    Novel Budesonide Suppository and Standard Budesonide Rectal Foam Induce High Rates of Clinical Remission and Mucosal Healing in Active Ulcerative Proctitis: a Randomised, Controlled, Non-inferiority Trial.
    J Crohns Colitis. 2022;16:1714-1724.
    PubMed     Abstract available


  325. ZUO L, Li J, Zhang X, Geng Z, et al
    Aberrant Mesenteric Adipose Extracellular Matrix Remodelling is Involved in Adipocyte Dysfunction in Crohn's Disease: The Role of TLR-4-mediated Macrophages.
    J Crohns Colitis. 2022;16:1762-1776.
    PubMed     Abstract available


  326. BACHOUR SP, Shah RS, Rieder F, Qazi T, et al
    Intra-abdominal septic complications after ileocolic resection increases risk for endoscopic and surgical postoperative Crohn's disease recurrence.
    J Crohns Colitis. 2022;16:1696-1705.
    PubMed     Abstract available


  327. BERERA S, Ioannou SC, Morillo D, Mantero AMA, et al
    Combining Pentoxifylline With Vedolizumab for Crohn's Disease: Results of a Randomised, Placebo-controlled Pilot Study.
    J Crohns Colitis. 2022;16:1687-1695.
    PubMed     Abstract available


  328. KORI M, Zamir Y, Yermiyahu SO, Ainbinder I, et al
    The association of Inflammatory Bowel Disease with Celiac Disease and Celiac Autoimmunity in children and adults: A nationwide study from the epi-IIRN.
    J Crohns Colitis. 2022 Nov 17. pii: 6832168. doi: 10.1093.
    PubMed     Abstract available


  329. KUMAR L, Doherty G
    The Tortoise (Endoscopy-Driven Treatment) and the Hare (Prophylactic Treatment): Who Wins the Race to Beat Post-Operative Recurrence of Crohn's Disease?
    J Crohns Colitis. 2022 Nov 17:jjac165. doi: 10.1093.
    PubMed    


  330. VAN DER DOES DE WILLEBOIS EML, Duijvestein M, Wasmann KA, D'Haens GRAM, et al
    Endoscopic Recurrence or Anastomotic Wound Healing Phenomenon after Ileocolic Resection for Crohn's Disease: The Challenges of Accurate Endoscopic Scoring.
    J Crohns Colitis. 2022 Nov 16:jjac175. doi: 10.1093.
    PubMed     Abstract available


  331. BATTAT R, Scherl EJ, Lukin D, Charilaou P, et al
    Increased Primary Bile Acids with Ileocolonic Resection Impact Ileal Inflammation and Gut Microbiota in Inflammatory Bowel Disease.
    J Crohns Colitis. 2022 Nov 2. pii: 6794155. doi: 10.1093.
    PubMed     Abstract available


  332. ELLUL P, Schembri J, Baldacchino VA, Molnar T, et al
    Post-inflammatory polyps burden as a prognostic marker of disease-outcome in patients with inflammatory bowel disease.
    J Crohns Colitis. 2022 Nov 2. pii: 6794125. doi: 10.1093.
    PubMed     Abstract available


  333. DUPONT-LUCAS C, Leroyer A, Ley D, Spyckerelle C, et al
    Increased risk of cancer and mortality in a large French population-based paediatric-onset inflammatory bowel disease retrospective cohort.
    J Crohns Colitis. 2022 Nov 1. pii: 6783208. doi: 10.1093.
    PubMed     Abstract available


  334. BOUCHER D, Barnich N
    Phage Therapy Against Adherent-invasive E. coli: Towards a Promising Treatment of Crohn's Disease Patients?
    J Crohns Colitis. 2022;16:1509-1510.
    PubMed    


  335. DAL BUONO A, Faita F, Peyrin-Biroulet L, Danese S, et al
    Ultrasound Elastography in Inflammatory Bowel Diseases: A Systematic Review of Accuracy Compared with Histopathological Assessment.
    J Crohns Colitis. 2022;16:1637-1646.
    PubMed     Abstract available


  336. DE VOOGD F, Bots S, Gecse K, Gilja OH, et al
    Intestinal Ultrasound Early on in Treatment Follow-up Predicts Endoscopic Response to Anti-TNFalpha Treatment in Crohn's Disease.
    J Crohns Colitis. 2022;16:1598-1608.
    PubMed     Abstract available


  337. DUBINSKY V, Reshef L, Rabinowitz K, Wasserberg N, et al
    Escherichia coli Strains from Patients with Inflammatory Bowel Diseases have Disease-specific Genomic Adaptations.
    J Crohns Colitis. 2022;16:1584-1597.
    PubMed     Abstract available


  338. MONFORT-FERRE D, Caro A, Menacho M, Marti M, et al
    The Gut Microbiota Metabolite Succinate Promotes Adipose Tissue Browning in Crohn's Disease.
    J Crohns Colitis. 2022;16:1571-1583.
    PubMed     Abstract available


  339. HU S, Mok J, Gowans M, Ong DEH, et al
    Oral Microbiome of Crohn's Disease Patients With and Without Oral Manifestations.
    J Crohns Colitis. 2022;16:1628-1636.
    PubMed     Abstract available


  340. KUMAR S, Parry T, Mallett S, Bhatnagar G, et al
    Diagnostic Performance of Magnetic Resonance Enterography Disease Activity Indices Compared with a Histological Reference Standard for Adult Terminal Ileal Crohn's Disease: Experience from the METRIC Trial.
    J Crohns Colitis. 2022;16:1531-1539.
    PubMed     Abstract available


    October 2022
  341. BARRAU M, Duprat M, Veyrard P, Tournier Q, et al
    A Systematic Review on the interest of Drug Tolerant assay in the monitoring of Inflammatory Bowel Disease.
    J Crohns Colitis. 2022 Oct 27. pii: 6775962. doi: 10.1093.
    PubMed     Abstract available


  342. LE HD, Pflaum T, Labrenz J, Sari S, et al
    Interobserver reliability of the Nancy index for ulcerative colitis: An assessment of the practicability and ease of use in a single-centre real-world setting.
    J Crohns Colitis. 2022 Oct 25. pii: 6773056. doi: 10.1093.
    PubMed     Abstract available


  343. TARGOWNIK L, Dubinsky MC, Steinwurz F, Bushmakin AG, et al
    Disease Activity and Health-related Quality of Life Relationships with Work Productivity in Patients with Ulcerative Colitis in OCTAVE Induction 1&2 and OCTAVE Sustain.
    J Crohns Colitis. 2022 Oct 22. pii: 6769962. doi: 10.1093.
    PubMed     Abstract available


  344. BYRNE MF, Panaccione R, East JE, Iacucci M, et al
    Application of Deep Learning Models to Improve Ulcerative Colitis Endoscopic Disease Activity Scoring Under Multiple Scoring Systems.
    J Crohns Colitis. 2022 Oct 18. pii: 6762568. doi: 10.1093.
    PubMed     Abstract available



  345. Erratum to: Prevalence and Outcomes of COVID-19 Among Patients With Inflammatory Bowel Disease-A Danish Prospective Population-based Cohort Study.
    J Crohns Colitis. 2022 Oct 17. pii: 6761987. doi: 10.1093.
    PubMed    


  346. FOLLIN-ARBELET B, Milada SC, Hovde O, Jelsness-Jorgensen LP, et al
    Mortality in patients with Inflammatory Bowel Disease: Results from 30 years of follow-up in a Norwegian inception cohort (the IBSEN study).
    J Crohns Colitis. 2022 Oct 14. pii: 6761119. doi: 10.1093.
    PubMed     Abstract available


  347. VIEUJEAN S, Moens A, Hassid D, Rothfuss K, et al
    Pneumocystis jirovecii pneumonia in patients with inflammatory bowel disease - A case series.
    J Crohns Colitis. 2022 Oct 12. pii: 6759599. doi: 10.1093.
    PubMed     Abstract available


  348. OTERO-PINEIRO AM, Jia X, Pedersen KE, Hull T, et al
    Surgical Intervention is Effective for the Treatment of Crohn's related Rectovaginal Fistulas: Experience From A Tertiary Inflammatory Bowel Disease Practice.
    J Crohns Colitis. 2022 Oct 11. pii: 6758392. doi: 10.1093.
    PubMed     Abstract available


  349. BAHNAM P, Hanzel J, Ma C, Zou L, et al
    Most placebo-controlled trials in inflammatory bowel disease were underpowered because of overestimated drug efficacy rates: Results from a systematic review of induction studies.
    J Crohns Colitis. 2022 Oct 11. pii: 6758390. doi: 10.1093.
    PubMed     Abstract available


  350. NYSTROM N, Prast-Nielsen S, Correia M, Globisch D, et al
    Mucosal and plasma metabolomes in new-onset paediatric inflammatory bowel disease: correlations with disease characteristics and plasma inflammation protein markers.
    J Crohns Colitis. 2022 Oct 11. pii: 6758389. doi: 10.1093.
    PubMed     Abstract available


  351. HANZEL J, Bossuyt P, Pittet V, Samaan M, et al
    Development of a Core Outcome Set for Real-World Data in Inflammatory Bowel Disease: A European Crohn's and Colitis Organisation (ECCO) Position Paper.
    J Crohns Colitis. 2022 Oct 3. pii: 6747109. doi: 10.1093.
    PubMed     Abstract available


    September 2022
  352. SCHOEFS E, Vermeire S, Ferrante M, Sabino J, et al
    What are the unmet needs and most relevant treatment outcomes according to patients with inflammatory bowel disease? A qualitative patient preference study.
    J Crohns Colitis. 2022 Sep 27. pii: 6722595. doi: 10.1093.
    PubMed     Abstract available


  353. CROFT NM, de Ridder L, Griffiths AM, Hyams JS, et al
    Paediatric inflammatory bowel disease: a multi-stakeholder perspective to improve development of drugs for children and adolescents.
    J Crohns Colitis. 2022 Sep 21. pii: 6710188. doi: 10.1093.
    PubMed     Abstract available


  354. LOUIS E, Siegel CA, James B, Heidenreich S, et al
    Patients with Inflammatory Bowel Disease Have Heterogeneous Treatment Preferences That Are Largely Determined by the Avoidance of Abdominal Pain and Side Effects [P-POWER IBD Study].
    J Crohns Colitis. 2022 Sep 20. pii: 6708291. doi: 10.1093.
    PubMed     Abstract available



  355. Erratum to: You Are What You Eat? Growing Evidence That Diet Influences the Risk of Inflammatory Bowel Disease.
    J Crohns Colitis. 2022 Sep 19. pii: 6706938. doi: 10.1093.
    PubMed    


  356. KURTI Z, Gonczi L, Lakatos L, Golovics P, et al
    Epidemiology, treatment strategy, natural disease course and surgical outcomes of patients with ulcerative colitis in Western Hungary - a population-based study between 2007 and 2018, data from the Veszprem County cohort.
    J Crohns Colitis. 2022 Sep 19. pii: 6705518. doi: 10.1093.
    PubMed     Abstract available


  357. DORN-RASMUSSEN M, Lo B, Zhao M, Kaplan GG, et al
    The incidence and prevalence of paediatric- and adult-onset inflammatory bowel disease in Denmark during a 37-year period - a nationwide cohort study (1980-2017).
    J Crohns Colitis. 2022 Sep 19. pii: 6705459. doi: 10.1093.
    PubMed     Abstract available


  358. WEWER MD, Langholz E, Munkholm P, Bendtsen F, et al
    Disease Activity Patterns of Inflammatory Bowel Disease - A Danish Nationwide Cohort Study 1995-2018.
    J Crohns Colitis. 2022 Sep 19. pii: 6705004. doi: 10.1093.
    PubMed     Abstract available


  359. SANDBORN WJ, D'Haens GR, Sands BE, Panaccione R, et al
    Tofacitinib for the treatment of ulcerative colitis: an integrated summary of up to 7.8 years of safety data from the global clinical program.
    J Crohns Colitis. 2022 Sep 17. pii: 6702643. doi: 10.1093.
    PubMed     Abstract available


  360. MORTLOCK S, Lord A, Montgomery G, Zakrzewski M, et al
    An extremes of phenotype approach confirms significant genetic heterogeneity in patients with ulcerative colitis.
    J Crohns Colitis. 2022 Sep 16. pii: 6701957. doi: 10.1093.
    PubMed     Abstract available


  361. OLIVERA PA, Lasa JS, Zubiaurre I, Jairath V, et al
    Opportunistic Infections in Patients with Inflammatory Bowel Disease Treated with Advanced Therapies: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    J Crohns Colitis. 2022 Sep 10. pii: 6695362. doi: 10.1093.
    PubMed     Abstract available


  362. DREWES AM
    Pain in Patients with Crohn's and Colitis: Can We Solve the Puzzle?
    J Crohns Colitis. 2022;16:1345-1346.
    PubMed    


  363. MAGRO F, Estevinho MM
    COVID-19 Vaccines in IBD Patients: Particularities and Future Perspectives.
    J Crohns Colitis. 2022;16:1343-1344.
    PubMed    


  364. SMITH PJ, Critchley L, Storey D, Gregg B, et al
    Efficacy and Safety of Elective Switching from Intravenous to Subcutaneous Infliximab [CT-P13]: A Multicentre Cohort Study.
    J Crohns Colitis. 2022;16:1436-1446.
    PubMed     Abstract available


  365. XU C, Jiang W, Wang L, Mao X, et al
    Intestinal Ultrasound for Differentiating Fibrotic or Inflammatory Stenosis in Crohn's Disease: A Systematic Review and Meta-analysis.
    J Crohns Colitis. 2022;16:1493-1504.
    PubMed     Abstract available


  366. BURRELLO C, Strati F, Lattanzi G, Diaz-Basabe A, et al
    IL10 Secretion Endows Intestinal Human iNKT Cells with Regulatory Functions Towards Pathogenic T Lymphocytes.
    J Crohns Colitis. 2022;16:1461-1474.
    PubMed     Abstract available


  367. SAVELKOUL EHJ, Maas MHJ, Bourgonje AR, Crouwel F, et al
    Favourable Tolerability and Drug Survival of Tioguanine Versus Methotrexate After Failure of Conventional Thiopurines in Crohn's Disease.
    J Crohns Colitis. 2022;16:1372-1379.
    PubMed     Abstract available


  368. SONNENBERG A, Genta RM
    Temporal changes in the histology of microscopic colitis.
    J Crohns Colitis. 2022;16:1415-1419.
    PubMed     Abstract available


  369. DOHERTY J, Morain NO, Stack R, Girod P, et al
    Reduced Serological Response to COVID-19 Vaccines in Patients with IBD is Further Diminished by TNF Inhibitor Therapy; Early Results of the VARIATION study [VAriability in Response in IBD Against SARS-COV-2 ImmunisatiON].
    J Crohns Colitis. 2022;16:1354-1362.
    PubMed     Abstract available


    August 2022
  370. VITALI R, Palone F, Armuzzi A, Fulci V, et al
    Proteomic analysis identifies three reliable biomarkers of intestinal inflammation in the stools of patients with Inflammatory Bowel Disease.
    J Crohns Colitis. 2022 Aug 30. pii: 6679173. doi: 10.1093.
    PubMed     Abstract available


  371. JULIEN C, Anakok E, Treton X, Nachury M, et al
    Impact of the Ileal Microbiota on Surgical Site Infections in Crohn's Disease: A Nationwide Prospective Cohort.
    J Crohns Colitis. 2022;16:1211-1221.
    PubMed     Abstract available


  372. BRETON J, Tanes C, Tu V, Albenberg L, et al
    A Microbial Signature for Paediatric Perianal Crohn's Disease.
    J Crohns Colitis. 2022;16:1281-1292.
    PubMed     Abstract available


  373. SUDHAKAR P, Alsoud D, Wellens J, Verstockt S, et al
    Tailoring Multi-omics to Inflammatory Bowel Diseases: All for One and One for All.
    J Crohns Colitis. 2022;16:1306-1320.
    PubMed     Abstract available


  374. NGOLLO M, Perez K, Hammoudi N, Gorelik Y, et al
    Identification of Gene Expression Profiles Associated with an Increased Risk of Post-Operative Recurrence in Crohn's Disease.
    J Crohns Colitis. 2022;16:1269-1280.
    PubMed     Abstract available


  375. KALLA R, Adams AT, Nowak JK, Bergemalm D, et al
    Analysis of systemic epigenetic alterations in inflammatory bowel disease: defining geographical, genetic, and immune-inflammatory influences on the circulating methylome.
    J Crohns Colitis. 2022 Aug 27. pii: 6677995. doi: 10.1093.
    PubMed     Abstract available


  376. LOFTUS EV, Vermeire S, Feagan BG, Le Brun FO, et al
    Corticosteroid-sparing Effects of Filgotinib in Moderate to Severely Active Ulcerative Colitis: Data from the Phase 2b/3 SELECTION Study.
    J Crohns Colitis. 2022 Aug 25. pii: 6675518. doi: 10.1093.
    PubMed     Abstract available


  377. NARULA N, Merat S, Liu D, Pugatch D, et al
    Time to endorse a sensitive method for scoring endoscopic activity of ulcerative colitis in clinical research.
    J Crohns Colitis. 2022 Aug 24. pii: 6674697. doi: 10.1093.
    PubMed     Abstract available


  378. JOUSTRA V, Hageman IL, Satsangi J, Adams A, et al
    Systematic Review and Meta-analysis of Peripheral Blood DNA methylation studies in Inflammatory Bowel Disease.
    J Crohns Colitis. 2022 Aug 23. pii: 6674036. doi: 10.1093.
    PubMed     Abstract available



  379. Corrigendum to: P169 Vitamin D levels are inversely associated with inflammation in pediatric Inflammatory Bowel Disease patients.
    J Crohns Colitis. 2022 Aug 22. pii: 6673037. doi: 10.1093.
    PubMed    


  380. LIN V, Gogenur S, Pachler F, Fransgaard T, et al
    Risk prediction for complications in Inflammatory Bowel Disease surgery: External validation of the American College of Surgeons' National Surgical Quality Improvement Program Surgical Risk Calculator.
    J Crohns Colitis. 2022 Aug 17. pii: 6668838. doi: 10.1093.
    PubMed     Abstract available


  381. HONAP S, Irving PM, Samaan MA
    Ustekinumab-Induced Inflammatory Demyelinating Polyneuropathy in a Patient with Ulcerative Colitis.
    J Crohns Colitis. 2022 Aug 12. pii: 6663939. doi: 10.1093.
    PubMed    


  382. CARON B, D'Amico F, Jairath V, Netter P, et al
    Available methods for benefit-risk assessment: lessons for inflammatory bowel disease drugs.
    J Crohns Colitis. 2022 Aug 11. pii: 6661406. doi: 10.1093.
    PubMed     Abstract available


  383. HARVEY PR, Coupland B, Mytton J, De Silva S, et al
    Venous thromboembolism following discharge from hospital in patients admitted for inflammatory bowel disease.
    J Crohns Colitis. 2022 Aug 10. pii: 6660709. doi: 10.1093.
    PubMed     Abstract available


  384. TORRES J, Gomes C, Jensen C, Agrawal M, et al
    Risk factors for developing Inflammatory Bowel Disease Within and Across Families with Family History of IBD.
    J Crohns Colitis. 2022 Aug 9. pii: 6659033. doi: 10.1093.
    PubMed     Abstract available


  385. LIU X, Ren X, Zhou L, Liu K, et al
    Tollip Orchestrates Macrophage Polarization to Alleviate Intestinal Mucosal Inflammation.
    J Crohns Colitis. 2022;16:1151-1167.
    PubMed     Abstract available


  386. NARULA N, Pray C, Wong ECL, Colombel JF, et al
    Categorising Endoscopic Severity of Crohn's Disease Using the Modified Multiplier SES-CD [MM-SES-CD].
    J Crohns Colitis. 2022;16:1011-1019.
    PubMed     Abstract available


  387. HUANG L, Qian W, Xu Y, Guo Z, et al
    Mesenteric Adipose Tissue Contributes to Intestinal Fibrosis in Crohn's Disease Through the ATX-LPA Axis.
    J Crohns Colitis. 2022;16:1124-1139.
    PubMed     Abstract available


  388. BARREIRO-DE ACOSTA M, Riestra S, Calafat M, Soto MP, et al
    Management and Long-term Outcomes of Crohn's Disease Complicated with Enterocutaneous Fistula: ECUFIT Study from GETECCU.
    J Crohns Colitis. 2022;16:1049-1058.
    PubMed     Abstract available


  389. FIERENS L, Liefferinckx C, Hoefkens E, Lobaton T, et al
    Introduction of Subcutaneous Infliximab CT-P13 and Vedolizumab in Clinical Practice: A Multi-Stakeholder Position Statement Highlighting the Need for Post-Marketing Studies.
    J Crohns Colitis. 2022;16:1059-1069.
    PubMed     Abstract available


  390. ABD EL AZIZ MA, Abdalla S, Calini G, Saeed H, et al
    Postoperative Safety Profile of Minimally Invasive Ileocolonic Resections for Crohn's Disease in the Era of Biologic Therapy.
    J Crohns Colitis. 2022;16:1079-1088.
    PubMed     Abstract available


  391. GAO H, He Q, Xu C, Pang Z, et al
    The Development and Validation of Anti-paratuberculosis-nocardia Polypeptide Antibody [Anti-pTNP] for the Diagnosis of Crohn's Disease.
    J Crohns Colitis. 2022;16:1110-1123.
    PubMed     Abstract available


  392. CROUWEL F, Buiter HJC, de Boer NK
    The Thiopurine Tale: An Unexpected Journey.
    J Crohns Colitis. 2022;16:1177-1183.
    PubMed     Abstract available


  393. DOUADI C, Vazeille E, Chambon C, Hebraud M, et al
    Anti-TNF Agents Restrict Adherent-invasive Escherichia coli Replication Within Macrophages Through Modulation of Chitinase 3-like 1 in Patients with Crohn's Disease.
    J Crohns Colitis. 2022;16:1140-1150.
    PubMed     Abstract available


  394. ATIA O, Kang B, Orlansky-Meyer E, Ledder O, et al
    Existing Prediction Models of Disease Course in Paediatric Crohn's Disease Are Poorly Replicated in a Prospective Inception Cohort.
    J Crohns Colitis. 2022;16:1039-1048.
    PubMed     Abstract available


    July 2022
  395. DIRVANSKYTE P, Gurram B, Bolton C, Warner N, et al
    Chromosomal numeric aberrations and rare copy number variation in patients with inflammatory bowel disease.
    J Crohns Colitis. 2022 Jul 30. pii: 6652479. doi: 10.1093.
    PubMed     Abstract available


  396. WONG D, Matini L, Kormilitzin A, Kantschuster R, et al
    Patient Reported Outcomes: the ICHOM Standard Set for inflammatory bowel disease in real life practice helps quantify deficits in current care.
    J Crohns Colitis. 2022 Jul 22. pii: 6648780. doi: 10.1093.
    PubMed     Abstract available


  397. YARUR AJ
    Intestinal Tissue Levels of Anti-Tumour Necrosis Factor Agents in Patients with Inflammatory Bowel Diseases: Are We Looking in The Right Place at The Right Time?
    J Crohns Colitis. 2022;16:869-870.
    PubMed    


  398. MAGRO F, Sabino J, Rosini F, Tripathi M, et al
    ECCO Position on Harmonisation of Crohn's Disease Mucosal Histopathology.
    J Crohns Colitis. 2022;16:876-883.
    PubMed     Abstract available


  399. SENSI B, Khan J, Warusavitarne J, Nardi A, et al
    Long-term Oncological Outcome of Segmental Versus Extended Colectomy for Colorectal Cancer in Crohn's Disease: Results from an International Multicentre Study.
    J Crohns Colitis. 2022;16:954-962.
    PubMed     Abstract available


  400. CHAKRABORTY R, Maltz MR, Del Castillo D, Tandel PN, et al
    Selective Targeting of Tumour Necrosis Factor Receptor 1 Induces Stable Protection from Crohn's-Like Ileitis in TNFDeltaARE Mice.
    J Crohns Colitis. 2022;16:978-991.
    PubMed     Abstract available


  401. PETERS V, Bolte L, Schuttert EM, Andreu-Sanchez S, et al
    Western and Carnivorous Dietary Patterns are Associated with Greater Likelihood of IBD Development in a Large Prospective Population-based Cohort.
    J Crohns Colitis. 2022;16:931-939.
    PubMed     Abstract available


  402. CARON B, Sandborn WJ, Panaccione R, Schreiber S, et al
    Efficacy of Pharmacological Agents for Ulcerative Proctitis: A Systematic Literature Review.
    J Crohns Colitis. 2022;16:922-930.
    PubMed     Abstract available


  403. WALSHE M, Nayeri S, Ji J, Hernandez-Rocha C, et al
    A Role for CXCR3 Ligands as Biomarkers of Post-Operative Crohn's Disease Recurrence.
    J Crohns Colitis. 2022;16:900-910.
    PubMed     Abstract available


  404. SWAMINATHAN A, Borichevsky GM, Edwards TS, Hirschfeld E, et al
    Faecal Myeloperoxidase as a Biomarker of Endoscopic Activity in Inflammatory Bowel Disease.
    J Crohns Colitis. 2022 Jul 8. pii: 6634254. doi: 10.1093.
    PubMed     Abstract available


    June 2022
  405. ZHANG R, Lauwers GY, Choi WT
    Increased Risk of Non-Conventional and Invisible Dysplasias in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease.
    J Crohns Colitis. 2022 Jun 30. pii: 6623587. doi: 10.1093.
    PubMed     Abstract available



  406. Corrigendum to: ECCO CONFER Investigators, Diagnosis and Outcome of Extranodal Primary Intestinal Lymphoma in Inflammatory Bowel Disease: An ECCO CONFER Case Series.
    J Crohns Colitis. 2022 Jun 25. pii: 6617788. doi: 10.1093.
    PubMed    


  407. HONAP S, Meade S, Spencer A, Pavlidis P, et al
    Anogenital Crohn's Disease and Granulomatosis: A Systematic Review of Epidemiology, Clinical Manifestations, and Treatment.
    J Crohns Colitis. 2022;16:822-834.
    PubMed     Abstract available


  408. VIGORITA V, Cano-Valderrama O, Celentano V, Vinci D, et al
    Inflammatory Bowel Diseases Benefit from Enhanced Recovery After Surgery [ERAS] Protocol: A Systematic Review with Practical Implications.
    J Crohns Colitis. 2022;16:845-851.
    PubMed     Abstract available


  409. ATIA O, Harel S, Ledderman N, Greenfeld S, et al
    Risk of Cancer in Paediatric onset Inflammatory Bowel Diseases: A Nation-wide Study From the epi-IIRN.
    J Crohns Colitis. 2022;16:786-795.
    PubMed     Abstract available


  410. ATIA O, Orlanski-Meyer E, Lujan R, Ledderman N, et al
    Improved Outcomes of Paediatric and Adult Crohn's Disease and Association With Emerging Use of Biologics-A Nationwide Study From the Epi-IIRN.
    J Crohns Colitis. 2022;16:778-785.
    PubMed     Abstract available


  411. ALMRADI A, Sedano R, Hogan M, Zou GY, et al
    Clinical, Endoscopic, and Safety Placebo Rates in Induction and Maintenance Trials of Crohn's Disease: Meta-Analysis of Randomised Controlled Trials.
    J Crohns Colitis. 2022;16:717-736.
    PubMed     Abstract available


  412. D'HAENS G, Danese S, Davies M, Watanabe M, et al
    A phase II, Multicentre, Randomised, Double-Blind, Placebo-controlled Study to Evaluate Safety, Tolerability, and Efficacy of Amiselimod in Patients with Moderate to Severe Active Crohn's Disease.
    J Crohns Colitis. 2022;16:746-756.
    PubMed     Abstract available


  413. ATTAUABI M, Dahlerup JF, Poulsen A, Hansen MR, et al
    Outcomes and Long-Term Effects of COVID-19 in Patients with Inflammatory Bowel Diseases - A Danish Prospective Population-Based Cohort Study with Individual-Level Data.
    J Crohns Colitis. 2022;16:757-767.
    PubMed     Abstract available


  414. VAN RIJN KL, Meima-van Praag EM, Bossuyt PM, D'Haens GR, et al
    Fibrosis and MAGNIFI-CD Activity Index at Magnetic Resonance Imaging to Predict Treatment Outcome in Perianal Fistulizing Crohn's Disease Patients.
    J Crohns Colitis. 2022;16:708-716.
    PubMed     Abstract available


  415. REENAERS C, Louis E
    Progressing Towards the Implementation of a Treat-To-Target Strategy in Perianal Crohn's Disease.
    J Crohns Colitis. 2022;16:693-694.
    PubMed    


  416. ILVEMARK JFKF, Wilkens R, Thielsen P, Dige A, et al
    Early intestinal ultrasound predicts intravenous corticosteroid response in hospitalized patients with severe ulcerative colitis.
    J Crohns Colitis. 2022 Jun 13. pii: 6607631. doi: 10.1093.
    PubMed     Abstract available


  417. KIM KO, Kim EY, Lee YJ, Lee HS, et al
    Efficacy, safety and tolerability of oral sulfate tablet for bowel preparation in patients with inflammatory bowel disease: Multicenter randomized controlled study.
    J Crohns Colitis. 2022 Jun 11. pii: 6605993. doi: 10.1093.
    PubMed     Abstract available


  418. JAGT JZ, Verburgt CM, de Vries R, de Boer NKH, et al
    Faecal metabolomics in paediatric inflammatory bowel disease: a systematic review.
    J Crohns Colitis. 2022 Jun 9. pii: 6605030. doi: 10.1093.
    PubMed     Abstract available


  419. CLARKSTON K, Karns R, Jegga AG, Sharma M, et al
    Targeted Assessment of Mucosal Immune Gene Expression Predicts Clinical Outcomes in Children with Ulcerative Colitis.
    J Crohns Colitis. 2022 Jun 4. pii: 6602063. doi: 10.1093.
    PubMed     Abstract available


    May 2022
  420. TORRENTE F, Meade S, Benchimol EI, de Ridder L, et al
    Thromboprophylaxis use in paediatric inflammatory bowel disease: an international RAND appropriateness panel.
    J Crohns Colitis. 2022 May 24. pii: 6591364. doi: 10.1093.
    PubMed     Abstract available


  421. DANESE S, Peyrin-Biroulet L
    Evolution of IL-23 Blockade in Inflammatory Bowel Disease.
    J Crohns Colitis. 2022;16.
    PubMed    


  422. SEWELL GW, Kaser A
    Interleukin-23 in the Pathogenesis of Inflammatory Bowel Disease and Implications for Therapeutic Intervention.
    J Crohns Colitis. 2022;16.
    PubMed     Abstract available


  423. PARIGI TL, Iacucci M, Ghosh S
    Blockade of IL-23: What is in the Pipeline?
    J Crohns Colitis. 2022;16.
    PubMed     Abstract available


  424. D'AMICO F, Peyrin-Biroulet L, Danese S
    Ustekinumab in Crohn's Disease: New Data for Positioning in Treatment Algorithm.
    J Crohns Colitis. 2022;16.
    PubMed     Abstract available


  425. MCDONALD BD, Dyer EC, Rubin DT
    IL-23 Monoclonal Antibodies for IBD: So Many, So Different?
    J Crohns Colitis. 2022;16.
    PubMed     Abstract available


  426. VALENTI M, Narcisi A, Pavia G, Gargiulo L, et al
    What Can IBD Specialists Learn from IL-23 Trials in Dermatology?
    J Crohns Colitis. 2022;16.
    PubMed     Abstract available


  427. ATREYA R, Neurath MF
    IL-23 Blockade in Anti-TNF Refractory IBD: From Mechanisms to Clinical Reality.
    J Crohns Colitis. 2022;16.
    PubMed     Abstract available


  428. GOTTLIEB ZS, Sands BE
    Personalised Medicine with IL-23 Blockers: Myth or Reality?
    J Crohns Colitis. 2022;16.
    PubMed     Abstract available


  429. CALVET X, Panes J, Gallardo-Escudero J, de la Cuadra-Grande A, et al
    Multicriteria Decision Analysis for Updating of Quality Indicators for Inflammatory Bowel Disease Comprehensive Care Units in Spain.
    J Crohns Colitis. 2022 May 11. pii: 6584605. doi: 10.1093.
    PubMed     Abstract available


  430. ROGLER G
    No Need to Scope? Monitoring of Treatment Response in IBD Patients by Transabdominal Ultrasound.
    J Crohns Colitis. 2022;16:521-522.
    PubMed    


  431. KAKUTA Y, Iwaki H, Umeno J, Kawai Y, et al
    Crohn's Disease and Early Exposure to Thiopurines are Independent Risk Factors for Mosaic Chromosomal Alterations in Patients with Inflammatory Bowel Diseases.
    J Crohns Colitis. 2022;16:643-655.
    PubMed     Abstract available


  432. VERBURGT CM, Dunn KA, Van Limbergen JE
    Dietary Therapy Reduces Pro-inflammatory Microbiome Features in Paediatric Crohn's Disease.
    J Crohns Colitis. 2022;16:682-684.
    PubMed    


  433. NARULA N, Wong ECL, Colombel JF, Sandborn WJ, et al
    Early Reduction in MM-SES-CD Score After Initiation of Biologic Therapy is Highly Specific for 1-year Endoscopic Remission in Moderate to Severe Crohn's Disease.
    J Crohns Colitis. 2022;16:616-624.
    PubMed     Abstract available


  434. BOTS S, De Voogd F, De Jong M, Ligtvoet V, et al
    Point-of-care Intestinal Ultrasound in IBD Patients: Disease Management and Diagnostic Yield in a Real-world Cohort and Proposal of a Point-of-care Algorithm.
    J Crohns Colitis. 2022;16:606-615.
    PubMed     Abstract available


  435. DAOUD ND, Hashash JG, Picco MF, Farraye FA, et al
    Faecal Calprotectin from Ileostomy Output Is Sensitive and Specific for the Prediction of Small Bowel Inflammation in Patients with Crohn's Disease.
    J Crohns Colitis. 2022;16:601-605.
    PubMed     Abstract available


  436. KUCHARZIK T, Tielbeek J, Carter D, Taylor SA, et al
    ECCO-ESGAR Topical Review on Optimizing Reporting for Cross-Sectional Imaging in Inflammatory Bowel Disease.
    J Crohns Colitis. 2022;16:523-543.
    PubMed     Abstract available


  437. SUN TY, Li YQ, Zhao FQ, Sun HM, et al
    MiR-1-3p and MiR-124-3p Synergistically Damage the Intestinal Barrier in the Ageing Colon.
    J Crohns Colitis. 2022;16:656-667.
    PubMed     Abstract available


  438. ALSOUD D, De Hertogh G, Compernolle G, Tops S, et al
    Real-world endoscopic and histologic outcomes are correlated with ustekinumab exposure in patients with ulcerative colitis.
    J Crohns Colitis. 2022 May 9. pii: 6582859. doi: 10.1093.
    PubMed     Abstract available


  439. STODTMANN S, Chen MJ, Siovitz L, Bereswill M, et al
    Bridging Fixed Dose to Body Weight-Based Regimen of Adalimumab in Pediatric Ulcerative Colitis Using a Pharmacometric Modeling Approach: Case Study with the Phase 3 ENVISION I Trial.
    J Crohns Colitis. 2022 May 8. pii: 6582407. doi: 10.1093.
    PubMed     Abstract available


  440. SHRESTHA S, Brand JS, Jaras J, Schoultz I, et al
    Association between inflammatory bowel disease and spondyloarthritis: findings from a nationwide study in Sweden.
    J Crohns Colitis. 2022 May 5. pii: 6581445. doi: 10.1093.
    PubMed     Abstract available


  441. WONG C, van Oostrom J, Bossuyt P, Pittet V, et al
    A narrative systematic review and categorisation of outcomes in Inflammatory Bowel Disease to inform a Core Outcome Set for real-world evidence.
    J Crohns Colitis. 2022 May 5. pii: 6580715. doi: 10.1093.
    PubMed     Abstract available


  442. POULLENOT F, Amiot A, Nachury M, Viennot S, et al
    Comparative risk of incident cancer in patients with Inflammatory Bowel Disease with prior non-digestive malignancy according to immunomodulator: a multicenter cohort study.
    J Crohns Colitis. 2022 May 5. pii: 6580681. doi: 10.1093.
    PubMed     Abstract available


    April 2022
  443. DE GALAN C, Truyens M, Peeters H, Mesonero Gismero F, et al
    The impact of vedolizumab and ustekinumab on articular extra-intestinal manifestations in inflammatory bowel disease patients: a real-life multicentric cohort study.
    J Crohns Colitis. 2022 Apr 20. pii: 6571450. doi: 10.1093.
    PubMed     Abstract available


  444. FERNANDEZ ME, Nazar FN, Moine LB, Jaime CE, et al
    Network analysis of inflammatory bowel disease research: towards the interactome.
    J Crohns Colitis. 2022 Apr 19. pii: 6570854. doi: 10.1093.
    PubMed     Abstract available


  445. UNGARO RC, Chou B, Mo J, Ursos L, et al
    Impact of COVID-19 on Healthcare Resource Utilization among Patients with Inflammatory Bowel Disease in the USA.
    J Crohns Colitis. 2022 Apr 9. pii: 6565722. doi: 10.1093.
    PubMed     Abstract available


  446. DONG C, Chan SSM, Jantchou P, Racine A, et al
    Meat intake is associated with a higher risk of ulcerative colitis in a large European prospective cohort study.
    J Crohns Colitis. 2022 Apr 9. pii: 6565743. doi: 10.1093.
    PubMed     Abstract available


  447. DOLINGER MT, Rolfes P, Spencer E, Stoffels G, et al
    Outcomes of Children With Inflammatory Bowel Disease Who Develop Anti-Tumor Necrosis Factor Induced Skin Reactions.
    J Crohns Colitis. 2022 Apr 7. pii: 6564796. doi: 10.1093.
    PubMed     Abstract available


  448. HARDY PY, Fikri J, Libbrecht D, Louis E, et al
    Pain characteristics in patients with inflammatory bowel disease: A monocentric cross-sectional study.
    J Crohns Colitis. 2022 Apr 4. pii: 6563361. doi: 10.1093.
    PubMed     Abstract available


  449. CHAPARRO M, Kunovsky L, Aguas M, Livne M, et al
    Surgery Due to Inflammatory Bowel Disease During Pregnancy: Mothers and Offspring Outcomes From an Ecco Confer Multicentre Case Series (Scar Study).
    J Crohns Colitis. 2022 Apr 4. pii: 6563346. doi: 10.1093.
    PubMed     Abstract available


  450. COLLEN LV, Kim DY, Field M, Okoroafor I, et al
    Clinical Phenotypes and Outcomes in Monogenic versus Non-Monogenic Very Early Onset Inflammatory Bowel Disease.
    J Crohns Colitis. 2022 Apr 2. pii: 6562761. doi: 10.1093.
    PubMed     Abstract available


    March 2022
  451. CERNA K, Duricova D, Hindos M, Hindos HJ, et al
    Cellular and humoral immune responses to SARS-CoV-2 vaccination in inflammatory bowel disease patients.
    J Crohns Colitis. 2022 Mar 31. pii: 6561818. doi: 10.1093.
    PubMed     Abstract available


  452. KHAN N, Trivedi C, Aberra F, Pernes T, et al
    Safety of Recombinant Zoster Vaccine in Patients with Inflammatory Bowel Disease.
    J Crohns Colitis. 2022 Mar 29. pii: 6555677. doi: 10.1093.
    PubMed     Abstract available


  453. DING NS, Tassone D, Al-Bakir I, Wu K, et al
    Systematic review: The impact and importance of body composition in Inflammatory Bowel Disease.
    J Crohns Colitis. 2022 Mar 24. pii: 6553364. doi: 10.1093.
    PubMed     Abstract available


  454. MORTENSEN JH, Sinkeviciute D, Manon-Jensen T, Domislovic V, et al
    A specific calprotectin neo-epitope (CPa9-HNE) in serum from inflammatory bowel disease patients is associated with neutrophil activity and endoscopic severity.
    J Crohns Colitis. 2022 Mar 19. pii: 6550845. doi: 10.1093.
    PubMed     Abstract available


  455. HYAMS JS, Turner D, Cohen SA, Szakos E, et al
    Pharmacokinetics, Safety, and Efficacy of Intravenous Vedolizumab in Paediatric Patients with Ulcerative Colitis or Crohn's Disease: Results from the Phase 2 HUBBLE Study.
    J Crohns Colitis. 2022 Mar 17. pii: 6550285. doi: 10.1093.
    PubMed     Abstract available


  456. VELOSA M, Hochner H, Yerushalmi B, Harel S, et al
    Pre and perinatal factors predicting Inflammatory Bowel Disease - a population-based study with fifty years follow-up.
    J Crohns Colitis. 2022 Mar 17. pii: 6550290. doi: 10.1093.
    PubMed     Abstract available


  457. SANDBORN WJ, Lewis JD, Panes J, Loftus EV, et al
    Association Between Proposed Definitions of Clinical Remission/Response and Well-Being in Patients With Crohn's Disease.
    J Crohns Colitis. 2022;16:444-451.
    PubMed     Abstract available


  458. SUAU R, Pardina E, Domenech E, Loren V, et al
    The Complex Relationship Between Microbiota, Immune Response and Creeping Fat in Crohn's Disease.
    J Crohns Colitis. 2022;16:472-489.
    PubMed     Abstract available


  459. BLE A, Renzulli C, Cenci F, Grimaldi M, et al
    The Relationship Between Endoscopic and Clinical Recurrence in Postoperative Crohn's Disease: A Systematic Review and Meta-analysis.
    J Crohns Colitis. 2022;16:490-499.
    PubMed     Abstract available


  460. PHILLIPS F, Verstockt B, Sladek M, de Boer N, et al
    Orofacial Granulomatosis Associated with Crohn's Disease: a Multicentre Case Series.
    J Crohns Colitis. 2022;16:430-435.
    PubMed     Abstract available


  461. NGUYEN NH, Picetti D, Dulai PS, Jairath V, et al
    Machine Learning-based Prediction Models for Diagnosis and Prognosis in Inflammatory Bowel Diseases: A Systematic Review.
    J Crohns Colitis. 2022;16:398-413.
    PubMed     Abstract available


  462. VIEUJEAN S, Loly JP, Boutaffala L, Meunier P, et al
    Mesenchymal Stem Cell Injection in Crohn's Disease Strictures: A Phase I-II Clinical Study.
    J Crohns Colitis. 2022;16:506-510.
    PubMed     Abstract available


  463. CHANCHLANI N, Lin S, Chee D, Hamilton B, et al
    Adalimumab and Infliximab Impair SARS-CoV-2 Antibody Responses: Results from a Therapeutic Drug Monitoring Study in 11 422 Biologic-Treated Patients.
    J Crohns Colitis. 2022;16:389-397.
    PubMed     Abstract available


  464. LEVER G, Chipeta H, Glanville T, Selinger C, et al
    Perineal Outcomes After Delivery in 179 Mothers with Inflammatory Bowel Disease Compared to 31 258 Controls: A Single-Centre Cohort Study.
    J Crohns Colitis. 2022;16:511-514.
    PubMed     Abstract available


  465. FEAKINS R, Torres J, Borralho-Nunes P, Burisch J, et al
    ECCO Topical Review on Clinicopathological Spectrum and Differential Diagnosis of Inflammatory Bowel Disease.
    J Crohns Colitis. 2022;16:343-368.
    PubMed     Abstract available


  466. ROBERTSON AR, Webster KL
    Disease activity in the final years of life for patients with longstanding Inflammatory Bowel Disease.
    J Crohns Colitis. 2022 Mar 7. pii: 6543872. doi: 10.1093.
    PubMed    


  467. ABREU MT, Rowbotham DS, Danese S, Sandborn WJ, et al
    Efficacy and Safety of Maintenance Ustekinumab for Ulcerative Colitis Through 3 Years: UNIFI Long-term Extension.
    J Crohns Colitis. 2022 Mar 3. pii: 6542054. doi: 10.1093.
    PubMed     Abstract available


  468. SCIBERRAS M, Karmiris K, Nascimento C, Tabone T, et al
    Mental health, work presenteeism and exercise in inflammatory bowel disease.
    J Crohns Colitis. 2022 Mar 3. pii: 6542057. doi: 10.1093.
    PubMed     Abstract available


  469. BURGESS CJ, Schnier C, Wood R, Henderson P, et al
    Prematurity, delivery method and infant feeding type are not associated with paediatric-onset inflammatory bowel disease risk: A Scottish retrospective birth cohort study.
    J Crohns Colitis. 2022 Mar 1. pii: 6540489. doi: 10.1093.
    PubMed     Abstract available


    February 2022
  470. COTTRON C, Treton X, Altwegg R, Reenaers C, et al
    How to manage inflammatory bowel disease patients when they withdraw anti-TNF due to severe anti-TNF-induced skin lesions? A multicenter cohort study.
    J Crohns Colitis. 2022 Feb 26. pii: 6537448. doi: 10.1093.
    PubMed     Abstract available


  471. NOWAK JK, Adams AT, Kalla R, Lindstrom JC, et al
    Characterization of the circulating transcriptomic landscape in inflammatory bowel disease provides evidence for dysregulation of multiple transcription factors including NFE2, SPI1, CEBPB, and IRF2.
    J Crohns Colitis. 2022 Feb 25. pii: 6536718. doi: 10.1093.
    PubMed     Abstract available


  472. TRACY M, Khalili H
    You Are What You Eat? Growing Evidence That Diet Influences the Risk of Inflammatory Bowel Disease.
    J Crohns Colitis. 2022 Feb 23. pii: 6534662. doi: 10.1093.
    PubMed    


  473. BISLENGHI G, Sucameli F, Fieuws S, Ferrante M, et al
    Non-conventional Versus Conventional Strictureplasties for Crohn's Disease. A Systematic Review and Meta-analysis of Treatment Outcomes.
    J Crohns Colitis. 2022;16:319-330.
    PubMed     Abstract available


  474. DHALIWAL J, Carroll MW, deBruyn JC, Ricciuto A, et al
    The Phenotypic Spectrum of New-onset IBD in Canadian Children of South Asian Ethnicity: A Prospective Multi-Centre Comparative Study.
    J Crohns Colitis. 2022;16:216-223.
    PubMed     Abstract available


  475. CLEMENT F, Nougarede A, Combe S, Kermarrec F, et al
    Therapeutic siRNAs Targeting the JAK/STAT Signalling Pathway in Inflammatory Bowel Diseases.
    J Crohns Colitis. 2022;16:286-300.
    PubMed     Abstract available


  476. ELDRIDGE F, Raine T
    Understanding and Addressing the Psychological Burden of IBD.
    J Crohns Colitis. 2022;16:177-178.
    PubMed    


  477. LAUDISI F, Stolfi C, Bevivino G, Maresca C, et al
    GATA6 Deficiency Leads to Epithelial Barrier Dysfunction and Enhances Susceptibility to Gut Inflammation.
    J Crohns Colitis. 2022;16:301-311.
    PubMed     Abstract available


  478. BACSUR P, Farkas K, Molnar T
    Area of the IBD Disk Correlated Strongly with Disease Activity Compared with the Conventionally Used IBD Disk Score.
    J Crohns Colitis. 2022;16:336.
    PubMed    


  479. OSTROWSKI S, Croft A
    Viral enteric infections in acute severe ulcerative colitis.
    J Crohns Colitis. 2022 Feb 15. pii: 6528523. doi: 10.1093.
    PubMed     Abstract available


  480. CROFT A, Lord A, Radford-Smith G
    Markers of systemic inflammation in acute attacks of ulcerative colitis: What level of C-reactive protein constitutes severe colitis?
    J Crohns Colitis. 2022 Feb 11. pii: 6527048. doi: 10.1093.
    PubMed     Abstract available


  481. MOOKHOEK A, Haasnoot ML, Bredenoord AJ, Ma C, et al
    The clinical significance of eosinophils in ulcerative colitis: a systematic review.
    J Crohns Colitis. 2022 Feb 9. pii: 6524727. doi: 10.1093.
    PubMed     Abstract available


  482. HUA X, Lopes EW, Burke KE, Ananthakrishnan AN, et al
    Smoking behavior changes after diagnosis of inflammatory bowel disease and risk of all-cause mortality.
    J Crohns Colitis. 2022 Feb 1. pii: 6518234. doi: 10.1093.
    PubMed     Abstract available


    January 2022
  483. VERMEIRE S, D'Haens G, Baert F, Danese S, et al
    Efficacy and Safety of Subcutaneous Vedolizumab in Patients With Moderately to Severely Active Crohn's Disease: Results From the VISIBLE 2 Randomised Trial.
    J Crohns Colitis. 2022;16:27-38.
    PubMed     Abstract available


  484. ALBSHESH A, Eder P, Ribaldone DG, Oldenburg B, et al
    Primary Hypogammaglobulinaemia with Inflammatory Bowel Disease-Like Features: An ECCO CONFER Multicentre Case Series.
    J Crohns Colitis. 2022;16:91-97.
    PubMed     Abstract available


  485. ZILBAUER M, Heuschkel R
    Disease Prognostic Biomarkers in Inflammatory Bowel Diseases-A Reality Check.
    J Crohns Colitis. 2022;16:162-165.
    PubMed     Abstract available


  486. FERREIRA JPS, de Mascarenhas Saraiva MJDQEC, Afonso JPL, Ribeiro TFC, et al
    Identification of Ulcers and Erosions by the Novel Pillcam Crohn's Capsule Using a Convolutional Neural Network: A Multicentre Pilot Study.
    J Crohns Colitis. 2022;16:169-172.
    PubMed     Abstract available


  487. HELWIG U, Fischer I, Hammer L, Kolterer S, et al
    Transmural Response and Transmural Healing Defined by Intestinal Ultrasound: New Potential Therapeutic Targets?
    J Crohns Colitis. 2022;16:57-67.
    PubMed     Abstract available


  488. KABIR M, Thomas-Gibson S, Hart AL, Wilson A, et al
    Perception of Cancer Risk and Management Practice for Colitis-associated Dysplasia Is Influenced by Colonoscopy Experience and Workplace Affiliation: Results of an International Clinician Survey.
    J Crohns Colitis. 2022;16:39-48.
    PubMed     Abstract available


  489. FULFORTH J, Gearry R
    Inequitable Access to IBD Therapies Extends Beyond Developing Nations.
    J Crohns Colitis. 2022;16:173-174.
    PubMed    


  490. HANZEL J, Jairath V
    A TIGER Among Endoscopic Indices in Inflammatory Bowel Disease.
    J Crohns Colitis. 2022 Jan 21. pii: 6513472. doi: 10.1093.
    PubMed    


  491. NUNEZ F P, Quera R, Bay C, Castro F, et al
    Drug-induced liver injury used in the treatment of Inflammatory Bowel Disease.
    J Crohns Colitis. 2022 Jan 19. pii: 6511546. doi: 10.1093.
    PubMed     Abstract available


  492. ELLUL P, Reves J, Abreu B, Chaparro M, et al
    Implementation and short-term adverse events of anti-SARS-CoV-2 vaccines in Inflammatory Bowel Disease patients: an international web-based survey.
    J Crohns Colitis. 2022 Jan 17. pii: 6509060. doi: 10.1093.
    PubMed     Abstract available


  493. JUZENAS S, Hubenthal M, Lindqvist CM, Kruse R, et al
    Detailed transcriptional landscape of peripheral blood points to increased neutrophil activation in treatment-naive inflammatory bowel disease.
    J Crohns Colitis. 2022 Jan 11. pii: 6503823. doi: 10.1093.
    PubMed     Abstract available


  494. DE BOER NK, van Lookeren FL, Tack GJ
    The launch of an online national multidisciplinary expert panel for inflammatory bowel disease.
    J Crohns Colitis. 2022 Jan 6. pii: 6499222. doi: 10.1093.
    PubMed    


  495. HERNANDEZ-ROCHA C, Nayeri S, Turpin W, Steel M, et al
    Combined histo-endoscopic remission but not endoscopic healing alone in ulcerative colitis is associated with a mucosal transcriptional profile resembling healthy mucosa.
    J Crohns Colitis. 2022 Jan 6. pii: 6499459. doi: 10.1093.
    PubMed     Abstract available


  496. TORRENTE F, Hansen R
    Venous Thromboembolism in Children with Inflammatory Bowel Disease: When is the Right Time for Thromboprophylaxis?
    J Crohns Colitis. 2022 Jan 3. pii: 6494523. doi: 10.1093.
    PubMed    


    December 2021
  497. VENTRESS E, Young D, Rahmany S, Harris C, et al
    Transitioning from intRavenous to subcutAneous VEdolizumab in patients with infLammatory bowEl diSeaSe (TRAVELESS).
    J Crohns Colitis. 2021 Dec 22. pii: 6478741. doi: 10.1093.
    PubMed     Abstract available


  498. GIANNINI EG, Demarzo MG, Bodini G
    Elevated Adherence to Vaccination Against SARS-CoV-2 Among Patients with Inflammatory Bowel Disease.
    J Crohns Colitis. 2021;15:2142-2143.
    PubMed    


  499. GOLDBERG R, Clough JN, Roberts LB, Sanchez J, et al
    A Crohn's Disease-associated IL2RA Enhancer Variant Determines the Balance of T Cell Immunity by Regulating Responsiveness to IL-2 Signalling.
    J Crohns Colitis. 2021;15:2054-2065.
    PubMed     Abstract available


  500. RYVCHIN R, Dubinsky V, Rabinowitz K, Wasserberg N, et al
    Alteration in Urease-producing Bacteria in the Gut Microbiomes of Patients with Inflammatory Bowel Diseases.
    J Crohns Colitis. 2021;15:2066-2077.
    PubMed     Abstract available


  501. SPALINGER MR, Schwarzfischer M, Niechcial A, Atrott K, et al
    Loss of PTPN22 Promotes Intestinal Inflammation by Compromising Granulocyte-mediated Antibacterial Defence.
    J Crohns Colitis. 2021;15:2118-2130.
    PubMed     Abstract available


  502. DERIKX LAAP, Dolby HW, Plevris N, Lucaciu L, et al
    Effectiveness and Safety of Adalimumab Biosimilar SB5 in Inflammatory Bowel Disease: Outcomes in Originator to SB5 Switch, Double Biosimilar Switch and Bio-Naive SB5 Observational Cohorts.
    J Crohns Colitis. 2021;15:2011-2021.
    PubMed     Abstract available


  503. FERRANTE M, Feagan BG, Panes J, Baert F, et al
    Long-Term Safety and Efficacy of Risankizumab Treatment in Patients with Crohn's Disease: Results from the Phase 2 Open-Label Extension Study.
    J Crohns Colitis. 2021;15:2001-2010.
    PubMed     Abstract available


  504. NI H, Chen Y, Xia W, Wang C, et al
    SATB2 Defect Promotes Colitis and Colitis-associated Colorectal Cancer by Impairing Cl-/HCO3- Exchange and Homeostasis of Gut Microbiota.
    J Crohns Colitis. 2021;15:2088-2102.
    PubMed     Abstract available


  505. WANG L, Zhang N, Han D, Su P, et al
    MTDH Promotes Intestinal Inflammation by Positively Regulating TLR Signalling.
    J Crohns Colitis. 2021;15:2103-2117.
    PubMed     Abstract available


  506. CASADO-BEDMAR M, Viennois E
    microRNA and gut microbiota: Tiny but mighty - Novel insights of their crosstalk in inflammatory bowel disease pathogenesis and therapeutics.
    J Crohns Colitis. 2021 Dec 16. pii: 6464304. doi: 10.1093.
    PubMed     Abstract available


  507. CALAFAT M, Manosa M, Ricart E, Nos P, et al
    Risk of immunomediated adverse events and loss of response to infliximab in elderly patients with inflammatory bowel disease. A cohort study of the ENEIDA registry.
    J Crohns Colitis. 2021 Dec 3. pii: 6448705. doi: 10.1093.
    PubMed     Abstract available


  508. FESTA S, Zerboni G, Derikx LAAP, Ribaldone DG, et al
    Gastroenteropancreatic Neuroendocrine Neoplasms in Patients with Inflammatory Bowel Disease: An ECCO CONFER Multicentre Case Series.
    J Crohns Colitis. 2021 Dec 1. pii: 6447455. doi: 10.1093.
    PubMed     Abstract available


    November 2021
  509. GORDON IO, Abushamma S, Kurowski JA, Holubar SD, et al
    Pediatric Ulcerative Colitis Is A Fibrotic Disease And Linked With Chronicity Of Inflammation.
    J Crohns Colitis. 2021 Nov 29. pii: 6445941. doi: 10.1093.
    PubMed     Abstract available


  510. BAR-YOSEPH H, Blatt A, Gerassy S, Pressman S, et al
    Differential serum-intestinal dynamics of infliximab and adalimumab in inflammatory bowel disease patients.
    J Crohns Colitis. 2021 Nov 24. pii: 6438514. doi: 10.1093.
    PubMed     Abstract available


  511. PRENTICE RE, Ross AL, Flanagan EK
    Management of Pregnant Women with Inflammatory Bowel Disease and COVID-19-Balancing Risks of Delayed Treatment Recommencement.
    J Crohns Colitis. 2021 Nov 23. pii: 6433604. doi: 10.1093.
    PubMed    


  512. PAPAEFTHYMIOU A, Potamianos S, Goulas A, Doulberis M, et al
    Inflammatory Bowel Disease-associated Fatty Liver Disease: the Potential Effect of Biologic Agents.
    J Crohns Colitis. 2021 Nov 22. pii: 6433262. doi: 10.1093.
    PubMed     Abstract available


  513. ATIA O, Orlanski-Meyer E, Lujan R, Ledderman N, et al
    Colectomy Rates did not Decrease in Paediatric- and Adult-Onset Ulcerative Colitis During the Biologics Era: A Nationwide Study From the epi-IIRN.
    J Crohns Colitis. 2021 Nov 20. pii: 6432553. doi: 10.1093.
    PubMed     Abstract available


  514. BACSUR P, Farkas K, Molnar T
    Outcome of immediate dose optimization of infliximab in inflammatory bowel disease patients.
    J Crohns Colitis. 2021 Nov 18. pii: 6430840. doi: 10.1093.
    PubMed    


  515. GUPTA R, MacIsaac M, Wright EK
    Sleeve gastrectomy in patients with inflammatory bowel disease is not associated with worsening disease.
    J Crohns Colitis. 2021 Nov 17. pii: 6430439. doi: 10.1093.
    PubMed    


  516. D'AMICO F, Magro F, Peyrin-Biroulet L, Danese S, et al
    Positioning filgotinib in the treatment algorithm of moderate to severe ulcerative colitis.
    J Crohns Colitis. 2021 Nov 16. pii: 6429427. doi: 10.1093.
    PubMed     Abstract available


  517. NICHOLSON MR, Alexander E, Ballal S, Davidovics Z, et al
    Efficacy and Outcomes of Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection in Children with Inflammatory Bowel Disease.
    J Crohns Colitis. 2021 Nov 12. pii: 6425925. doi: 10.1093.
    PubMed     Abstract available


  518. VAN ERP LW, Neijenhuis MK, Heida W, Derwig J, et al
    Improving care for recently diagnosed inflammatory bowel disease patients: Lessons learned from a patient-centred, mixed-method study.
    J Crohns Colitis. 2021 Nov 10. pii: 6425110. doi: 10.1093.
    PubMed     Abstract available


  519. CHARPY F, Altwegg R, Debourdeau A
    Disseminated tuberculosis in a patient treated with tofacitinib for ulcerative colitis.
    J Crohns Colitis. 2021 Nov 9. pii: 6424411. doi: 10.1093.
    PubMed    


  520. AGRAWAL M, Zhang X, Brenner EJ, Ungaro RC, et al
    The Impact of Vedolizumab on COVID-19 Outcomes Among Adult IBD Patients in the SECURE-IBD Registry.
    J Crohns Colitis. 2021;15:1877-1884.
    PubMed     Abstract available


  521. WETWITTAYAKHLANG P, Lakatos PL
    Comforting Data on the Incidence of Rectal Cancer After Subtotal Colectomy in IBD: The Risk Is Low, Yet Surveillance Matters!
    J Crohns Colitis. 2021;15:1783-1784.
    PubMed    


  522. ROSH JR, Turner D, Griffiths A, Cohen SA, et al
    Ustekinumab in Paediatric Patients with Moderately to Severely Active Crohn's Disease: Pharmacokinetics, Safety, and Efficacy Results from UniStar, a Phase 1 Study.
    J Crohns Colitis. 2021;15:1931-1942.
    PubMed     Abstract available


  523. REZAZADEH ARDABILI A, Goudkade D, Wintjens D, Romberg-Camps M, et al
    Histopathological Features in Colonic Biopsies at Diagnosis Predict Long-term Disease Course in Patients with Crohn's Disease.
    J Crohns Colitis. 2021;15:1885-1897.
    PubMed     Abstract available


  524. SELIN KA, Hedin CRH, Villablanca EJ
    Immunological Networks Defining the Heterogeneity of Inflammatory Bowel Diseases.
    J Crohns Colitis. 2021;15:1959-1973.
    PubMed     Abstract available


  525. NAFTALI T, Bar-Lev Schleider L, Almog S, Meiri D, et al
    Oral CBD-rich Cannabis Induces Clinical but Not Endoscopic Response in Patients with Crohn's Disease, a Randomised Controlled Trial.
    J Crohns Colitis. 2021;15:1799-1806.
    PubMed     Abstract available


  526. LUO J, Xu Z, Noordam R, van Heemst D, et al
    Depression and Inflammatory Bowel Disease: A Bidirectional two-sample Mendelian Randomization Study.
    J Crohns Colitis. 2021 Nov 5. pii: 6421452. doi: 10.1093.
    PubMed     Abstract available


    October 2021
  527. GARRIDO I, Lopes S, Macedo G
    "Safety of COVID-19 vaccination in inflammatory bowel disease patients on biologic therapy".
    J Crohns Colitis. 2021 Oct 30. pii: 6414658. doi: 10.1093.
    PubMed    


  528. LIMA SF, Longman RS
    Eating for Two: Diet and the Microbiome in Ulcerative Colitis.
    J Crohns Colitis. 2021 Oct 27. pii: 6412629. doi: 10.1093.
    PubMed    


  529. FRIEDMAN S, Zegers FD, Jolving LR, Nielsen J, et al
    Postpartum surgical complications in women with inflammatory bowel disease after caesarian section: A Danish nationwide cohort study.
    J Crohns Colitis. 2021 Oct 27. pii: 6412778. doi: 10.1093.
    PubMed     Abstract available


  530. CHARKAOUI M, Hajage D, Tubach F, Laurent B, et al
    Impact of anti-tumor necrosis factor agents on the risk of colorectal cancer in patients with ulcerative colitis: nationwide French cohort study.
    J Crohns Colitis. 2021 Oct 18. pii: 6399096. doi: 10.1093.
    PubMed     Abstract available


  531. RAINE T, Bonovas S, Burisch J, Kucharzik T, et al
    ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment.
    J Crohns Colitis. 2021 Oct 12. pii: 6390052. doi: 10.1093.
    PubMed    


  532. SPINELLI A, Bonovas S, Burisch J, Kucharzik T, et al
    ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment.
    J Crohns Colitis. 2021 Oct 12. pii: 6390023. doi: 10.1093.
    PubMed     Abstract available


  533. ELFIKY AMI, Ghiboub M, Li Yim AYF, Hageman IL, et al
    Carboxylesterase-1 assisted targeting of HDAC inhibitors to mononuclear myeloid cells in Inflammatory Bowel Disease.
    J Crohns Colitis. 2021 Oct 11. pii: 6387695. doi: 10.1093.
    PubMed     Abstract available


  534. WALENTYNOWICZ M, van de Pavert I, Fierens L, Coenen S, et al
    Inflammatory Bowel Disease-related Behaviours [IBD-Bx] questionnaire: Development, validation, and prospective associations with fatigue.
    J Crohns Colitis. 2021 Oct 8. pii: 6383644. doi: 10.1093.
    PubMed     Abstract available


  535. JOJART B, Molnar T, Szabo V, Varga A, et al
    Erratum to: P459 Expression of SerpinE1, a potential new disease activity marker, reflects therapeutic response in Inflammatory Bowel Disease.
    J Crohns Colitis. 2021 Oct 7. pii: 6383122. doi: 10.1093.
    PubMed    


  536. ADAMINA M, Fiorino G
    At the Crossroads of Caution and Intervention: Anti-TNF Therapy Prior to Elective CD Surgery.
    J Crohns Colitis. 2021;15:1778-1779.
    PubMed    


  537. MEKORI-DOMACHEVSKY E, Ben-Horin S
    Holistic approach to IBD patients.
    J Crohns Colitis. 2021;15:1782.
    PubMed    


  538. SOOP M, Hancock L, Davies J
    Anti-TNF Therapy Before Intestinal Surgery for Crohn's Disease and the Risks of Postoperative Complications.
    J Crohns Colitis. 2021;15:1777.
    PubMed    


  539. HONAP S, Irving PM, Kennedy NA
    Response to 'Clinical Efficacy of Tofacitinib in Moderate to Severe Ulcerative Colitis'.
    J Crohns Colitis. 2021;15:1775-1776.
    PubMed    


  540. RAINE T, Verstockt B, Kopylov U, Karmiris K, et al
    ECCO Topical Review: Refractory Inflammatory Bowel Disease.
    J Crohns Colitis. 2021;15:1605-1620.
    PubMed     Abstract available


  541. UNGAR B, Malickova K, Hanzel J, Abu Arisha M, et al
    Dose optimisation for Loss of Response to Vedolizumab- Pharmacokinetics and Immune Mechanisms.
    J Crohns Colitis. 2021;15:1707-1719.
    PubMed     Abstract available


  542. VIEUJEAN S, Hu S, Bequet E, Salee C, et al
    Potential Role of Epithelial Endoplasmic Reticulum Stress and Anterior Gradient Protein 2 Homologue in Crohn's Disease Fibrosis.
    J Crohns Colitis. 2021;15:1737-1750.
    PubMed     Abstract available


  543. NARULA N, Wong ECL, Dulai PS, Marshall JK, et al
    Outcomes of Passable and Non-passable Strictures in Clinical Trials of Crohn's Disease: A Post-hoc Analysis.
    J Crohns Colitis. 2021;15:1649-1657.
    PubMed     Abstract available


  544. ILVEMARK JFKF, Hansen T, Goodsall TM, Seidelin JB, et al
    Defining transabdominal Intestinal Ultrasound treatment response and remission in Inflammatory Bowel Disease: Systematic review and expert consensus statement.
    J Crohns Colitis. 2021 Oct 6. pii: 6382324. doi: 10.1093.
    PubMed     Abstract available


  545. AARDOOM MA, Klomberg RCW, Kemos P, Ruemmele FM, et al
    The incidence and characteristics of venous thromboembolisms in paediatric-onset inflammatory bowel disease; a prospective international cohort study based on the PIBD-SETQuality Safety Registry.
    J Crohns Colitis. 2021 Oct 2. pii: 6380289. doi: 10.1093.
    PubMed     Abstract available


    September 2021
  546. RICCIUTO A, Lamb CA, Benchimol EI, Walker GJ, et al
    Inflammatory Bowel Disease Clinical Activity Is Associated with COVID-19 Severity Especially in Younger Patients.
    J Crohns Colitis. 2021 Sep 27. pii: 6376474. doi: 10.1093.
    PubMed     Abstract available


  547. DART RJ, Ellul P, Scharl M, Lamb CA, et al
    Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD - Challenges and Future Directions.
    J Crohns Colitis. 2021;15:1407-1409.
    PubMed    


  548. FIOCCHI C, Dragoni G, Iliopoulos D, Katsanos K, et al
    Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD-What, Why, and How.
    J Crohns Colitis. 2021;15:1410-1430.
    PubMed     Abstract available


  549. VERSTOCKT B, Noor NM, Marigorta UM, Pavlidis P, et al
    Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD-Disease Outcome and Response to Therapy.
    J Crohns Colitis. 2021;15:1431-1442.
    PubMed     Abstract available


  550. LI Y, Zhu L, Chen P, Wang Y, et al
    MALAT1 Maintains the Intestinal Mucosal Homeostasis in Crohn's Disease via the miR-146b-5p-CLDN11/NUMB Pathway.
    J Crohns Colitis. 2021;15:1542-1557.
    PubMed     Abstract available


  551. DE KRIJGER M, Wildenberg ME, Mookhoek A, Verheul S, et al
    Expression of MAdCAM-1 and Gut-homing T Cells in Inflamed Pouch Mucosa.
    J Crohns Colitis. 2021;15:1491-1499.
    PubMed     Abstract available


  552. RUSSO E, Giudici F, Ricci F, Scaringi S, et al
    Diving into Inflammation: A Pilot Study Exploring the Dynamics of the Immune-Microbiota Axis in Ileal Tissue Layers of Patients with Crohn's Disease.
    J Crohns Colitis. 2021;15:1500-1516.
    PubMed     Abstract available


  553. SOLA TAPIAS N, Denadai-Souza A, Rolland-Fourcade C, Quaranta-Nicaise M, et al
    Colitis Linked to Endoplasmic Reticulum Stress Induces Trypsin Activity Affecting Epithelial Functions.
    J Crohns Colitis. 2021;15:1528-1541.
    PubMed     Abstract available


  554. CHEN D, Fulmer C, Gordon IO, Syed S, et al
    Application of Artificial Intelligence to Clinical Practice in Inflammatory Bowel Disease - What the Clinician Needs to Know.
    J Crohns Colitis. 2021 Sep 24. pii: 6374854. doi: 10.1093.
    PubMed     Abstract available


  555. WONG D, Travis SPL
    Patient-reported Goals in Inflammatory Bowel Disease: What's the Problem?
    J Crohns Colitis. 2021 Sep 21. pii: 6373333. doi: 10.1093.
    PubMed    


  556. SARBAGILI SHABAT C, Scaldaferri F, Zittan E, Hirsch A, et al
    Use of Fecal transplantation with a novel diet for mild to moderate active ulcerative colitis: The CRAFT UC randomized controlled trial.
    J Crohns Colitis. 2021 Sep 13. pii: 6369227. doi: 10.1093.
    PubMed     Abstract available


  557. PHILLIPS F, Verstockt B, Ribaldone DG, Guerra I, et al
    Diagnosis and outcome of extranodal primary intestinal lymphoma in inflammatory bowel disease: an ECCO CONFER case series.
    J Crohns Colitis. 2021 Sep 11. pii: 6368841. doi: 10.1093.
    PubMed     Abstract available


  558. KIM GH, Lee YC, Kim TJ, Kim ER, et al
    Risk of neurodegenerative diseases in patients with inflammatory bowel disease: a nationwide population-based cohort study.
    J Crohns Colitis. 2021 Sep 9. pii: 6367800. doi: 10.1093.
    PubMed     Abstract available


  559. BOURGONJE AR, Hu S, Spekhorst LM, Zhernakova DV, et al
    The Effect of Phenotype and Genotype on the Plasma Proteome in Patients with Inflammatory Bowel Disease.
    J Crohns Colitis. 2021 Sep 7. pii: 6365883. doi: 10.1093.
    PubMed     Abstract available


    August 2021
  560. BOTS S, Nylund K, Gecse K
    Response to letter to the editor "Intestinal Ultrasound to Assess Disease Activity in Ulcerative Colitis: Development of a novel UC-Ultrasound index".
    J Crohns Colitis. 2021 Aug 14. pii: 6352305. doi: 10.1093.
    PubMed    


  561. CARON B, D'Amico F, Danese S, Peyrin-Biroulet L, et al
    Cluster Randomized Trials: Lessons for Inflammatory Bowel Disease Trials.
    J Crohns Colitis. 2021 Aug 14. pii: 6352195. doi: 10.1093.
    PubMed     Abstract available


  562. REUKEN PA, Andreas N, Grunert PC, Glockner S, et al
    T cell response after SARS-CoV-2 vaccination in immunocompromised patients with inflammatory bowel disease.
    J Crohns Colitis. 2021 Aug 11. pii: 6348138. doi: 10.1093.
    PubMed     Abstract available


  563. CROWLEY E, Ma C, Andic M, Feagan BG, et al
    Impact of Drug Approval Pathways for Paediatric Inflammatory Bowel Disease.
    J Crohns Colitis. 2021 Aug 11. pii: 6348023. doi: 10.1093.
    PubMed     Abstract available


  564. TSE CS, Van Citters AD, Ricci B, Freundlich NZ, et al
    Identifying and Predicting the Goals and Concerns Prioritized by Individuals with Inflammatory Bowel Disease.
    J Crohns Colitis. 2021 Aug 5. pii: 6341120. doi: 10.1093.
    PubMed     Abstract available


  565. CARVELLO M, Bellato V, Maroli A, Hart A, et al
    A multidisciplinary approach to rectal cancer treatment in ulcerative colitis results in high rate of restorative minimally invasive surgery.
    J Crohns Colitis. 2021 Aug 4. pii: 6338719. doi: 10.1093.
    PubMed     Abstract available


  566. PROIETTI E, Fuhler GM, Peppelenbosch MP
    Mycobacterium Avium Subspecies Paratuberculosis Infection and Biological Treatment of IBD: Cause or Consequence?
    J Crohns Colitis. 2021;15:1247-1249.
    PubMed    


  567. WELLENS J, Colombel JF, Satsangi JJ, Wong SY, et al
    SARS-CoV-2 Vaccination in IBD: Past Lessons, Current Evidence, and Future Challenges.
    J Crohns Colitis. 2021;15:1376-1386.
    PubMed     Abstract available


  568. LOCHHEAD P, Khalili H, Sachs MC, Chan AT, et al
    Statin Use and Risk of Inflammatory Bowel Diseases: Authors' Reply.
    J Crohns Colitis. 2021;15:1403-1404.
    PubMed    


  569. TURSI A, Mocci G, Maconi G
    Effect of Ustekinumab on Extraintestinal Diseases in Refractory Crohn's Disease.
    J Crohns Colitis. 2021;15:1399-1400.
    PubMed    


  570. CARON B, D'Amico F, Danese S, Peyrin-Biroulet L, et al
    Endpoints for Perianal Crohn's Disease Trials: Past, Present and Future.
    J Crohns Colitis. 2021;15:1387-1398.
    PubMed     Abstract available


  571. ELLRICHMANN M, Bethge J, Boesenkoetter J, Conrad C, et al
    Subclinical Pulmonary Involvement in Active IBD Responds to Biologic Therapy.
    J Crohns Colitis. 2021;15:1339-1345.
    PubMed     Abstract available


  572. CAER C, Gorreja F, Forsskahl SK, Brynjolfsson SF, et al
    TREM-1+ Macrophages Define a Pathogenic Cell Subset in the Intestine of Crohn's Disease Patients.
    J Crohns Colitis. 2021;15:1346-1361.
    PubMed     Abstract available


  573. CAMBI MPC, Yamamoto T, Kotze PG
    Importance of Nutrition and Hypoalbuminaemia in Postoperative Morbidity in Crohn's Disease: Thinking Outside of the Box on Biologics as Single Risk Factors.
    J Crohns Colitis. 2021;15:1401-1402.
    PubMed    


  574. CHANG I, Park S, Lee HJ, Kim I, et al
    Interpretation of XIAP Variants of Uncertain Significance in Paediatric Patients with Refractory Crohn's Disease.
    J Crohns Colitis. 2021;15:1291-1304.
    PubMed     Abstract available


  575. PETERS V, Spooren CEGM, Pierik MJ, Weersma RK, et al
    Dietary Intake Pattern is Associated with Occurrence of Flares in IBD Patients.
    J Crohns Colitis. 2021;15:1305-1315.
    PubMed     Abstract available


    July 2021
  576. SEDANO R, Hogan M, Nguyen TM, Chang J, et al
    Systematic review and Meta-analysis: Clinical, Endoscopic, Histologic and Safety Placebo Rates in Induction and Maintenance trials of Ulcerative Colitis.
    J Crohns Colitis. 2021 Jul 26. pii: 6328606. doi: 10.1093.
    PubMed     Abstract available


  577. PARK SH, Im JP, Park H, Jeong SK, et al
    Clinical features and long-term outcomes of pediatric-onset inflammatory bowel disease in a population-based cohort in the Songpa-Kangdong district of Seoul, Korea.
    J Crohns Colitis. 2021 Jul 26. pii: 6328476. doi: 10.1093.
    PubMed     Abstract available


  578. BOSSUYT P, Pouillon L, Claeys S, D'Haens S, et al
    Ultra-proactive therapeutic drug monitoring of infliximab based on point-of-care-testing in inflammatory bowel disease: results of a pragmatic trial.
    J Crohns Colitis. 2021 Jul 23. pii: 6326544. doi: 10.1093.
    PubMed     Abstract available


  579. CHEE D, Nice R, Hamilton B, Jones E, et al
    Patient-led Remote IntraCapillary pharmacoKinetic Sampling (fingerPRICKS) for therapeutic drug monitoring in patients with inflammatory bowel disease.
    J Crohns Colitis. 2021 Jul 21. pii: 6325142. doi: 10.1093.
    PubMed     Abstract available


  580. DIEZ-OBRERO V, Moratalla-Navarro F, Ibanez-Sanz G, Guardiola J, et al
    Transcriptome-wide association study for inflammatory bowel disease reveals novel candidate susceptibility genes in specific colon subsites and tissue categories.
    J Crohns Colitis. 2021 Jul 21. pii: 6324884. doi: 10.1093.
    PubMed     Abstract available


  581. ZITTAN E, Steinhart AH, Aran H, Milgrom R, et al
    The Toronto Ibd Global Endoscopic Reporting (Tiger) Score: A Single, Easy To Use Endoscopic Score For Both Crohn's Disease And Ulcerative Colitis Patients.
    J Crohns Colitis. 2021 Jul 17. pii: 6323260. doi: 10.1093.
    PubMed     Abstract available


  582. DINALLO V, Di Fusco D, Di Grazia A, Laudisi F, et al
    The deubiquitinating enzyme OTUD5 sustains inflammatory cytokine response in inflammatory bowel disease.
    J Crohns Colitis. 2021 Jul 7. pii: 6316763. doi: 10.1093.
    PubMed     Abstract available


  583. CHOI WT, Salomao M, Zhao L, Alpert L, et al
    Hypermucinous, Goblet Cell Deficient, and Crypt Cell Dysplasias in Inflammatory Bowel Disease are Often Associated with Flat/Invisible Endoscopic Appearance and Advanced Neoplasia on Follow-Up.
    J Crohns Colitis. 2021 Jul 7. pii: 6316756. doi: 10.1093.
    PubMed     Abstract available


  584. DELISLE M, Wilkens R, Novak KL
    Keeping It Simple: Using Intestinal Ultrasound to Assess Ulcerative Colitis with a Novel UC-Ultrasound Index.
    J Crohns Colitis. 2021 Jul 5. pii: 6315708. doi: 10.1093.
    PubMed    


  585. RESTELLINI S, Lakatos PL
    Patient-Reported Outcomes in Inflammatory Bowel Diseases: Another Piece in the Puzzle.
    J Crohns Colitis. 2021;15:1085-1086.
    PubMed    


  586. GUPTA V, Mohsen W, Chapman TP, Satsangi J, et al
    Predicting Outcome in Acute Severe Colitis-Controversies in Clinical Practice in 2021.
    J Crohns Colitis. 2021;15:1211-1221.
    PubMed     Abstract available


  587. DAI C, Jiang M, Huang YH
    Association Between Statin Use and Inflammatory Bowel Diseases.
    J Crohns Colitis. 2021;15:1246.
    PubMed    


  588. ADAMINA M, Feakins R, Iacucci M, Spinelli A, et al
    ECCO Topical Review Optimising Reporting in Surgery, Endoscopy, and Histopathology.
    J Crohns Colitis. 2021;15:1089-1105.
    PubMed     Abstract available


  589. XU M, Shen Y, Cen M, Zhu Y, et al
    Modulation of the Gut Microbiota-farnesoid X Receptor Axis Improves Deoxycholic Acid-induced Intestinal Inflammation in Mice.
    J Crohns Colitis. 2021;15:1197-1210.
    PubMed     Abstract available


  590. LI XH, Feng ST, Cao QH, Coffey JC, et al
    Degree of Creeping Fat Assessed by Computed Tomography Enterography is Associated with Intestinal Fibrotic Stricture in Patients with Crohn's Disease: A Potentially Novel Mesenteric Creeping Fat Index.
    J Crohns Colitis. 2021;15:1161-1173.
    PubMed     Abstract available


  591. KIM PH, Kim SH, Cho YA, Yoon HM, et al
    Ability of Pelvic Magnetic Resonance Imaging to Predict Clinical Course of Perianal Fistula in Paediatric Crohn's Disease Patients.
    J Crohns Colitis. 2021;15:1152-1160.
    PubMed     Abstract available


  592. SHAH RS, Bachour S, Jia X, Holubar SD, et al
    Hypoalbuminaemia, Not Biologic Exposure, Is Associated with Postoperative Complications in Crohn's Disease Patients Undergoing Ileocolic Resection.
    J Crohns Colitis. 2021;15:1142-1151.
    PubMed     Abstract available


  593. POLETTI M, Arnauts K, Ferrante M, Korcsmaros T, et al
    Organoid-based Models to Study the Role of Host-microbiota Interactions in IBD.
    J Crohns Colitis. 2021;15:1222-1235.
    PubMed     Abstract available


  594. WONG ECL, Buffone E, Lee SJ, Dulai PS, et al
    End of Induction Patient-reported Outcomes Predict Clinical Remission but Not Endoscopic Remission in Crohn's Disease.
    J Crohns Colitis. 2021;15:1114-1119.
    PubMed     Abstract available


  595. COX SR, Clarke H, O'Keeffe M, Dubois P, et al
    Nutrient, fibre and FODMAP intakes and food-related quality of life in patients with inflammatory bowel disease and their relationship with gastrointestinal symptoms of differing aetiologies.
    J Crohns Colitis. 2021 Jul 3. pii: 6314229. doi: 10.1093.
    PubMed     Abstract available


    June 2021
  596. WATANABE S, Hibiya S, Katsukura N, Kitagawa S, et al
    Importance of telomere shortening in the pathogenesis of ulcerative colitis: A new treatment from the aspect of telomeres in intestinal epithelial cells.
    J Crohns Colitis. 2021 Jun 28. pii: 6310549. doi: 10.1093.
    PubMed     Abstract available


  597. GUBATAN J, Rubin SJS, Bai L, Haileselassie Y, et al
    Vitamin D is Associated with alpha4beta7+ Immunophenotypes and Predicts Vedolizumab Therapy Failure in Patients with Inflammatory Bowel Disease.
    J Crohns Colitis. 2021 Jun 28. pii: 6310486. doi: 10.1093.
    PubMed     Abstract available


  598. KUENZIG ME, Bitton A, Carroll MW, Kaplan GG, et al
    Inflammatory bowel disease increases the risk of venous thromboembolism in children: a population-based matched cohort study.
    J Crohns Colitis. 2021 Jun 27. pii: 6310166. doi: 10.1093.
    PubMed     Abstract available


  599. KIM PH, Yoon HM, Jung AY, Lee JS, et al
    Diagnostic Performance of Diffusion-weighted Imaging for Evaluation of Bowel Inflammation in Pediatric Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    J Crohns Colitis. 2021 Jun 22. pii: 6308099. doi: 10.1093.
    PubMed     Abstract available


  600. GILMORE R, Hilley P, Srinivasan A, Choy M, et al
    Sequential use of high-dose tofacitinib after infliximab salvage therapy in acute severe ulcerative colitis.
    J Crohns Colitis. 2021 Jun 22. pii: 6308093. doi: 10.1093.
    PubMed     Abstract available


  601. ABAKKOUY Y, Cleynen I
    The Promise of Polygenic Risk Scores as a Research Tool to Analyse the Genetics Underlying IBD Phenotypes.
    J Crohns Colitis. 2021;15:877-878.
    PubMed    


  602. ATTAUABI M, Seidelin JB, Burisch J
    Authors' Reply to: 'COVID-19 in the IBD Population: The Need for Correct Nomenclature'.
    J Crohns Colitis. 2021;15:1080.
    PubMed    


  603. STOCKER D, King MJ, El Homsi M, Carbonell G, et al
    Luminal Narrowing Alone Allows an Accurate Diagnosis of Crohn's Disease Small Bowel Strictures at Cross-Sectional Imaging.
    J Crohns Colitis. 2021;15:1009-1018.
    PubMed     Abstract available


  604. BUISSON A, Filippi J, Amiot A, Cadiot G, et al
    Defining and Assessing the Reproducibility of Crohn's Disease Endoscopic Lesions: A Delphi-like Method from the GETAID.
    J Crohns Colitis. 2021;15:1000-1008.
    PubMed     Abstract available


  605. SYAL G, Shemtov R, Bonthala N, Vasiliauskas EA, et al
    Pre-pouch Ileitis is Associated with Development of Crohn's Disease-like Complications and Pouch Failure.
    J Crohns Colitis. 2021;15:960-968.
    PubMed     Abstract available


  606. GIANOTTI RJ, Cheifetz AS
    Cannabis and Inflammatory Bowel Disease: All Smoke and Mirrors?
    J Crohns Colitis. 2021 Jun 17. pii: 6301791. doi: 10.1093.
    PubMed    


  607. JOHNSON AM, Harmsen WS, Aniwan S, Tremaine WJ, et al
    Prevalence and Impact of Obesity on Disease-Specific Outcomes in a Population-Based Cohort of Patients with Ulcerative Colitis.
    J Crohns Colitis. 2021 Jun 12. pii: 6297429. doi: 10.1093.
    PubMed     Abstract available


  608. PORTER RJ, Arends MJ, Churchhouse AMD, Din S, et al
    Inflammatory bowel disease-associated colorectal cancer: translational risks from mechanisms to medicines.
    J Crohns Colitis. 2021 Jun 10. pii: 6295922. doi: 10.1093.
    PubMed     Abstract available


  609. GHOSH S, Sanchez Gonzalez Y, Zhou W, Clark R, et al
    Upadacitinib Treatment Improves Symptoms of Bowel Urgency and Abdominal Pain, and Correlates With Quality of Life Improvements in Patients With Moderate to Severe Ulcerative Colitis.
    J Crohns Colitis. 2021 Jun 9. pii: 6295522. doi: 10.1093.
    PubMed     Abstract available


  610. HERNANDEZ-ROCHA C, Borowski K, Turpin W, Filice M, et al
    Integrative analysis of colonic biopsies from inflammatory bowel disease patients identifies an interaction between microbial bile-acid inducible gene abundance and human Angiopoietin-like 4 gene expression.
    J Crohns Colitis. 2021 Jun 2. pii: 6291049. doi: 10.1093.
    PubMed     Abstract available


    May 2021
  611. FUMERY M, Chatelain D
    Histological Scores in Inflammatory Bowel Disease: A New Kid in the Block.
    J Crohns Colitis. 2021 May 27. pii: 6286012. doi: 10.1093.
    PubMed    


  612. DHERI AK, Kuenzig ME, Mack DR, Murthy SK, et al
    Shifting health care use from hospitalizations and surgeries to outpatient visits in children with inflammatory bowel disease: a population-based cohort study from Ontario, Canada.
    J Crohns Colitis. 2021 May 21. pii: 6279878. doi: 10.1093.
    PubMed     Abstract available


  613. WEISSMAN S, Patel K, Kolli S, Lipcsey M, et al
    Obesity in Inflammatory Bowel Disease is Associated with Early Readmissions characterized by an Increased Systems and Patient-level Burden.
    J Crohns Colitis. 2021 May 17. pii: 6276891. doi: 10.1093.
    PubMed     Abstract available


  614. REZAZADEH ARDABILI A, Creemers RH, van Bodegraven AA
    COVID-19 in the IBD Population: The Need for Correct Nomenclature.
    J Crohns Colitis. 2021;15:872-873.
    PubMed    


  615. BERTE' R, Mazza S, Stefanucci MR, Noviello D, et al
    Seroprevalence of SARS-CoV2 in IBD Patients Treated with Biologic Therapy.
    J Crohns Colitis. 2021;15:864-868.
    PubMed     Abstract available


  616. REZAZADEH ARDABILI A, Hendrix EMB, Pierik MJ
    Remote Monitoring of Inflammatory Bowel Disease: What Kind of Patient-Reported Questionnaires Should We Use?
    J Crohns Colitis. 2021;15:869-870.
    PubMed    


  617. CROSBY S, Schuh MJ, Farraye FA
    Rechallenge with Subcutaneous Ustekinumab After Hypersensitivity Reaction to Intravenous Ustekinumab.
    J Crohns Colitis. 2021;15:871.
    PubMed    


  618. ASHTON JJ, Boukas K, Davies J, Stafford IS, et al
    Ileal Transcriptomic Analysis in Paediatric Crohn's Disease Reveals IL17- and NOD-signalling Expression Signatures in Treatment-naive Patients and Identifies Epithelial Cells Driving Differentially Expressed Genes.
    J Crohns Colitis. 2021;15:774-786.
    PubMed     Abstract available


  619. LOCHHEAD P, Khalili H, Sachs MC, Chan AT, et al
    Association Between Statin Use and Inflammatory Bowel Diseases: Results from a Swedish, Nationwide, Population-based Case-control Study.
    J Crohns Colitis. 2021;15:757-765.
    PubMed     Abstract available


  620. KLANG E, Grinman A, Soffer S, Margalit Yehuda R, et al
    Automated Detection of Crohn's Disease Intestinal Strictures on Capsule Endoscopy Images Using Deep Neural Networks.
    J Crohns Colitis. 2021;15:749-756.
    PubMed     Abstract available


  621. MOTTA JP, Palese S, Giorgio C, Chapman K, et al
    Increased Mucosal Thrombin is Associated with Crohn's Disease and Causes Inflammatory Damage through Protease-activated Receptors Activation.
    J Crohns Colitis. 2021;15:787-799.
    PubMed     Abstract available


  622. NELSON A, Stewart CJ, Kennedy NA, Lodge JK, et al
    The Impact of NOD2 Genetic Variants on the Gut Mycobiota in Crohn's Disease Patients in Remission and in Individuals Without Gastrointestinal Inflammation.
    J Crohns Colitis. 2021;15:800-812.
    PubMed     Abstract available


  623. MULLER M, D'Amico F, Bonovas S, Danese S, et al
    TNF Inhibitors and Risk of Malignancy in Patients with Inflammatory Bowel Diseases: A Systematic Review.
    J Crohns Colitis. 2021;15:840-859.
    PubMed     Abstract available


    April 2021
  624. VAN ERP LW, van Gerven J, Bloem S, Groenen MJM, et al
    Acceptance and perceived control are independently associated with quality of life in inflammatory bowel disease: Introduction of a new segmentation model.
    J Crohns Colitis. 2021 Apr 28. pii: 6257076. doi: 10.1093.
    PubMed     Abstract available


  625. STRAATMIJER T, Biemans VBC, Hoentjen F, de Boer NKH, et al
    Ustekinumab for Crohn's Disease: Two-Year Results of the Initiative on Crohn and Colitis (ICC) Registry, a Nationwide Prospective Observational Cohort Study.
    J Crohns Colitis. 2021 Apr 28. pii: 6256992. doi: 10.1093.
    PubMed     Abstract available


  626. OUAHED J, Kelsen JR, Spessott WA, Kooshesh K, et al
    Variants in STXBP3 Are Associated With Very Early Onset Inflammatory Bowel Disease, Bilateral Sensorineural Hearing Loss and Immune Dysregulation.
    J Crohns Colitis. 2021 Apr 23. pii: 6247960. doi: 10.1093.
    PubMed     Abstract available


  627. SLEIMAN J, Hitawala AA, Cohen B, Falloon K, et al
    Systematic review: Sweet syndrome associated with inflammatory bowel disease.
    J Crohns Colitis. 2021 Apr 23. pii: 6247949. doi: 10.1093.
    PubMed     Abstract available


  628. UNTERWEGER AL, Jensen MO, Giordanetto F, Jogini V, et al
    Suppressing Kv1.3 Ion Channel Activity with a Novel Small Molecule Inhibitor Ameliorates Inflammation in a Humanized Mouse Model of Ulcerative Colitis.
    J Crohns Colitis. 2021 Apr 23. pii: 6247959. doi: 10.1093.
    PubMed     Abstract available


  629. PANES J, Vermeire S, Dubinsky MC, Loftus EV, et al
    Efficacy and Safety of Tofacitinib Retreatment for Ulcerative Colitis After Treatment Interruption: Results From the OCTAVE Clinical Trials.
    J Crohns Colitis. 2021 Apr 22. pii: 6245086. doi: 10.1093.
    PubMed     Abstract available


  630. CHAPARRO M, Garre A, Iborra M, Sierra M, et al
    Effectiveness and safety of ustekinumab in ulcerative colitis: Real-world evidence from the ENEIDA registry.
    J Crohns Colitis. 2021 Apr 16. pii: 6228235. doi: 10.1093.
    PubMed     Abstract available


  631. JUNG S, Ye BD, Lee HS, Baek J, et al
    Identification of three novel susceptibility loci for inflammatory bowel disease in Koreans in an extended genome-wide association study.
    J Crohns Colitis. 2021 Apr 14. pii: 6225940. doi: 10.1093.
    PubMed     Abstract available


  632. FUMERY M, Yzet C, Chatelain D, Yzet T, et al
    Colonic strictures in inflammatory bowel disease: epidemiology, complications, and management.
    J Crohns Colitis. 2021 Apr 12. pii: 6222697. doi: 10.1093.
    PubMed     Abstract available


  633. ATTAR A, Branche J, Coron E, Privat J, et al
    An Anti-migration Self-expandable and Removable Metal Stent for Crohn's Disease Strictures: A Nationwide Study From GETAID and SFED.
    J Crohns Colitis. 2021;15:521-528.
    PubMed     Abstract available


  634. NOVAK KL, Nylund K, Maaser C, Petersen F, et al
    Expert Consensus on Optimal Acquisition and Development of the International Bowel Ultrasound Segmental Activity Score [IBUS-SAS]: A Reliability and Inter-rater Variability Study on Intestinal Ultrasonography in Crohn's Disease.
    J Crohns Colitis. 2021;15:609-616.
    PubMed     Abstract available


  635. ZHAO J, Wang H, Zhou J, Qian J, et al
    miR-130a-3p, a Preclinical Therapeutic Target for Crohn's Disease.
    J Crohns Colitis. 2021;15:647-664.
    PubMed     Abstract available


  636. DE VRIES LCS, Ghiboub M, van Hamersveld PHP, Welting O, et al
    Tyrosine Kinase 2 Signalling Drives Pathogenic T cells in Colitis.
    J Crohns Colitis. 2021;15:617-630.
    PubMed     Abstract available


  637. CON D, Parthasarathy N, Bishara M, Luber RP, et al
    Development of a Simple, Serum Biomarker-based Model Predictive of the Need for Early Biologic Therapy in Crohn's Disease.
    J Crohns Colitis. 2021;15:583-593.
    PubMed     Abstract available


  638. HUGOT JP, Dumay A, Barreau F, Meinzer U, et al
    Crohn's Disease: Is the Cold Chain Hypothesis Still Hot?
    J Crohns Colitis. 2021;15:678-686.
    PubMed     Abstract available


  639. LUND K, Larsen MD, Knudsen T, Kjeldsen J, et al
    Infliximab, Immunomodulators and Treatment Failures in Paediatric and Adolescent Patients with Crohn's Disease: a Nationwide Cohort Study.
    J Crohns Colitis. 2021;15:575-582.
    PubMed     Abstract available


  640. VERSTOCKT B, Pouillon L, Bossuyt P
    Tofacitinib and Subacute Pneumonitis: Don't Hold Your Breath.
    J Crohns Colitis. 2021;15:692-693.
    PubMed    


  641. RUTKA M, Pigniczki D, Molnar T
    Tofacitinib Therapy, the Lender of Last Resort.
    J Crohns Colitis. 2021;15:694.
    PubMed    


  642. D'AMICO F, Guillo L, Baumann C, Danese S, et al
    Histological disease activity measured by the Nancy index is associated with long-term outcomes in patients with ulcerative colitis.
    J Crohns Colitis. 2021 Apr 5. pii: 6211061. doi: 10.1093.
    PubMed     Abstract available


  643. NG A
    Clinical efficacy of tofacitinib in moderate to severe ulcerative colitis.
    J Crohns Colitis. 2021 Apr 5. pii: 6211060. doi: 10.1093.
    PubMed    


    March 2021
  644. BRESSLER B, Yarur A, Silverberg MS, Bassel M, et al
    Vedolizumab and Anti-TNFalpha Real-World Outcomes in Biologic-Naive Inflammatory Bowel Disease Patients: Results from the EVOLVE Study.
    J Crohns Colitis. 2021 Mar 31. pii: 6205394. doi: 10.1093.
    PubMed     Abstract available


  645. LANG-SCHWARZ C, Angeloni M, Agaimy A, Atreya R, et al
    Validation of the "Inflammatory Bowel Disease - Distribution, Chronicity, Activity (IBD-DCA) Score" for Ulcerative Colitis and Crohn s disease.
    J Crohns Colitis. 2021 Mar 27. pii: 6196021. doi: 10.1093.
    PubMed     Abstract available


  646. PALMIERI C, Muller G, Kroesen AJ, Galata C, et al
    Perianal fistula-associated carcinoma in Crohn s disease: a multicenter retrospective case control study.
    J Crohns Colitis. 2021 Mar 27. pii: 6189787. doi: 10.1093.
    PubMed     Abstract available


  647. NORSA L, Berni Canani R, Duclaux-Loras R, Bequet E, et al
    Inflammatory bowel disease in patients with congenital chloride diarrhoea.
    J Crohns Colitis. 2021 Mar 26. pii: 6189668. doi: 10.1093.
    PubMed     Abstract available


  648. RUDDY J, Taft T, Keszthelyi D
    Gut-Brain Interactions in patients with Inflammatory Bowel Disease (IBD) and the role of Hypnotherapy in Managing Symptoms.
    J Crohns Colitis. 2021 Mar 18. pii: 6175701. doi: 10.1093.
    PubMed    


  649. TORRES J, Halfvarson J, Rodriguez-Lago I, Hedin CRH, et al
    Results of the Seventh Scientific Workshop of ECCO: Precision medicine in IBD- prediction and prevention of inflammatory bowel disease.
    J Crohns Colitis. 2021 Mar 17. pii: 6175312. doi: 10.1093.
    PubMed     Abstract available


  650. KUCHARZIK T, Ellul P, Greuter T, Rahier JF, et al
    ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease.
    J Crohns Colitis. 2021 Mar 17. pii: 6175313. doi: 10.1093.
    PubMed    


  651. PIOVANI D, Pansieri C, Kotha SRR, Piazza AC, et al
    Ethnic Differences in the Smoking-Related Risk of Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    J Crohns Colitis. 2021 Mar 15. pii: 6171987. doi: 10.1093.
    PubMed     Abstract available


  652. VERSTOCKT B, Verstockt S, Abdu Rahiman S, Ke BJ, et al
    Intestinal Receptor of SARS-CoV-2 in Inflamed IBD Tissue Seems Downregulated by HNF4A in Ileum and Upregulated by Interferon Regulating Factors in Colon.
    J Crohns Colitis. 2021;15:485-498.
    PubMed     Abstract available


  653. COLLARD MK, Benoist S, Maggiori L, Zerbib P, et al
    A Reappraisal of Outcome of Elective Surgery After Successful Non-Operative Management of an Intra-Abdominal Abscess Complicating Ileocolonic Crohn's Disease: A Subgroup Analysis of a Nationwide Prospective Cohort.
    J Crohns Colitis. 2021;15:409-418.
    PubMed     Abstract available


  654. RICCIUTO A, Mack DR, Huynh HQ, Jacobson K, et al
    Diagnostic Delay Is Associated With Complicated Disease and Growth Impairment in Paediatric Crohn's Disease.
    J Crohns Colitis. 2021;15:419-431.
    PubMed     Abstract available


  655. MOREAU J, Hammoudi N, Marthey L, Trang-Poisson C, et al
    Impact of an Education Programme on IBD Patients' Skills: Results of a Randomised Controlled Multicentre Study [ECIPE].
    J Crohns Colitis. 2021;15:432-440.
    PubMed     Abstract available


  656. NARULA N, Wong ECL, Dulai PS, Marshall JK, et al
    Week 6 Calprotectin Best Predicts Likelihood of Long-term Endoscopic Healing in Crohn's Disease: A Post-hoc Analysis of the UNITI/IM-UNITI Trials.
    J Crohns Colitis. 2021;15:462-470.
    PubMed     Abstract available


  657. BARELLO S, Guida E, Bonanomi A, Menichetti J, et al
    WE-CARE IBD SCORE: Assessing High-quality Care From the Perspective of Patients With Inflammatory Bowel Disease.
    J Crohns Colitis. 2021;15:349-357.
    PubMed     Abstract available


  658. WINTJENS D, Bergey F, Saccenti E, Jeuring S, et al
    Disease Activity Patterns of Crohn's Disease in the First Ten Years After Diagnosis in the Population-based IBD South Limburg Cohort.
    J Crohns Colitis. 2021;15:391-400.
    PubMed     Abstract available


  659. FOURIE S, Norton C, Jackson D, Czuber-Dochan W, et al
    'These discussions aren't happening'. Experiences of people living with inflammatory bowel disease talking about sexual well-being with healthcare professionals.
    J Crohns Colitis. 2021 Mar 4. pii: 6158978. doi: 10.1093.
    PubMed     Abstract available


  660. PAI RK, Hartman DJ, Leighton JA, Shabana PF, et al
    Validated Indices for Histopathologic Activity Predict Development of Colorectal Neoplasia in Ulcerative Colitis.
    J Crohns Colitis. 2021 Mar 4. pii: 6158975. doi: 10.1093.
    PubMed     Abstract available


  661. ATREYA R, Neurath MF
    Can Serum Proteomic Profiling Annunciate Individual Disease Progression in Newly Diagnosed Inflammatory Bowel Disease Patients?
    J Crohns Colitis. 2021 Mar 2. pii: 6156783. doi: 10.1093.
    PubMed    


    February 2021
  662. LUDVIGSSON JF, Olen O, Larsson H, Halfvarson J, et al
    Association between inflammatory bowel disease and psychiatric morbidity and suicide: A Swedish nationwide population-based cohort study with sibling comparisons.
    J Crohns Colitis. 2021 Feb 26. pii: 6153473. doi: 10.1093.
    PubMed     Abstract available


  663. GUILLO L, Peyrin-Biroulet L, Louis E
    Tofacitinib De-escalation Strategy in Ulcerative Colitis: Is It the End of the Story?
    J Crohns Colitis. 2021 Feb 23. pii: 6146725. doi: 10.1093.
    PubMed    


  664. ALLIN KH, Jacobsen RK, Ungaro RC, Colombel JF, et al
    Bariatric surgery and risk of new-onset inflammatory bowel disease: A nationwide cohort study.
    J Crohns Colitis. 2021 Feb 20. pii: 6145790. doi: 10.1093.
    PubMed     Abstract available


  665. GOETGEBUER RL, Kreijne JE, Aitken CA, Dijkstra G, et al
    Increased risk of high-grade cervical neoplasia in women with inflammatory bowel disease: a case-controlled cohort study.
    J Crohns Colitis. 2021 Feb 20. pii: 6145789. doi: 10.1093.
    PubMed     Abstract available


  666. REINISCH W, Sandborn WJ, Danese S, Hebuterne X, et al
    Long-term safety and efficacy of the anti-MAdCAM-1 monoclonal antibody ontamalimab (SHP647) for the treatment of ulcerative colitis: the open-label study TURANDOT II.
    J Crohns Colitis. 2021 Feb 18. pii: 6144575. doi: 10.1093.
    PubMed     Abstract available


  667. ARAKI T, Mitsuyama K, Yamasaki H, Morita M, et al
    Therapeutic Potential of a Self-Assembling Peptide Hydrogel to Treat Colonic Injuries Associated with Inflammatory Bowel Disease.
    J Crohns Colitis. 2021 Feb 17. pii: 6141509. doi: 10.1093.
    PubMed     Abstract available


  668. ACKERMANN M, Mucci A, McCabe A, Frei S, et al
    Restored macrophage function ameliorates disease pathophysiology in a mouse model for IL10 receptor deficient very early onset inflammatory bowel disease.
    J Crohns Colitis. 2021 Feb 17. pii: 6141466. doi: 10.1093.
    PubMed     Abstract available


  669. WATANABE S, Nishimura R, Shirasaki T, Katsukura N, et al
    Schlafen 11 is a novel target for mucosal regeneration in Ulcerative Colitis.
    J Crohns Colitis. 2021 Feb 17. pii: 6141476. doi: 10.1093.
    PubMed     Abstract available


  670. ZHAO M, Gonczi L, Lakatos PL, Burisch J, et al
    The burden of inflammatory bowel disease in Europe in 2020.
    J Crohns Colitis. 2021 Feb 14. pii: 6134782. doi: 10.1093.
    PubMed     Abstract available


  671. BARNES EL, Holubar SD, Herfarth HH
    Systematic Review and Meta-Analysis of Outcomes after Ileal Pouch-Anal Anastomosis in Primary Sclerosing Cholangitis-Ulcerative Colitis.
    J Crohns Colitis. 2021 Feb 5. pii: 6129144. doi: 10.1093.
    PubMed     Abstract available


  672. GHOSH S, Iacucci M
    Measuring Patient Experience in Inflammatory Bowel Disease Care: A Key Component of Continuous Quality Improvement.
    J Crohns Colitis. 2021 Feb 5. pii: 6129099. doi: 10.1093.
    PubMed    


    January 2021
  673. RUIGROK RAAA, Collij V, Sureda P, Klaassen MAY, et al
    The composition and metabolic potential of the human small intestinal microbiota within the context of inflammatory bowel disease.
    J Crohns Colitis. 2021 Jan 30. pii: 6123997. doi: 10.1093.
    PubMed     Abstract available


  674. GRIM C, Noble R, Uribe G, Khanipov K, et al
    Impairment of tissue resident mesenchymal stem cells in chronic ulcerative colitis and Crohn's disease.
    J Crohns Colitis. 2021 Jan 28. pii: 6121690. doi: 10.1093.
    PubMed     Abstract available


  675. ALLOCCA M, Bonovas S, Danese S
    Letter to the Editor Intestinal Ultrasound to Assess Disease Activity in Ulcerative Colitis: Development of a novel UC-Ultrasound index.
    J Crohns Colitis. 2021 Jan 25. pii: 6119566. doi: 10.1093.
    PubMed    


  676. LOVE BL, Finney CJ, Gaidos JKJ
    Effectiveness of Conjugate and Polysaccharide Pneumococcal Vaccines for Prevention of Severe Pneumococcal Disease Among Inflammatory Bowel Disease Patients.
    J Crohns Colitis. 2021 Jan 25. pii: 6118663. doi: 10.1093.
    PubMed     Abstract available


  677. VERMEIRE S, Chiorean M, Panes J, Peyrin-Biroulet L, et al
    Long-term Safety and Efficacy of Etrasimod for Ulcerative Colitis: Results from the Open-label Extension of the OASIS Study.
    J Crohns Colitis. 2021 Jan 21. pii: 6105062. doi: 10.1093.
    PubMed     Abstract available


  678. ZAIATZ BITTENCOURT V, Jones F, Tosetto M, Doherty GA, et al
    Dysregulation of metabolic pathways in circulating natural killer cells isolated from inflammatory bowel disease patients.
    J Crohns Colitis. 2021 Jan 18. pii: 6103919. doi: 10.1093.
    PubMed     Abstract available


  679. SANDBORN WJ, Feagan BG, Hanauer S, Vermeire S, et al
    Long-Term Efficacy And Safety Of Ozanimod In Moderate-To-Severe Ulcerative Colitis: Results From The Open-Label Extension Of The Randomized, Phase 2 Touchstone Study.
    J Crohns Colitis. 2021 Jan 13. pii: 6092404. doi: 10.1093.
    PubMed     Abstract available


  680. EFFENBERGER M, Reider S, Waschina S, Bronowski C, et al
    Microbial Butyrate Synthesis Indicates Therapeutic Efficacy of Azathioprine in IBD Patients.
    J Crohns Colitis. 2021;15:88-98.
    PubMed     Abstract available


  681. LEE S, Kuenzig ME, Ricciuto A, Zhang Z, et al
    Smoking May Reduce the Effectiveness of Anti-TNF Therapies to Induce Clinical Response and Remission in Crohn's Disease: A Systematic Review and Meta-analysis.
    J Crohns Colitis. 2021;15:74-87.
    PubMed     Abstract available


  682. THOMAS PWA, Ferwerda G, West RL, Hoentjen F, et al
    Immediate Infusion Reaction to Intravenous Ustekinumab in Three Crohn's Disease Patients: A Case Report and Review of the Literature.
    J Crohns Colitis. 2021;15:162-164.
    PubMed     Abstract available


  683. WEWER MD, Zhao M, Nordholm-Carstensen A, Weimers P, et al
    The Incidence and Disease Course of Perianal Crohn's Disease: A Danish Nationwide Cohort Study, 1997-2015.
    J Crohns Colitis. 2021;15:5-13.
    PubMed     Abstract available


  684. DE CAMPOS RJDS, Lucchetti G, Lucchetti ALG, Chebli LA, et al
    Influence of Religiousness and Spirituality on Remission Rate, Mental Health, and Quality of Life of Patients With Active Crohn's Disease: A Longitudinal 2-Year Follow-up Study.
    J Crohns Colitis. 2021;15:55-63.
    PubMed     Abstract available


  685. ZOLLNER A, Schmiderer A, Reider SJ, Oberhuber G, et al
    Faecal Biomarkers in Inflammatory Bowel Diseases: Calprotectin Versus Lipocalin-2-a Comparative Study.
    J Crohns Colitis. 2021;15:43-54.
    PubMed     Abstract available


  686. SAEVIK F, Eriksen R, Eide GE, Gilja OH, et al
    Development and Validation of a Simple Ultrasound Activity Score for Crohn's Disease.
    J Crohns Colitis. 2021;15:115-124.
    PubMed     Abstract available


  687. D'AMICO F, Nancey S, Danese S, Peyrin-Biroulet L, et al
    A Practical Guide for Faecal Calprotectin Measurement: Myths and Realities.
    J Crohns Colitis. 2021;15:152-161.
    PubMed     Abstract available


  688. KUCHARZIK T, Maaser C, Maconi G
    A Simple Intestinal Ultrasound Score in Crohn's Disease: First Big Step Towards New Paradigms.
    J Crohns Colitis. 2021;15:3-4.
    PubMed    


  689. MAASER C, Kucharzik T, Gecse K
    Is Intestinal Ultrasound Ready to be Used as Standard Monitoring Tool in Daily Practice and as Endpoint in Clinical Trials?
    J Crohns Colitis. 2021;15:1-2.
    PubMed    


  690. DAI C, Jiang M, Huang YH
    Anti-Tubercular Therapy on the Long-Term Disease Course of Patients with Crohn's disease.
    J Crohns Colitis. 2021;15:169.
    PubMed    


  691. BARBERIO B, Segal JP, Quraishi MN, Black CJ, et al
    Efficacy of Oral, Topical, or Combined Oral and Topical 5-Aminosalicylates, in Ulcerative Colitis: Systematic Review and Network Meta-Analysis.
    J Crohns Colitis. 2021 Jan 12. pii: 6089122. doi: 10.1093.
    PubMed     Abstract available


  692. DE VOOGD F, Wilkens R, Gecse K, Allocca M, et al
    A reliability study - strong inter-observer agreement of an expert panel for intestinal ultrasound in ulcerative colitis.
    J Crohns Colitis. 2021 Jan 9. pii: 6073674. doi: 10.1093.
    PubMed     Abstract available


  693. BOTS S, Nylund K, Lowenberg M, Gecse K, et al
    Intestinal Ultrasound to Assess Disease Activity in Ulcerative Colitis: Development of a novel UC-Ultrasound index.
    J Crohns Colitis. 2021 Jan 7. pii: 6067606. doi: 10.1093.
    PubMed     Abstract available


    December 2020
  694. VAN DER SLOOT KWJ, Voskuil MD, Blokzijl T, Dinkla A, et al
    Isotype specific antibody responses to Mycobacterium Avium subspecies Paratuberculosis antigens are associated with the use of biological therapy in Inflammatory Bowel Disease.
    J Crohns Colitis. 2020 Dec 30. pii: 6055607. doi: 10.1093.
    PubMed     Abstract available


  695. GUILLO L, D'Amico F, Danese S, Peyrin-Biroulet L, et al
    Ustekinumab for extra-intestinal manifestations of inflammatory bowel disease: a systematic literature review.
    J Crohns Colitis. 2020 Dec 24. pii: 6046385. doi: 10.1093.
    PubMed     Abstract available


  696. CROUWEL F, Waaijenberg-Warmenhoven P, Buiter HJC, de Boer NK, et al
    Recurrent COVID-19 in a patient with ulcerative colitis on vedolizumab therapy.
    J Crohns Colitis. 2020 Dec 22. pii: 6044002. doi: 10.1093.
    PubMed    


  697. RAHMI G, Coron E, Perrod G, Levy M, et al
    Probe-based confocal laser endomicroscopy for in vivo assessment of histological healing in ulcerative colitis: development and validation of the ENHANCE index.
    J Crohns Colitis. 2020 Dec 18. pii: 6041240. doi: 10.1093.
    PubMed     Abstract available


  698. BANCIL AS, Sandall AM, Rossi M, Chassaing B, et al
    Food additive emulsifiers and their impact on gut microbiome, permeability and inflammation: mechanistic insights in inflammatory bowel disease.
    J Crohns Colitis. 2020 Dec 18. pii: 6041235. doi: 10.1093.
    PubMed     Abstract available


  699. VENTIN-HOLMBERG R, Eberl A, Saqib S, Korpela K, et al
    Bacterial and fungal profiles as markers of infliximab drug response in inflammatory bowel disease.
    J Crohns Colitis. 2020 Dec 10. pii: 6029424. doi: 10.1093.
    PubMed     Abstract available


  700. VERMEIRE S, Su C, Lawendy N, Kobayashi T, et al
    Outcomes of Tofacitinib Dose Reduction in Patients with Ulcerative Colitis in Stable Remission from the Randomized RIVETING Trial.
    J Crohns Colitis. 2020 Dec 8. pii: 6027842. doi: 10.1093.
    PubMed     Abstract available


  701. MONSTAD IL, Solberg IC, Cvancarova M, Hovde O, et al
    Outcome of Ulcerative Colitis 20 Years after Diagnosis in a Prospective Population-based Inception Cohort from South-Eastern Norway, the IBSEN Study.
    J Crohns Colitis. 2020 Dec 2. pii: 6015889. doi: 10.1093.
    PubMed     Abstract available


    November 2020
  702. JOHNSON LE, Lee MJ, Turner-Moore T, Grinsted Tate LR, et al
    Systematic review of factors affecting transition readiness skills in patients with inflammatory bowel disease.
    J Crohns Colitis. 2020 Nov 30. pii: 6012510. doi: 10.1093.
    PubMed     Abstract available


  703. HAMAMA-RAZ Y, Nativ S, Hamama L
    Posttraumatic Growth in Inflammatory Bowel Disease Patients: The Role of Illness Cognitions and Physical Quality in Life.
    J Crohns Colitis. 2020 Nov 30. pii: 6012764. doi: 10.1093.
    PubMed     Abstract available


  704. TADBIRI S, Nachury M, Bouhnik Y, Serrero M, et al
    The IBD-disk is a reliable tool to assess the daily-life burden of patients with inflammatory bowel disease.
    J Crohns Colitis. 2020 Nov 27. pii: 6007776. doi: 10.1093.
    PubMed     Abstract available


  705. WINTHROP KL, Loftus EV Jr, Baumgart DC, Reinisch W, et al
    Tofacitinib for the Treatment of Ulcerative Colitis: Analysis of Infection Rates from the Ulcerative Colitis Clinical Programme.
    J Crohns Colitis. 2020 Nov 27. pii: 6007683. doi: 10.1093.
    PubMed     Abstract available


  706. VAN DEN BERGHE N, Verstockt B, Gils A, Sabino J, et al
    Tissue exposure does not explain non-response in ulcerative colitis patients with adequate serum vedolizumab concentrations.
    J Crohns Colitis. 2020 Nov 27. pii: 6007493. doi: 10.1093.
    PubMed     Abstract available


  707. EVERHOV AH, Bruze G, Soderling J, Askling J, et al
    Women's earnings are more affected by inflammatory bowel disease than men's: a register-based Swedish cohort study.
    J Crohns Colitis. 2020 Nov 27. pii: 6007494. doi: 10.1093.
    PubMed     Abstract available


  708. HOEKMAN DR, Vlieger AM, Stokkers PC, Mahhmod N, et al
    Hypnotherapy for irritable bowel syndrome-type symptoms in patients with quiescent inflammatory bowel disease: a randomized, controlled trial.
    J Crohns Colitis. 2020 Nov 27. pii: 6007495. doi: 10.1093.
    PubMed     Abstract available


  709. AGRAWAL M, Brenner EJ, Zhang X, Colombel JF, et al
    Physician practice patterns on holding inflammatory bowel disease medications due to COVID-19 in the SECURE-IBD registry.
    J Crohns Colitis. 2020 Nov 24. pii: 6000079. doi: 10.1093.
    PubMed     Abstract available


  710. TRAN-MINH ML, Gornet JM, Maillet M, Houze P, et al
    Safety of hydrocortisone premedication discontinuation in patients with inflammatory bowel disease on maintenance therapy with Infliximab: a prospective clinical and pharmacological study.
    J Crohns Colitis. 2020 Nov 18. pii: 5986749. doi: 10.1093.
    PubMed     Abstract available


  711. KALLA R, Adams AT, Bergemalm D, Vatn S, et al
    Serum proteomic profiling at diagnosis predicts clinical course, and need for intensification of treatment in inflammatory bowel disease.
    J Crohns Colitis. 2020 Nov 17. pii: 5985635. doi: 10.1093.
    PubMed     Abstract available


  712. GALLAGHER K, Catesson A, Griffin JL, Holmes E, et al
    Metabolomic Analysis in Inflammatory Bowel Disease: A Systematic Review.
    J Crohns Colitis. 2020 Nov 11. pii: 5974408. doi: 10.1093.
    PubMed     Abstract available


  713. KIM MA, Kim YH, Chun J, Lee HS, et al
    The influence of disease activity on pregnancy outcomes in women with inflammatory bowel disease: A systematic review and meta-analysis.
    J Crohns Colitis. 2020 Nov 11. pii: 5974276. doi: 10.1093.
    PubMed     Abstract available


  714. BARBERIO B, Black CJ, Savarino EV, Ford AC, et al
    Ciclosporin or Infliximab as Rescue Therapy in Acute Glucorticosteroid-refractory Ulcerative Colitis: Systematic Review and Network Meta-Analysis.
    J Crohns Colitis. 2020 Nov 11. pii: 5974124. doi: 10.1093.
    PubMed     Abstract available


  715. SEBASTIAN S, Gonzalez HA, Peyrin-Biroulet L
    Safety of Drugs During Previous and Current Coronavirus Pandemics: Lessons for Inflammatory Bowel Disease.
    J Crohns Colitis. 2020;14:1632-1643.
    PubMed     Abstract available


  716. TURSI A, Papa A
    Impact of Anti-TNFalpha Antibodies on the Risk of Covid-19 and its Severity in Patients with Inflammatory Bowel Diseases.
    J Crohns Colitis. 2020;14:1646-1647.
    PubMed    


  717. VOSKUIL MD, Spekhorst LM, van der Sloot KWJ, Jansen BH, et al
    Genetic risk scores identify genetic aetiology of inflammatory bowel disease phenotypes.
    J Crohns Colitis. 2020 Nov 6. pii: 5957220. doi: 10.1093.
    PubMed     Abstract available


  718. YOKOYAMA Y, Sawada K, Aoyama N, Yoshimura N, et al
    Erratum to: Efficacy of Granulocyte and Monocyte Adsorptive Apheresis in Patients With Inflammatory Bowel Disease Showing Lost Response to Infliximab.
    J Crohns Colitis. 2020 Nov 6. pii: 5958727. doi: 10.1093.
    PubMed    


    October 2020
  719. MAHMOUD R, van Lieshout C, Frederix GWJ, Jharap B, et al
    Continuation of anti-TNF in patients with Ulcerative Colitis in Remission is not Cost-effective compared to Treatment Withdrawal: a Markov Model.
    J Crohns Colitis. 2020 Oct 30. pii: 5944009. doi: 10.1093.
    PubMed     Abstract available


  720. SIEGEL CA, Christensen B, Kornbluth A, Rosh JR, et al
    Guidance for Restarting Inflammatory Bowel Disease Therapy in Patients Who Withheld Immunosuppressant Medications During COVID-19.
    J Crohns Colitis. 2020;14.
    PubMed     Abstract available


  721. LEWIN S, Lees C, Regueiro M, Hart A, et al
    International Organization for the Study of Inflammatory Bowel Disease: Global Strategies for Telemedicine and Inflammatory Bowel Diseases.
    J Crohns Colitis. 2020;14.
    PubMed     Abstract available


  722. DE LIMA-KARAGIANNIS A, Juillerat P, Sebastian S, Pedersen N, et al
    Management of Pregnant Inflammatory Bowel Disease Patients During the COVID-19 Pandemic.
    J Crohns Colitis. 2020;14.
    PubMed     Abstract available


  723. ABREU MT, Peyrin-Biroulet L
    Providing Guidance During a Global Viral Pandemic for the Care of Patients With Inflammatory Bowel Disease.
    J Crohns Colitis. 2020;14.
    PubMed    


  724. NG SC, Mak JWY, Hitz L, Chowers Y, et al
    COVID-19 Pandemic: Which IBD Patients Need to Be Scoped-Who Gets Scoped Now, Who Can Wait, and how to Resume to Normal.
    J Crohns Colitis. 2020;14.
    PubMed     Abstract available


  725. DOTAN I, Panaccione R, Kaplan GG, O'Morain C, et al
    Best Practice Guidance for Adult Infusion Centres during the COVID-19 Pandemic: Report from the COVID-19 International Organization for the Study of IBD [IOIBD] Task Force.
    J Crohns Colitis. 2020;14.
    PubMed     Abstract available


  726. ALLEZ M, Fleshner P, Gearry R, Lakatos PL, et al
    Care of the Patient With IBD Requiring Hospitalisation During the COVID-19 Pandemic.
    J Crohns Colitis. 2020;14.
    PubMed     Abstract available


  727. QURAISHI MN, Iqbal TH, Hart AL
    Precision Medicine with FMT for Ulcerative Colitis: Are We There Yet?
    J Crohns Colitis. 2020 Oct 20. pii: 5932516. doi: 10.1093.
    PubMed    


  728. DERIKX LAAP, Lantinga MA, de Jong DJ, van Dop WA, et al
    Clinical Outcomes of Covid-19 in Patients with Inflammatory Bowel Disease: A Nationwide Cohort Study.
    J Crohns Colitis. 2020 Oct 20. pii: 5932316. doi: 10.1093.
    PubMed     Abstract available


  729. BOSSUYT P, Bisschops R, Vermeire S, De Hertogh G, et al
    Variability in the distribution of histological disease activity in the colon of patients with ulcerative colitis.
    J Crohns Colitis. 2020 Oct 14. pii: 5923369. doi: 10.1093.
    PubMed     Abstract available


  730. ATTAUABI M, Poulsen A, Theede K, Pedersen N, et al
    Prevalence and outcomes of COVID-19 among patients with inflammatory bowel disease - A Danish prospective population-based cohort study.
    J Crohns Colitis. 2020 Oct 9. pii: 5920382. doi: 10.1093.
    PubMed     Abstract available


  731. ALOI M, Bramuzzo M, Norsa L, Arrigo S, et al
    Disease activity patterns in the first 5 years after diagnosis in children with ulcerative colitis: a population-based study.
    J Crohns Colitis. 2020 Oct 6. pii: 5918427. doi: 10.1093.
    PubMed     Abstract available


    September 2020
  732. MEREDITH J, Khedim CA, Henderson P, Wilson DC, et al
    Paediatric Inflammatory Multisystem Syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in a patient receiving Infliximab therapy for Inflammatory Bowel Disease.
    J Crohns Colitis. 2020 Sep 30. pii: 5913452. doi: 10.1093.
    PubMed     Abstract available


  733. ARHI C, Askari A, Nachiappan S, Bottle A, et al
    Stage at diagnosis and survival of colorectal cancer with or without underlying inflammatory bowel disease: a population-based study.
    J Crohns Colitis. 2020 Sep 29. pii: 5912977. doi: 10.1093.
    PubMed     Abstract available


    June 2020
  734. D'AMICO F, Baumann C, Rousseau H, Danese S, et al
    Phase I, II and III Trials in Inflammatory Bowel Diseases: A Practical Guide for the Non-specialist.
    J Crohns Colitis. 2020;14:710-718.
    PubMed     Abstract available


  735. SOMERS M, Bossuyt P, Ferrante M, Peeters H, et al
    Belgian IBD Research Group [BIRD] Position Statement 2019 on the Use of Adalimumab Biosimilars in Inflammatory Bowel Diseases.
    J Crohns Colitis. 2020;14:680-685.
    PubMed     Abstract available


  736. VON MARTELS JZH, Bourgonje AR, Klaassen MAY, Alkhalifah HAA, et al
    Riboflavin Supplementation in Patients with Crohn's Disease [the RISE-UP study].
    J Crohns Colitis. 2020;14:595-607.
    PubMed     Abstract available


  737. FAUNY M, D'Amico F, Bonovas S, Netter P, et al
    Faecal Calprotectin for the Diagnosis of Bowel Inflammation in Patients With Rheumatological Diseases: A Systematic Review.
    J Crohns Colitis. 2020;14:688-693.
    PubMed     Abstract available


  738. ZHOU C, Wu XR, Liu HS, Liu XH, et al
    Immunomodulatory Effect of Urine-derived Stem Cells on Inflammatory Bowel Diseases via Downregulating Th1/Th17 Immune Responses in a PGE2-dependent Manner.
    J Crohns Colitis. 2020;14:654-668.
    PubMed     Abstract available


  739. VALE RODRIGUES R, Sladek M, Katsanos K, van der Woude CJ, et al
    Diagnosis and Outcome of Oesophageal Crohn's Disease.
    J Crohns Colitis. 2020;14:624-629.
    PubMed     Abstract available


  740. AL NABHANI Z, Berrebi D, Martinez-Vinson C, Montcuquet N, et al
    Nod2 Protects the Gut From Experimental Colitis Spreading to Small Intestine.
    J Crohns Colitis. 2020;14:669-679.
    PubMed     Abstract available


  741. ZHAO M, Burisch J
    The Sooner the Better? Cost-effectiveness of Early Biological Therapy in Patients With Crohn's Disease.
    J Crohns Colitis. 2020;14:573-574.
    PubMed    


  742. EDER P, Dobrowolska A, Rydzewska G
    Historical Upheavals and Eponyms in Crohn's Disease-Is There Any Relation?
    J Crohns Colitis. 2020;14:719.
    PubMed    


    May 2020
  743. NEHRA AK, Sheedy SP, Wells ML, VanBuren WM, et al
    Imaging Findings of Ileal Inflammation at Computed Tomography and Magnetic Resonance Enterography: What do They Mean When Ileoscopy and Biopsy are Negative?
    J Crohns Colitis. 2020;14:455-464.
    PubMed     Abstract available


  744. DANIELOU M, Sarter H, Pariente B, Fumery M, et al
    Natural History of Perianal Fistulising Lesions in Patients With Elderly-onset Crohn's Disease: A Population-based Study.
    J Crohns Colitis. 2020;14:501-507.
    PubMed     Abstract available


  745. PILLAI N, Lupatsch JE, Dusheiko M, Schwenkglenks M, et al
    Evaluating the Cost-Effectiveness of Early Compared with Late or No Biologic Treatment to Manage Crohn's Disease using Real-World Data.
    J Crohns Colitis. 2020;14:490-500.
    PubMed     Abstract available


  746. CONDAMINA M, Diaz E, Jamart C, Loget J, et al
    Severe Attack of Henoch-Schonlein Purpura With Neurological Involvement During Adalimumab Treatment for Crohn's Disease.
    J Crohns Colitis. 2020;14:538-542.
    PubMed     Abstract available


  747. SPARROW MP, Papamichael K, Ward MG, Riviere P, et al
    Therapeutic Drug Monitoring of Biologics During Induction to Prevent Primary Non-Response.
    J Crohns Colitis. 2020;14:542-556.
    PubMed     Abstract available


  748. RODRIGUEZ-LAGO I, Gisbert JP
    The Role of Immunomodulators and Biologics in the Medical Management of Stricturing Crohn's Disease.
    J Crohns Colitis. 2020;14:557-566.
    PubMed     Abstract available


  749. DHALIWAL J, Walters TD, Mack DR, Huynh HQ, et al
    Phenotypic Variation in Paediatric Inflammatory Bowel Disease by Age: A Multicentre Prospective Inception Cohort Study of the Canadian Children IBD Network.
    J Crohns Colitis. 2020;14:445-454.
    PubMed     Abstract available


  750. MADARAME A, Kimura H, Kunisaki R
    Successful Treatment With Ustekinumab for Enterocutaneous Fistulas in Crohn's Disease.
    J Crohns Colitis. 2020;14:569-570.
    PubMed    


  751. CHATEAU T, Angioi K, Peyrin-Biroulet L
    Two Cases of Successful Ustekinumab Treatment for Non-infectious Uveitis Associated With Crohn's Disease.
    J Crohns Colitis. 2020;14:571.
    PubMed    


    March 2020
  752. ANNESE V
    Small Bowel Adenocarcinoma in Crohn's Disease: An Underestimated Risk?
    J Crohns Colitis. 2020;14:285-286.
    PubMed    


  753. CARBONNEL F, Svrcek M
    Progress in the Molecular and Histological Dissection of Crohn's Disease-associated Small Bowel Adenocarcinomas.
    J Crohns Colitis. 2020;14:283-284.
    PubMed    


  754. DELATTRE C, Lewis A, Kirchgesner J, Nion-Larmurier I, et al
    Impact of Aphthous Colitis at Diagnosis on Crohn's Disease Outcomes.
    J Crohns Colitis. 2020;14:342-350.
    PubMed     Abstract available


  755. FELWICK RK, Dingley GJR, Martinez-Nunez R, Sanchez-Elsner T, et al
    MicroRNA23a Overexpression in Crohn's Disease Targets Tumour Necrosis Factor Alpha Inhibitor Protein 3, Increasing Sensitivity to TNF and Modifying the Epithelial Barrier.
    J Crohns Colitis. 2020;14:381-392.
    PubMed     Abstract available


  756. FIELDS AC, Hu FY, Lu P, Irani J, et al
    Small Bowel Adenocarcinoma: Is There a Difference in Survival for Crohn's Versus Sporadic Cases?
    J Crohns Colitis. 2020;14:303-308.
    PubMed     Abstract available


  757. BORREN NZ, Tan W, Colizzo FP, Luther J, et al
    Longitudinal Trajectory of Fatigue With Initiation of Biologic Therapy in Inflammatory Bowel Diseases: A Prospective Cohort Study.
    J Crohns Colitis. 2020;14:309-315.
    PubMed     Abstract available


  758. PIOVANI D, Danese S, Peyrin-Biroulet L, Bonovas S, et al
    Environmental, Nutritional, and Socioeconomic Determinants of IBD Incidence: A Global Ecological Study.
    J Crohns Colitis. 2020;14:323-331.
    PubMed     Abstract available


  759. FRANZE E, Monteleone I, Laudisi F, Rizzo A, et al
    Cadherin-11 Is a Regulator of Intestinal Fibrosis.
    J Crohns Colitis. 2020;14:406-417.
    PubMed     Abstract available


  760. VERSTOCKT B, Mertens E, Dreesen E, Outtier A, et al
    Influence of Drug Exposure on Vedolizumab-Induced Endoscopic Remission in Anti-Tumour Necrosis Factor [TNF] Naive and Anti-TNF Exposed IBD Patients.
    J Crohns Colitis. 2020;14:332-341.
    PubMed     Abstract available


  761. POREDSKA K, Kunovsky L, Marek F, Kala Z, et al
    The Influence of Microscopic Inflammation at Resection Margins on Early Postoperative Endoscopic Recurrence After Ileocaecal Resection for Crohn's Disease.
    J Crohns Colitis. 2020;14:361-368.
    PubMed     Abstract available


  762. ARPA G, Grillo F, Giuffrida P, Nesi G, et al
    Separation of Low- Versus High-grade Crohn's Disease-associated Small Bowel Carcinomas is Improved by Invasive Front Prognostic Marker Analysis.
    J Crohns Colitis. 2020;14:295-302.
    PubMed     Abstract available


  763. PELLINO G, Vinci D, Signoriello G, Kontovounisios C, et al
    Long-Term Bowel Function and Fate of the Ileal Pouch After Restorative Proctocolectomy in Patients With Crohn's Disease: A Systematic Review With Meta-Analysis and Metaregression.
    J Crohns Colitis. 2020;14:418-427.
    PubMed     Abstract available


  764. LIAO X, Li G, McBride R, Houldsworth J, et al
    Clinicopathological and Molecular Characterisation of Crohn's Disease-associated Small Bowel Adenocarcinomas.
    J Crohns Colitis. 2020;14:287-294.
    PubMed     Abstract available


    February 2020
  765. ADAMINA M, Bonovas S, Raine T, Spinelli A, et al
    ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical Treatment.
    J Crohns Colitis. 2020;14:155-168.
    PubMed     Abstract available


  766. MAGRO F, Lopes J, Borralho P, Lopes S, et al
    Comparing the Continuous Geboes Score With the Robarts Histopathology Index: Definitions of Histological Remission and Response and their Relation to Faecal Calprotectin Levels.
    J Crohns Colitis. 2020;14:169-175.
    PubMed     Abstract available


  767. WASMANN KA
    Complications While Waiting for IBD Surgery-Short Report.
    J Crohns Colitis. 2020;14:277-280.
    PubMed     Abstract available


  768. KEITA AV, Alkaissi LY, Holm EB, Heil SDS, et al
    Enhanced E. coli LF82 Translocation through the Follicle-associated Epithelium in Crohn's Disease is Dependent on Long Polar Fimbriae and CEACAM6 expression, and Increases Paracellular Permeability.
    J Crohns Colitis. 2020;14:216-229.
    PubMed     Abstract available


  769. AGRAWAL M, Burisch J, Colombel JF, C Shah S, et al
    Viewpoint: Inflammatory Bowel Diseases Among Immigrants From Low- to High-Incidence Countries: Opportunities and Considerations.
    J Crohns Colitis. 2020;14:267-273.
    PubMed     Abstract available


  770. PIERRE N, Salee C, Massot C, Bletard N, et al
    Proteomics Highlights Common and Distinct Pathophysiological Processes Associated with Ileal and Colonic Ulcers in Crohn's Disease.
    J Crohns Colitis. 2020;14:205-215.
    PubMed     Abstract available


  771. COSTA-MOREIRA P, Lopes S, Santos AL, Pedrosa AF, et al
    Leukocytoclastic Vasculitis Related to Ustekinumab in a Crohn's Disease Patient: First Case Report and Literature Review.
    J Crohns Colitis. 2020;14:274-276.
    PubMed     Abstract available


    January 2020
  772. TORRES J, Bonovas S, Doherty G, Kucharzik T, et al
    ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment.
    J Crohns Colitis. 2020;14:4-22.
    PubMed    


  773. TRAVIS S
    IM-UNITI at Three Years: Stellar Stelara(R) or Stardust? The Efficacy, Safety, and Immunogenicity of Ustekinumab Treatment of Crohn's Disease.
    J Crohns Colitis. 2020;14:1-3.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.